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Abstract 
 
A series of novel fluorinated lanthanide complexes has been synthesised for use as 
responsive probes for 
19
F MRS and MRI. The careful positioning of the CF3 group 
within 6.5 Å from the metal ion caused the fluorine longitudinal and transversal 
relaxation rates to be strongly enhanced. This allows faster MR signal acquisition, 
reducing the sample concentration and acquisition time required to obtain the 
desired signal intensity. The lanthanide ion also enhanced the chemical shift 
sensitivity of the fluorine nucleus to changes in the chemical environment. These 
characteristics have been exploited to develop responsive probes. 
A series of pH reporters containing an aromatic mono-amide arm has been prepared 
and their pH sensitivity assessed. Deprotonation of the amide proton caused a large 
variation of the 
19
F chemical shift. The pKa of the probe was modulated by varying 
the substituents on the aromatic group and an optimal value of 7.1 was obtained with 
an ortho cyano substituent. The introduction of phosphinate pendant arms allowed 
narrower linewidths and faster longitudinal relaxation rates to be achieved. 
The spectroscopic properties and the conformational isomerism of the same series of 
complexes have been analysed. In particular, their 
19
F NMR chemical shift, 
relaxation properties and 
1
H relaxivity characteristics were studied. 
A series of complexes bearing different ester functional groups was prepared and 
their ability as reporters for enzymatic activity assessed. PLE and -chymotripsin 
recognised the substrate and catalysed its transformation. Modification of the probe 
structure was revealed by variation of the relative signal intensity of the substrate 
and product fluorine resonances in the 
19
F NMR spectrum.  
Glycol chitosan conjugates with paramagnetic fluorinated complexes were prepared 
and their NMR properties assessed. In vivo MRI studies in animal models were 
undertaken and a selective uptake of the contrast agent in the tumour was observed 
with the Gd analogue. 
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Chapter 1 
 
Introduction 
 
1.1  
19
F as a probe nucleus for magnetic resonance 
spectroscopy   and imaging 
Magnetic resonance imaging (MRI) is recognised as one of the most important 
diagnostic tools in clinical practice
1,2
. MRI is a non-invasive, radiation-free 
technique, with an excellent (sub-millimetre) spatial resolution. Conventional 
proton-based images offer detailed anatomic information for thorough analysis of 
physiological processes and tissue morphology. Additional information is provided 
with the use of contrast agents (CA). Traditionally, these are paramagnetic Gd(III) 
complexes
3
 and super-paramagnetic iron oxide particles
4
, which highlight different 
tissues of the body selectively, affecting the longitudinal or transverse relaxation 
time of the nearby water protons. Nevertheless, the intense background of the water 
signal causes insufficient discrimination between normal and tumour tissues and 
complicates the detection of metabolites other than water because of the relative 
signal intensity. Hence, heteronuclear magnetic resonance has been investigated
5
. 
The most promising nucleus is 
19
F, which has a nuclear spin, I = ½, and a 100% 
natural abundance, being the only stable isotope of fluorine. The high NMR 
sensitivity of 
19
F, 0.83 relative to 
1
H, gives a strong NMR signal and the 
gyromagnetic ratio (γ) of 40.05 MHz/T (only 6 % lower than 1H) allows spectral or 
image acquisition on the existing instrumentation used for 
1
H NMR by appropriately 
tuning the RF coil.  
Fluorine atoms are present in low concentration in the body, mostly in the form of 
solid salts in the bones and teeth. The transverse relaxation time, T2, of endogenous 
fluorine is extremely short, causing the resulting signal to be below the NMR 
detection limit. When an exogenous fluorine-containing compound is administered, 
it can be monitored without interference from background signals
6
. The contrast is 
therefore a direct observation of the fluorine probe in which the signal to noise ratio 
is only due to the local concentration of the probe. Moreover, the proton MR image 
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can be acquired together with the image reporting the 
19
F-signal, identifying the 
spatial localisation of the probe, giving additional diagnostic information. 
The 
19
F chemical shift range covers more than 300 parts per million (ppm), 
compared to 10 ppm for protons, and shows a particular sensitivity to variations in 
the chemical microenvironment. These characteristics essentially guarantee 
chemical shift non-equivalence between different fluorinated signals and allow the 
examination of multiple agents simultaneously. Other than chemical shift and 
relative chemical shift changes, many parameters, as for proton NMR, can be 
interrogated, such as signal intensity (quantitative response), scalar coupling, 
chemical exchange, longitudinal relaxation rate, R1, and transverse relaxation rate, 
R2. These provide a pool of potential information but can also complicate the 
planning for an optimal experiment. 
The potential of 
19
F NMR has prompted the development of various fluorinated 
probes, aided also by the recent technological advancements in NMR instruments. 
Many common drugs contain a fluorine atom and are suitable to be investigated by 
magnetic resonance to follow metabolic and pharmacokinetic processes
7
. Fluorine 
can also be used to visualise anatomical characteristics when added as a simple 
tracking label, as in the case of angiography when the fluorinated probe is confined 
in the circulatory system
8
, or it can be accurately placed in a 
19
F-reporter agent 
designed to investigate various parameters of interest such as pH, gene activity, 
metal ion concentrations, oxygen tension, hypoxia, vascular flow and volume
9
. 
Finally bimodal 
1
H/
19
F imaging coils allow the use of dual probes. 
Therefore, fluorine is an attractive nucleus for study in MR spectroscopy and 
imaging applications. Furthermore, there is a great deal of interest in 
18
F-labeled 
probes used in Positron Emission Tomography (PET)
10,11
, but they will not be 
considered here. 
 
1.2  Fluorinated probes 
There is a wide range of fluorinated molecules used in magnetic resonance with 
different applications. They can be divided in three categories: 
- passive agents: which reveal anatomical properties without themselves 
experiencing any alteration; 
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- responsive agents: which undergo noticeable modification after interaction 
with the local environment; 
- fluorinated drugs: whose metabolism and pharmacokinetics can be followed 
by NMR. 
Each is considered in more detail below. 
  
1.2.1 Passive agents 
Passive agents are fluorinated molecules that give an indication of tissue or organ 
properties without any particular interaction, except for occupying a particular space 
or region in vivo, such as the lungs or blood vessels. Their spatial and temporal 
distributions are followed by means of their MR signal. 
Examples of such inert fluorinated compounds are perfluorocarbons. They are 
biologically inert and present high gas solubility and a great ability in carrying 
oxygen and carbon dioxide. Due to these characteristics they have been accepted as 
synthetic blood substitutes in emulsion form. As liquids, they have been used to 
support respiration in mice and cats, as demonstrated in the famous experiment of 
Clark and Gollan, in which mice breathing oxygen-saturated liquid perfluorocarbon 
(4 hours at 18°C) survived for several weeks
12
. Partial liquid ventilation in animal 
models (pigs in this example) enabled the monitoring of lung filling extension, using 
19
F MRI, and the evaluation of the regional oxygen partial pressure (pO2) 
distribution, measuring the fluorine T1 relaxation, thanks to the linear variation of 
the fluorine T1 of perfluorocarbons with pO2
13
. 
Due to the stress that can be induced by ventilation of liquid, inert fluorinated gases 
have also been studied, such as CF4, C2F6 and SF6. The last one in particular has 
been successfully used in rat models for lung imaging
14
 (Fig. 1.1) and in subsequent 
work to measure lung volume during the entire respiratory cycle. This allowed the 
discrimination between healthy subjects and emphysema-induced rats which showed 
greater lung volume and reduced expiratory flow rate, in a similar manner to humans 
with obstructive pulmonary diseases
15
. Fluorinated gases present extremely short 
relaxation times (typically T1 = 5.9 ± 0.2 ms for SF6) which require specialised 
instrumentation, so they have tended to be replaced by hyperpolarised gases such as 
xenon and helium despite their high cost of preparation. 
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Fig. 1.1 
19
F MRI of SF6 in the lungs of a large rat. Frames, from top left to bottom right 
are successive planes of the image from chest to back (Figure taken from reference 
6
). 
 
Perfluorooctylbromide (PFOB, 1) and perfluorononane 2 have been applied as 
contrast agents for gastrointestinal imaging. In clinical trials, an improved definition 
of bowel MR images at 0.38, 1.0, 1.5 T has been observed upon ingestion of PFOB 
without image artefacts or side effects, and the efficacy was independent of pulse 
sequence and magnetic field strength
16
. Perfluorononane has been employed in mice 
to obtain a three-dimensional reconstruction of the entire GI tract at 282 MHz, based 
on the 
19
F images of the intraluminal perfluorocarbon signal. Applying a frequency-
selective sequence, the terminal CF3 groups (T1 = 1692 ± 132 ms, T2 = 645 ± 15 ms 
in vivo) gave a strong positive contrast after saturation of the unwanted CF2 
resonances
17
 (Fig. 1.2). 
 
F F
F F
F F
F F
F F
F F
F F
F
F
F
F
F
F
Br
F F
F F
F F
F F
F F
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F
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1 2  
 
Intravenous emulsions of PFCs are retained for long periods (hours) in the 
vasculature and have been used both for angiography imaging
8
 and to measure 
vascular volume and tumour blood volume
6
. 
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Fig. 1.2 
19
F-MR images at 282 MHz of the GI tract of a mouse obtained after 0.3 ml 
meals of perfluorononane administered every 30 min over 2.5 h. A) Acquired 
immediately after the last meal. B) obtained after a period of 1 h. C-D) Cartoons 
describing the intestine 3D- arrangement corresponding to A and B. L, left-hand side; 
S, stomach; D, duodenum; SI, small intestine; C, cecum; Cn, colon (Figure taken from 
reference 
17
). 
 
Recent interest has grown around the application of perfluorocarbons for MRI cell 
tracking. Conventionally, cell labelling employed super-paramagnetic iron oxide 
particles to produce negative contrast (darkening) in 
1
H-based images. However, 
with this method it is often difficult to discriminate labelled cells from the 
background image. The use of fluorinated markers allows selective identification of 
the labelled cells (positive contrast, i.e. brightening) without endogenous 
background signal, and proton MR images acquired in the same imaging session 
provide anatomical localisation. Several examples have been recently published; 
Partlow et al. employed perfluorooctylbromide (PFOB) 1 and perfluoro-15-crown-5-
ether (15C5) 3 nanoparticles as fluorinated tags for stem cells. These cells, harvested 
from human umbilical cord blood and grown under pro-endothelial conditions, 
promptly internalised the particles while maintaining their functionality. Six million 
ex vivo labelled cells were injected intravenously in tumour-bearing mice and 
allowed to migrate for 5 days, then localised by 
19
F MRI (11.7 T research and 1.5 T 
clinic scanners) in the tumour vasculature. The homing ability of labelled cells to 
neovasculature is the sign of their maintained functionality in vivo
18
.  
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Different publications have described the application of perfluoropolyether (PFPE) 4 
to visualise a specific cell population. It has multiple signals in the 
19
F NMR but in 
vivo only the OCF2 resonance is observed, the others being below the detection 
limit. Ahrens’ group showed the early homing of diabetogenic T cells to the 
pancreas in diabetic mice, an established model of type 1 diabetes. This is one of the 
earliest events in the pathogenesis course and is asymptomatic, because it occurs 
before the destruction of the insulin-producing  cells of the islet of Langerhans. 
Therefore, early detection of this lymphoid cell infiltration would be of great benefit. 
A computational algorithm provided cell counting showing that approximately 2% 
of transferred cells reached the pancreas after 48 hours
19
 (Fig. 1.3). 
 
 
Fig. 1.3 In vivo MR images through the torso of a nonobese diabetic (NOD) mouse. a) 
Image of PFPE-labelled T cells transferred intraperitoneally (i.p.) 48 h prior. The image 
shows specific T cells (color) homing to the pancreas (P) (
19
F reference capillary (R), 
spleen (S), liver (L)). b) Negative control: mouse received cell-free PFPE nanoparticles 
in PBS at an equivalent fluorine dose of labelled T cells. PFPE detected only near the 
gut (G). c) Negative control: mouse received activated, labelled MHC mismatched T 
cells. No detect signal in the pancreas. Cells can be seen near the kidney (K) (Figure 
taken from reference 
19
). 
 
Other studies utilised dendritic cells (DC) which have a central role in the immune 
response and offer a wide range of medical applications i.e. cancer therapy, 
autoimmunity and organ transplantation research. Mature human DC have been 
labelled ex vivo with PFPE and inoculated into mice. After 18 hours, 5% of the cells 
reached the lymph node region. As a control, immature DC have also been injected 
which weren’t observed to leave the injection site20. PFPE has also been covalently 
conjugated to common fluorescent dyes to allow dual mode detection of labelled T 
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cells. The MRI images can be successively confirmed by fluorescence microscopy 
on biopsied tissues. The linear correlation between the intracellular fluorescence and 
19
F signal can be utilised to calibrate the in vitro cell loading of the MR agent
21
. A 
different example has been proposed by Maki et al. in which the linear cationic 
polymer (non perfluorinated) poly-L-lysine-CF3 5 has been linked through the amino 
group to fluorescein isothiocyanate. This allows the labelled stem cells of bone and 
cartilage to be detected via MRI and fluorescence imaging, following transplantation 
in the cranial bone of mice. The MR signal decreased with time and was visible for 7 
days (single signal at F = -59.3 ppm, 7 T)
22
.  
 
H
N
H
H
N
N
H
O
O
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NH2 NH2
OH
O n
O
CF3
O
OH
O
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Perfluorocarbons are non-toxic compounds, chemically stable and well tolerated in 
vivo. Despite these advantages they present some drawbacks such as multiple 
resonances that reduce sensitivity and long longitudinal relaxation rates (T1) which 
increase the time of image acquisition. In attempts to increase the signal intensity 
recent interest has grown around fluorinated polymers. They present the possibility 
of introducing a large number of fluorinated groups and also of functioning as 
delivery platforms for conjugated therapeutic agents. In fact, high molecular weight 
molecules can be passively targeted to the tumour periphery exploiting the enhanced 
permeability and retention (EPR) effect. Peng et al. synthesised block copolymers 
consisting of hydrophilic blocks of poly-acrylic acid and hydrophobic blocks of n-
butyl acrylate copolymerised with partially fluorinated acrylate or methacrylate. 
They spontaneously formed micelles in water/DMF mixture, in which the fluorine 
was in the core of the particle and showed a single peak in 
19
F NMR (2.5 wt% 
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polymer, 7 T, 310 K). The acrylate based polymers 6 were more stable after dialysis 
in water, had shorter T1 (511 ms vs 676 ms for methacrylate) and gave better images 
compared to the methacrylate analogue, thanks to the greater chain flexibility
23
. T2 is 
particularly influenced by local motion: if the fluorine nucleus is constrained, it 
shows a faster spin-spin relaxation compared to a less-static environment and this 
causes a signal broadening leading to loss of signal intensity. To increase the 
19
F 
mobility, the same group prepared fluorinated polyelectrolytes 7, in order to exploit 
the electrostatic repulsion between charged monomer units. They found longer T2 
values upon increasing charge density
24
.  
 
O O
CF3
OHO OO
a b c
O O
CF3
OO
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a b
hydrophilic
block
OO
N
c
hydrophobic block
I
or
cationic monomers
fluorine
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6 7
 
Hyperbranched polymers have also been studied. Du et al. prepared an example with 
a hydrophobic core and a copolymeric shell made of a fluorinated monomer and 
hydrophilic acrylic acid. They form micelles in water that have a single signal in the 
fluorine spectrum with linewidth of 130 Hz, T1 of 500 ms and T2 of 50 ms. A good 
signal is obtained but only after a long acquisition time (1 mg/ml, 13 hours, phantom 
imaging, 11.7 T)
25
. Hyperbranched fluorinated polymers can also be functionalised, 
as demonstrated in the work of Thurecht et al. where mannose has been conjugated 
to the polymer 8 and recognised by mannose-binding lectins which are important in 
the immune response. Good images of the parent non-functionalised polymer 
micelles were recorded in vivo in less than 10 minutes, with a concentration of 20 
mg/ml (16.4 T, T1 = 480 ms, T2 = 88 ms)
26
.  
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A different approach exploited bispherical symmetry to incorporate up to 27 fluorine 
atoms in a molecule 9 which contain one fluorine rich part that gives a single strong 
NMR signal, and a hydrophilic part which ensures the water solubility of the 
macromolecule (T1 = 163 ms at 11.7 T)
27
. Preliminary work was performed with 
polylysines and dextrans modified with fluorinated groups such as trifluoroacetyl, 
yielding a single 
19
F signal with good sensitivity
28
. 
 
O N
O
N
O
N
O
(F3C)3CO
(F3C)3CO
(F3C)3CO
CHONH(CH2CH2O)4H
CHONH(CH2CH2O)4H
CHONH(CH2CH2O)4H
CHONH(CH2CH2O)4H
fluorine
containing part
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9  
 
The fluorine nucleus can also be added as a simple label to different molecules, in 
order to make them visible in 
19
F NMR and allow the tracking of the conjugate. One 
example is the labelling of biomolecules, as in the case of 4-perfluoro-tert-butyl-
phenyliodoacetamide (PFP) 10. This has been coupled to the sulfhydryl groups of 
actin. The sharp 
19
F NMR signals of monomeric actin (located between F = 13.5 
and 13.8 ppm, 308 K, 470.5 MHz) gradually disappeared during the polymerization 
of the protein. The presence of nine equivalent fluorine atoms in the probe allows 
the detection of the labelled conjugate at low concentrations (1 µM for 1 h 
acquisition time) and can be potentially applied to track other biomolecules, such as 
antibodies
29
. 
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One interesting application is the detection of -amyloid plaques in vivo, using 
amyloidophilic compounds such as FSB 11. The formation of senile plaques of 
amyloid  peptide is one of the earliest signs of Alzheimer’s disease. Hence, an 
early diagnosis would allow preventive treatment of the patients before irreversible 
neurodegeneration. When FSB is administered intravenously in mice (20 mg/kg), it 
crosses the blood-brain barrier and targets the -amyloid plaques with high 
specificity. The 
19
F imaging results were successively confirmed by fluorescence 
experiments on brain sections of the sacrificed animals
30
. Modifications of the 
parent structure have also been proposed with addition of fluorine atoms on the 
central aromatic ring or CF3 group on the lateral ones, producing stronger NMR 
signals and increased binding affinities but reduced solubility
31
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1.2.2 Responsive agents 
Responsive agents are fluorinated probes precisely designed to respond through a 
change in 
19
F chemical shift or signal intensity, to a particular parameter such as pH, 
enzyme and gene activity, hypoxia or ion concentration. The response can lead to an 
irreversible modification of the probe structure - as in the case of enzymes 
recognising the probe as a substrate. Alternatively, a reversible change may occur - 
as for metal ion binding or pH variation. 
 
1.2.2.1 Gene transfection reporters 
Gene therapy has emerged as a potential strategy for the treatment of various 
diseases, but its development has been hindered by the lack of a non-invasive 
method to prove the quality of transfection.
 19
F NMR may be an effective technique 
for the detection of transgene expression in target tissues, as suggested in the study 
of gene-directed enzyme prodrug therapy, focussed on the cytosine deaminase (CD) 
gene. 
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CD is a microbial enzyme that transforms the low-toxicity pro-drug 5-fluorocytosine 
(5-FC) 12, into the active chemotherapeutic agent 5-fluorouracil (5-FU) 13. CD is 
not expressed in human cells; hence the selective localisation of the CD gene to the 
target tumour can impart local conversion of 5-FU production, reducing the toxicity 
related to its systemic administration. The enzyme-catalysed activation of 
transfected cells was revealed in vivo by a 
19
F chemical shift change of about 1.5 
ppm, proving the gene activity (F = -48.5 ppm 5-FC, F = -49.6 ppm 5-FU relative 
to NaF at 7 T), utilising human carcinoma xenografts tumour model in mice 
tranfected with yeast CD. The temporal profile of the fluorine spectrum obtained 
from the tumour (Fig. 1.4) was used to follow the metabolism of 5-FC and the 
presence of anabolism products such as FNuc, which is responsible for the 
antitumoral activity. Localised production of 5-FU in the tumour was confirmed by 
control spectra in muscle tissues, where only 5-FC was found
32
.  
 
 
Fig. 1.4 
19
F NMR spectra over time monitoring the changes of 5-FC in a subcutaneous 
tumour expressing yeast CD. Start 20 min after i.p. administration of 1g/kg 5-FC. 20-
min interval for each spectrum (Figure taken from reference 
32
). 
 
The most popular reporter gene employed to prove transfection efficacy is the 
bacterial LacZ gene that encodes the enzyme β-galactosidase. Mason and coworkers 
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developed a fluorinated arylgalactopyranoside prototype (PFONPG) 14, which acts 
as an effective substrate for the enzyme. 4-Fluoro-2-nitrophenyl-β-D-
galactopyranoside has a single sharp 
19
F NMR signal at F = -42.7 ppm (relative to 
NaTFA), which is invariant to pH (in the range 1 to 11) and temperature (25-37°C). 
It is stable in blood but in the presence of the enzyme or transfected cells that 
express β-galactosidase, undergoes hydrolysis of the glycosidic bond causing the 
release of the phenolic product. Upon cleavage, a chemical shift difference of more 
than 3.6 ppm at pH 7.4 is observed in solution. The same behaviour is recorded also 
when applied to whole blood or prostate cancer cells. The signal of the released 
aglycone fluoro-nitrophenol exhibits a pH sensitive response in a range of 9.3 ppm 
with a pKa of 6.85. This may prove to be useful in measuring the pH at the site of 
enzyme activity
33
.  
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A series of analogues has been synthesised in order to reduce the high toxicity of the 
prototype, with differences in chemical shift between the substrate and the product 
from a minimum of 3.6 ppm at pH 7.4, ranging from 1.6 to 12.9 ppm depending on 
the pH, with pKa values in the range 5.4-9.8 and different sensitivities to 
hydrolysis
34
. Introduction of CF3 groups as a replacement for mono-fluoro 
substituents yielded a higher signal intensity (1.1 mg, 3 mmol against 2.87 mg, 9 
mmol of PFONPG) but the chemical shift changes were smaller (F = 1.1 ppm) and 
the aqueous solubility lower
35
. Further work based on the less toxic 2-fluoro-4-
nitrophenol analogue (F = -55 ppm) reported 
19
F chemical shift imaging (CSI) 
studies of the -galactosidase-catalysed reaction in transfected cancer cell lines, in 
which the conversion was detected by the decrease of the substrate image intensity 
and the concurrent increase of the product signal (4-6 ppm chemical shift 
difference)
36
. The same experiment was also performed on prostate tumour 
xenografts in mice, after intratumoral injection of 50 l solution of the substrate (3.9 
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mg in water/DMSO, 4.7 T), with positive results obtained with 
19
F MRS but 
insufficient signal intensity for in vivo 
19
F CSI
37
.  
 
1.2.2.2 pH indicators 
Because of the exquisite sensitivity of the 
19
F NMR chemical shift towards changes 
in the microenvironment, many fluorinated pH indicators have been exploited. 
When the exchange between protonated and non-protonated forms is fast on the 
NMR time scale, a single 
19
F signal is observed. Under slow-exchange conditions, 
the acid and base forms produce two distinct signals that can be detected at the same 
time. Fluorinated amino acids were one of the first examples of fluorinated pH 
probes; they have been employed successfully for pH measurement of intracellular 
compartments. For example, human peripheral blood lymphocytes have been 
investigated with D-L-2-amino-3,3-difluoro-2-methylpropanoic acid (F2MeAla) 15. 
The fluorinated amino acid is internalised in the cells, with greater efficiency if 
administered in the liphophilic methyl ester form that is hydrolysed by endogenous 
esterases to the desired free acid. The chemical shift difference between the 
diastereotopic fluorines varies with pH. The fluorine signal appears as a quartet and 
the centre-line separation is pH sensitive due to the protonation equilibrium of the -
amino group (pKa = 7.3). This permits the measurement of the intracellular pH at 
25-30°C. When incubated with blood lymphocytes, two sets of signals appear, 
showing the presence of intra- and extra-cellular species, after equilibration through 
the membrane. Spectra were recorded at different values of external pH, 
demonstrating the presence of a regulatory mechanism in the lymphocytes that 
maintains the internal pH constant: with external pH values from 6.8 to 7.4 the 
internal pH was kept at 7.17 ± 0.06 while, outside this interval, it started changing 
accordingly to the ambient values. This system can lead to complex spectra, due to 
overlapping of intra- and extra-cellular resonances from both ester and acid species, 
and the splitting of the peaks produces an internal reference but also reduces signal 
intensity. Furthermore, a small chemical shift range is observed (≤ 2 ppm)38. 
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Better sensitivity to pH is expressed by fluorinated derivatives of vitamin B6, such as 
6-FPOL (2-fluoro-5-hydroxy-6-methyl-3,4-pyridinedimethanol) 16. It presents a 
single 
19
F signal (linewidth = 20 Hz at 282.3 MHz) with a chemical shift change 
between protonated and deprotonated forms of 9.8 ppm, that is independent of the 
presence of metal ions or variation in temperature (27-45°C). The basic pKa of 8.2 
can be exploited for interrogating alkaline conditions, but is too high for analysis of 
the normal physiological environment (6.5-7.5). Upon addition to whole blood, two 
resonances were observed immediately, reporting the intra- (i) and extra-cellular (e) 
species which corresponded to pHi = 7.19 and pHe = 7.45 (T1i = 0.87 s, T1e = 1.21 s). 
The rapid cell uptake probably exploits the natural transport of the vitamin
39
.  
Perfused rat hearts have been used as whole organ model for investigating alkalosis 
conditions. The addition of 6-FPOL to the perfusate (3.6 mM), gave rise to two 
resonances at F = -10.6 ppm (linewidth = 160 Hz) and F = -11.5 ppm (linewidth = 
120 Hz) representing pHi = 7.11 and pHe = 7.60 at 376 MHz. NaTFA was used as 
internal standard. Induced metabolic alkalosis and acidosis didn’t show significant 
change of pHi, while during respiratory alkalosis, an increase of pHe was 
accompanied by a simultaneous rise in pHi, which returned to normal values under 
physiological conditions
40
. The deprotonation equilibrium of the phenolic group in 
position 3 is responsible for the pH sensitivity of the probe. Therefore, introduction 
of electron withdrawing or donating groups in the meta and/or para positions could 
shift the pKa to the range of interest. A series of analogues has been synthesised, 
each presenting a single resonance and shifts ranging between 7.4 and 12.1 ppm. 
The 4-aminomethyl derivative, 6-FPAM 17, maintained the positive characteristics 
of the parent molecule 6-FPOL, but possessed a more suitable pKa of 7.05 and a 
greater chemical shift difference between intra- and extracellular resonances (F 
2.2 ppm) compared to 6-FPOL (F1.1 ppm) thereby improving resolution. An 
internal reference has been provided by introducing a CF3 group in the structure 18 
which produced an additional signal insensitive to pH, but the increased 
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liphophilicity of this analogue relegated the probe to the extracellular 
compartment
41
.  
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In order to exploit the enhanced vascular retention and tissue targeting imparted by 
polymeric carriers, conjugation of the pH indicator with polyaminodextran, 
polylysine and albumin has been attempted. The polymers have been attached 
through the aldehyde group in position 4 of the 6-FPAL 19 analogue, to obtain a 
macromolecule that exhibits a single 
19
F signal in each case, with a chemical shift 
sensitivity of 10.3-10.9 ppm and a more acidic pKa range (5.9-6.8). Thus, the 
polymer didn’t disturb the pH sensitivity of the probe, but caused line broadening 
(55 Hz compared to 22 Hz of 6-FPAL, 282.3 MHz) and when analysed in whole 
blood only the extracellular peak was detected, indicating a lack of cell 
penetration
42
.  
Another class of pH indicators is represented by fluoro-substituted aniline 
derivatives. The presence of a fluorine atom in the aromatic ring lowers the pKa of 
the amino group. A series of analogues has been explored, obtaining single 
resonances with good sensitivity (acid-base difference 5-15 ppm) and a range of pKa 
between 1 and 6. Further modification produced the candidate molecule N,N-
(methyl-2-carboxyisopropyl)-4-fluoroaniline 20, which retained a considerable 
chemical shift change of 12 ppm and a pKa of 6.8, suitable for in vivo evaluations. 
Line broadening due to chemical exchange between conjugated acid and base was 
observed around the aniline pKa value
43
. Similar probes have been based on N-
ethylaminophenol 21, these show chemical shift changes of 11 ppm and pKa values 
of about 6.8. Introduction of a second fluorine whose shift is insensitive to pH 
variations acts as internal chemical shift reference
44
. 
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An interesting approach is represented by the use of pH sensitive fluorinated 
nanosized particles that can accumulate in solid tumours through exploiting the EPR 
effect. PEGylated nanogels have been utilised for monitoring pH values between 6.5 
and 7.0, typical of tumour tissues, with a particular on-off regulation of the 
19
F 
signal. The probe is composed of a pH sensitive polyamine gel core cross-linked 
with CF3-containing groups, and an external shell formed by PEG chains carrying an 
acetal group for conjugating ligands of interest (Fig. 1.5).  
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Fig. 1.5 Schematic representation of the pH sensitive PEGylated nanogels. 
 
The internal matrix can undergo variation in size (swelling/shrinking) according to 
the environmental pH, due to the protonation-deprotonation process of the amino 
groups. At physiological pH the amino groups are deprotonated; inside the 
hydrophobic (solid-state) gel core the fluorine compounds suffer limited molecular 
motion which causes line broadening (short T2, <1 ms) of the 
19
F signal, resulting in 
it not being visible in the spectrum: this corresponds to the ‘off-state’. When the pH 
reaches 6.5 protonation occurs, corresponding to an increase in particle volume and 
in the fluorine motion, whose resonance now appears as a clear peak in the MR 
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spectrum (T2 = 56.8 ms, T1 = 280 ms, 470 MHz): this corresponds to the ‘on-state’. 
These nanoparticles have potential application in vivo, but the lower field scanners 
used in the clinic may lead to insufficient signal intensity, and addition of a 
19
F 
reference is required
45,46
. 
 
1.2.2.3 Metal ion probes 
Metal ions are involved in several physiological processes; therefore the 
development of responsive probes for their selective detection can help in 
understanding their key role. Calcium is of particular significance and has been 
measured in mouse thymocytes and perfused ferret hearts using fluorinated 
derivatives of BAPTA, in particular 4- and 5- substituted 22.  
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Upon binding of divalent cations, a change in the 
19
F chemical shift occurs. 5-
FBAPTA exhibits a slow exchange between free and bound forms on the NMR time 
scale (F(free) ~2 ppm, F(bound) ~8 ppm from a 6-fluorotryptophan external reference, 
188 MHz, pH 7.1, 37ºC); hence, in the presence of non-saturating concentrations of 
Ca
2+
 (0.33 mol equivalents), they appear as two separate resonances in the 
19
F 
spectrum and their area can be used to calculate the calcium concentration. In 
contrast, in the case of 4-FBAPTA the two forms (F(free) ~1 ppm, F(bound) ~2 ppm) 
are in fast exchange, giving a single peak with a chemical shift which is a function 
of their relative proportions, thus indicating the Ca
2+
 concentration. In both cases the 
resulting signals are broadened when the two forms co-exist compared to the all-free 
or all-bound resonances: a proof of the chemical exchange. The 5-substituted probe 
presents a small chemical shift F <0.2 ppm in the presence of Mg
2+
 up to 10 mM 
and F <0.1 ppm in the pH range 6.9-7.3; hence, intracellular variation of Mg
2+
 
concentration and pH will not disturb the evaluation of the amount of calcium by the 
chelator. The tetraacetoxymethyl ester derivatives have been used for cell studies 
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because they easily penetrate the membranes and are hydrolysed by esterases to 
release the free probe: after loading thymocytes with 1 mM 5-FBAPTA, two 
resonances emerged in the 
19
F NMR spectrum indicating a [Ca
2+
]i of 250 nM. These 
agents can also bind other divalent metal ions such as Zn
2+
, Fe
2+
 and Mn
2+
 giving for 
each chelate a characteristic chemical shift, allowing diverse metals to be detected 
without interference. The 
19
F chemical shifts of the saturated complexes (equimolar 
solution of M
2+
) have been measured at 94.1 and 188.3 MHz at 37ºC utilising 6-
fluorotryptophan as reference, reporting in the case of 5-FBAPTA: Zn
2+
 F = 5.6 
ppm, Ca
2+
 F = 7.8 ppm, Fe
2+
 F = 28.5 ppm. Mn
2+
 causes excessive line broadening, 
while the low affinity for Mg
2+
 does not allow the saturation of the chelate to be 
achieved
47
.  
5-FBAPTA has been utilised to measure the changes of [Ca
2+
]i during the cardiac 
cycle in perfused ferret hearts by means of the 
19
F peak ratio. The administration of 
the ester form caused a drop in the pressure, due to the induced increase of the buffer 
capacity for calcium in the cytosol. This effect has been proved by addition of ZnCl2 
to the medium: Zn
2+
 has a higher affinity for the probe and displaces the calcium, 
restoring the pressure. Though the heart appeared to be perturbed by the indicator, 
the calcium modifications can be promptly recorded. In the same experiment, 
fluorocitrate 23 has been employed for estimating the magnesium levels, by 
means of the chemical shift change that occurs upon binding. Only the (+)-
enantiomer can be used, due to the high toxicity of the (-)-isomer
48
. Similar 
behaviour to 5-FBAPTA was observed for the fluorinated magnesium chelator 
APTRA 24. The 5-substituted isomer is in the slow exchange regime on the NMR 
time scale and appears as two resonances in the NMR spectrum, while the 4-
substituted isomer exhibits fast exchange which results in a single peak. After 
infusion in rat hearts, both analogues induce a pressure fall
49
.  
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A peculiar example of fluorinated chelators are fluoro crown ethers 25 and fluoro 
cryptands 26, in which the C-F bond is directed toward the metal coordination site 
acting as a -donor bond. In the presence of divalent cations stable complexes 
formed showing a characteristic chemical shift up to 18.2 ppm from the ligand 
signal. For crown ethers, the metal-ion exchange is fast on the NMR time scale, 
while it is slow for the cryptands
50
.  
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1.2.2.4 pO2 and hypoxia reporters 
A key diagnostic marker in cancer treatment is pO2 (oxygen partial pressure), giving 
knowledge of the oxygenation level of diseased tissues. Hypoxic tumour cells are 
recognised to be more resistant to both radiotherapy and chemotherapy. Low levels 
of oxygenation also influence other aspects, such as angiogenesis, tumour invasion 
and metastasis. This information is therefore important in the evaluation of 
therapeutic planning, as hypoxic tumours are less responsive to treatment and often 
more aggressive. Mason and coworkers exploited the linear correlation between pO2 
and the relaxation rate, R1, exhibited by perfluorocarbons to measure tissue 
oxygenation in vivo. One problem with perfluorocarbons is the presence of multiple 
resonances which hampers the ease of acquisition and lowers the S/N ratio. 
Symmetric PFCs that appear as one major 
19
F signal are preferred, as occurs for 
hexafluorobenzene (HFB) 27 and perfluoro-15-crown-5-ether (15C5) 3, which are 
two of the most commonly used agents. HFB proved to be particularly sensitive to 
changes in pO2, and relatively insensitive to temperature variations which would 
compromise the accuracy of the measurements. These characteristics made it a 
better candidate than 15C5, which was less sensitive and more affected by 
temperature fluctuations.  
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After intratumoral injection (i.t.) of 20l HFB in a prostatic carcinoma in rat model, 
an HFB signal was observed in the same central or peripheral region where it was 
administered, indicating the absence of redistribution, which allowed the 
interrogation of the same area of interest for several hours. Basal values obtained 
during breathing of 66% oxygen were 4.0 ± 1.5 torr and 48.8 ± 2.6 torr for the 
internal and external tumour region respectively. The increase to 100% of the 
inhaled oxygen produced a large variation in the peripheral area of up to 61.9 torr, 
which returned to basal values after restoration of the oxygen level to 66%; the 
internal part of the tumour was only slightly perturbed. Previous studies employed 
the less invasive intravenous administration of HFB using a much higher infusion 
volume of 16 ml (compared to 20l i.t.). Comparative pO2 values were obtained 
after 7 days of infusion for detection of external tumour regions; while the detection 
of central regions required administration of HFB at the beginning of the tumour 
growth, in order to be sequestered in the central area which after 17 days of 
development became necrotic and no more vascularised. In contrast, i.t. injection 
allows immediate evaluation of the area of interest
51
.  
A different class of hypoxia markers are fluorinated nitroimidazoles: they are 
bioreductive agents which undergo 1-electron reduction by intracellular reductases 
generating reactive intermediates. Under physiological oxygen levels, the 
intermediates are re-oxidised and excreted from the cells, whereas in the presence of 
a hypoxic environment, they covalently bind to cellular elements. Their presence in 
the cells is therefore an indication of hypoxia. SR-4554 28, for example, has been 
evaluated in a mouse tumour model (carcinosarcoma) that closely resembles the 
characteristics of human tumours, with the purpose of validating the quality of this 
hypoxia marker prior to clinical studies. Because there is no detectable difference 
between the parent molecule and its metabolites, the retention is evaluated by means 
of the ratio between the fluorine signal at an early time point, which corresponds to 
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the parent molecule, and the same signal at a later point which corresponds to 
residual parent molecules plus the trapped products
52
. A different approach has been 
recently reported using a 
19
F-labelled indolequinone derivative (IQ-F) 29. Upon 
reduction in hypoxic cells by the intracellular reductases, the probe releases 
nonafluoro-tert-butyl alcohol which can be detected in the 
19
F NMR spectrum as a 
new signal, shifted by ~5 ppm from the resonance of the parent structure
53
.  
 
 
N
N
NO2
N
H
O
CF3
OH
SR 4554
28
MeO
O
O
N
OC(CF3)3
IQ-F
29  
 
1.2.2.5 Protein studies 
Fluorinated probes have been used for studying various macromolecules such as 
proteins, DNA/RNA and enzymes, for understanding the way biological molecules 
interact with one another or for investigating their structures and conformational 
changes
54
. Jackson et al. developed a method for site-specific genetic incorporation 
of the fluorinated amino acid trifluoromethyl-L-phenylalanine (tfm-Phe) 30 into E. 
Coli proteins and used the resulting 
19
F NMR signal to characterise the protein 
structure and monitor its reactivity.  
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Tfm-Phe was introduced at different positions in the active interface between the 
two homodimers nitroreductase (NTR) and histidinol dehydrogenase (HDH), and 
the chemical shift of the 
19
F signal was observed upon binding of substrate and 
inhibitor at the active site
9
. 
A singular approach has been recently reported for detection and imaging of specific 
proteins by means of nanoprobes with an on/off type of signal. The probe is 
                                                                                                  Chapter 1: Introduction 
25 
composed of monomers consisting of ligands with the ability of targeting a specific 
protein, in this case human carbonic anhydrase, and forming aggregates of about 
200-500 nm. The ligand also contains the fluorine moiety. When the probe is in the 
aggregate form the fluorine signal is largely broadened and is not visible in the 
spectrum. Upon addition of the protein, the probe disassembles and the 
19
F signal 
appears (Fig. 1.6)
55
.  
 
 
Fig. 1.6 Schematic representation of the on/off mechanism for the protein probe 
(Figure taken from reference 
55
). 
 
1.2.2.6 Enzyme reporters 
Several applications of fluorinated probes exploited a series of enzymes in pro-drug 
therapy or as means to release the active form of the probe as was discussed 
previously. However, enzymes may also be the object of study themselves, 
monitoring the presence of certain enzymes in cells or determining the kinetic 
parameters for new substrates. Carboxylesterases have been the focus of the study of 
Mendz et al. in which simple fluorinated compounds such as ethyl fluoroacetate and 
diethyl fluoromalonate have been used to measure the enzyme activity in 
erythrocytes and to confirm the presence of the enzyme in several strains of the 
bacterium Helicobacter pylori
56
.  
Nanoprobes formed by perfluorinated cubic silsesquioxane (F-POSS 31) 
immobilised onto silica particles have been applied to examine the action of alkaline 
phosphatase. The F-POSS were linked to the silica nanoparticles by a 
phosphordiamidate bond that is recognised by the enzyme. The impaired rotation of 
the linked F-POSS caused a large broadening of the fluorine MR signal, which is 
therefore not observable. Upon addition of the enzyme, the fluorinated cubic 
silsesquioxanes are released by the enzymatic reaction and the 
19
F MR signal is 
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restored. The enzymatic activity is hence monitored by an increase in the signal 
intensity
57
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1.2.3 Fluorinated pharmaceuticals 
There are several drugs containing a fluorine atom or a fluorinated group, which 
range from psychoactive compounds (e.g. fluoxetine) to anti-inflammatory agents 
(e.g. niflumic acid). They are good candidates to be studied by 
19
F MRS and MRI, 
allowing a deeper understanding of pharmacokinetics, metabolism processes and 
effectiveness of drug targeting. These aspects are important for drug design and are 
essential aspects of preclinical trials.  
A classic fluorinated drug is 5-fluorouracil (5-FU) 13, a chemotherapeutic 
compound, whose range of doses between efficacy and toxicity is very tight and 
thought to be related to pharmacokinetics.  
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The cytostatic activity is expressed in vivo by conversion of 5-FU to 
fluoronucleotides that bind irreversibly an essential enzyme for DNA replication, 
thymidylate synthase, and are incorporated in DNA and RNA as substitutes for the 
natural nucleotides. Competitive catabolic transformation to DHFU (5,6-
dihydrofluorouracil) and FBAL (-fluoro--alanine) occurs in the liver, reducing the 
bioavailability of 5-FU. From here, there is clearly an interest in understanding the 
                                                                                                  Chapter 1: Introduction 
27 
details of the different anabolic and catabolic pathways in order to enhance the 
therapeutic efficacy. Brix et al. integrated the investigation of pharmacokinetics 
aspects by dynamic 
18
F PET with the analysis of metabolic processes by 
19
F NMR, 
confirming the liver as the major site of metabolism, based on selective 5-FU and 
FBAL shift images
58
. 
19
F MR spectroscopy also supported the development of 
several pro-drugs, conceived to reduce 5-FU toxicity and its liver intensive 
extraction by exploiting the higher enzymatic level in tumours in order to improve 
targeting.  
2-Fluorodeoxyglucose (FDG) 32 is a glucose analogue utilised in PET (Positron 
Emission Tomography, 
18
F) as an imaging agent to assess the metabolic activity of 
tumours and metastases. Being a glucose analogue, it enters highly metabolically 
active cells, such as those of tumours, brain and heart, exploiting their glucose 
transporters. Here, it is converted to FDG-6-phosphate which is not recognised as a 
substrate for phosphohexose isomerase. Hence, it doesn’t undergo further 
metabolism, accumulating inside the cells. PET provides information about regional 
uptake with great sensitivity, but cannot differentiate between different metabolic 
products. For this purpose, a valuable method is 
19
F NMR, as demonstrated by the 
study of 2-FDG metabolism in rat brain, in which 
19
F MRS spectra and their 
temporal profile have been recorded, showing four metabolites, two of which have 
been recognised as FDG-6-phosphate and 2-fluoro-2-deoxy-6-phosphogluconate 
(the other two were not identified), proving the more extensive metabolism of FDG, 
which goes beyond the phosphorylation
59
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One of the earliest applications of 
19
F NMR in vivo was the study of gaseous 
fluorinated anaesthetics such as halothane, enflurane and isoflurane to understand 
their anaesthesia mechanisms. Of particular interest was their site of action, brain 
residence time and metabolite toxicity. They exhibit a short transverse relaxation 
time T2 (T1 = 1.0 s, T2 = 3.6 ms at 2.0 T for halothane), which makes imaging 
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approaches more difficult. Even so, maps of the local distribution of halothane were 
achieved in rabbit brains, showing the selective concentration of anaesthetic in the 
cerebral cortex, rather than deeper brain regions
60
. 
Clinical applications of 
19
F MRS have been reported for studying psychotropic 
drugs and antibiotics. Fluvoxamine 33 is used to treat various psychiatric conditions 
and its elimination from the human brain has been examined on subjects under 
clinical treatment: no direct correlation was found between plasma and cerebral t1/2 
(14-26 hours and 58 hours respectively) of fluvoxamine and these values were not 
related to age
61
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After oral administration of fleroxacin 34, a fluorinated antibiotic, healthy volunteer 
subjects have been studied for 24 hours, acquiring successive MR spectra of liver 
and calf muscles combined with HPLC analysis of plasma. Various 
pharmacokinetics parameters have been successfully measured (e.g. Cmax = 53 
mol/l plasma, 250 mol/l liver and 60 mol/l muscle). These studies confirm the 
potential of 
19
F MRS and MRI for observing non-invasively the fate of fluorinated 
drugs in vivo
62
. 
 
1.3  Paramagnetic NMR 
The lanthanides series presents distinctive characteristics in the periodic table, since 
the first and last trivalent ions, La
3+
 and Lu
3+
, are diamagnetic while all the others 
show paramagnetic properties thanks to the unpaired 4f electrons. These are shielded 
by 5s and 5p electrons and thus are not accessible for interacting with ligands to 
form covalent bonds. Therefore, the complexes are formed predominantly through 
electrostatic interactions. All the Ln
3+
 ions have similar chemical behaviour and 
differences are mainly related to the contraction of ionic radius along the series. 
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Different lanthanide complexes of the same ligand are almost isostructural but each 
of them presents peculiar NMR properties. When a Ln
3+
 ion interacts with an NMR 
active nucleus, the presence of the unpaired 4f electrons causes increased relaxation, 
broadening and sometimes shift to a different frequency of the resonance of the 
nucleus. While Gd
3+
 has an isotropic distribution of its unpaired electrons and hence 
cannot produce a dipolar shift, the other ions possess an anisotropic distribution. 
Therefore, they can generate a dipolar lanthanide induced shift (LIS) in solution, 
often called the pseudocontact shift, a property that renders them useful as shift 
agents to obtain structural information.  
  
1.3.1 Chemical shift 
The paramagnetic shift for a nucleus of a ligand that coordinates to a Ln ion is the 
sum of three terms: 
 
pcd            (1) 
 
Δd is the diamagnetic shift, usually insignificant except for nuclei directly 
coordinated to the Ln cation and derives from inductive and electrical field effects 
and conformational changes. It can be determined from the induced shift of 
diamagnetic La
3+
 and Lu
3+
 complexes. The term Δc is the contact shift (Fermi 
contact), resulting from the through-bond transmission of the spin density of the 
unpaired electrons from the 4f orbital of Ln
3+
 to the nucleus in study. The effect 
decreases rapidly with the number of bonds, allowing the identification of the ligand 
nuclei directly bonded to the metal. It is described by the following equation: 
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           (2) 
 
where B0 is the magnetic field strength, <Sz> the calculated spin expectation value 
for a paramagnetic ion (Table 1.1), A/ħ the hyperfine coupling constant (rad/s) and 
γI the gyromagnetic ratio of the observed nucleus. The Ln unpaired spin density can 
be transferred to the nucleus of the ligand by direct spin delocalisation through weak 
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covalent bonding using the 6s metal orbital or through spin polarisation from 4f 
orbitals. 
The term Δp is the pseudocontact or dipolar shift, which derives from the local 
magnetic field induced through space by the magnetic moment anisotropy of the 
lanthanide ion in the nucleus under study. If the principal magnetic axes are used as 
the coordinate system, Δp can be expressed by the following equation: 
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where μB is the Bohr magneton, k the Boltzmann constant, CJ the Bleaney’s constant 
characteristic of the Ln ion (Table 1.1), and <r
2
>A and <r
2
>A
’
 are ligand field 
coefficients that remain constant along the lanthanide series for isostructural 
complexes. r,  and  are the spherical coordinates which describe the position of 
the nucleus under study in the coordinate system with the Ln ion at its centre. The 
equation can be simplified to: 
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In the case of systems with axial symmetry the second term of equation (4) is zero. It 
is clear then, excluding the few nuclei directly coordinated to the metal, that for all 
the other nuclei only the dipolar shift contributes to the observed shift because 
unpaired electrons are shielded by the 5s and 5p valence electrons. Therefore, they 
are not available for covalent interaction with the ligand, but only for through space 
interactions
63
. 
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Table 1.1 NMR parameters for paramagnetic lanthanide ions. 
Ln 
2S+1
LJ CJ 
a 
<SZ> 
b 
µeff 
c 1
Hshift/aqua 
d 
Δ1/2 
e T1e 
f 
Ce 
2
F5/2 -6.3 -0.98 2.56 --- --- 0.9 
Pr 
3
H4 -11.0 -2.97 3.62 0.27 5.6 0.57 
Nd 
4
I9/2 -4.2 -4.49 3.68 0.32 4.0 1.15 
Pm 
5
I4 2.0 4.01 --- --- --- --- 
Sm 
6
H5/2 -0.7 0.06 1.55-1.65 --- 4.4 0.45 
Eu 
7
F0 4.0 10.7 3.40-3.51 --- 5.0 0.09 
Gd 
8
S7/2 0 31.5 7.94 3.01 Broad 10
4
-10
5
 
Tb 
7
F6 -86 31.8 9.7 -10.53 96 2.03 
Dy 
6
H15/2 -100 28.5 10.6 -6.95 200 2.99 
Ho 
5
I8 -39 22.6 10.6 -4.88 50 1.94 
Er 
4
I15/2 33 15.4 9.6 3.83 50 2.38 
Tm 
3
H6 53 8.21 7.6 9.29 65 3.69 
Yb 
2
F7/2 22 2.59 4.5 2.52 12 1.37 
a
 Normalised to 100 for Dy
64
; 
b
 Calculated values
65
; 
c
 
64
; 
d
 Values in ppm
65
; 
e
 Half-
height widths of 
1
H methyl resonance of 2-picoline in Ln[tris(dipivaloylmethane)3 
adduct, values in Hz
65
, 
f
 10
-13
s
64
. 
 
There have been many applications illustrating the use of paramagnetic complexes 
as shift reagents, for example, to simplify the interpretation of the NMR spectra of 
many biomolecules such as proteins and nucleic acids. Sherry and coworkers have 
studied the shift variation of the 
1
H and 
31
P resonances in the complex TmDOTP
5-
 
35 as a function of temperature, pH and Ca
2+
 concentration. 
1
H and 
31
P chemical 
shifts were found to change linearly with temperature ranging from 20 to 50°C ( 
~25 ppm for 
1
H and ~60 ppm for 31P, 7 T) as well as with pH over the range 6-8 
( ~5 ppm for 1H and ~25 ppm for 31P, 7 T). The temperature dependence 
showed little sensitivity to variations in pH or calcium concentrations up to 5.3 mM, 
allowing precise temperature measurements at similar Ca
2+
 concentrations to those 
encountered in vivo. The probe can also be applied to monitor simultaneously 
temperature and pH using multiple resonances, but only in extracellular 
compartments, as it cannot enter cells
66
. 
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1.3.2 Relaxation phenomena 
When a ligand coordinates a paramagnetic lanthanide ion, it experiences an 
enhancement of both the longitudinal (R1 = 1/T1) and the transverse relaxation rates 
(R2 = 1/T2). The ability of paramagnetic complexes to increase the relaxation rates of 
nearby nuclei is often termed its relaxivity (ri). Strictly, relaxivity is the increment of 
the observed relaxation rate per unit probe concentration and has the units of a 
second order rate constant, typically expressed as mM
-1
s
-1
. Most often, this is 
discussed in 
1
H MR, by examining the effect of a paramagnetic complex (mainly 
Gd
3+
) on the relaxation rate of bulk water: i.e. an intermolecular effect. The 
relaxation effect has contributions from the inner sphere and outer sphere. The 
second term is often small and is normally neglected in structural studies with Ln
3+
, 
but in some Gd
3+
 complexes it can contribute to the same extent as the inner sphere 
to the total relaxivity. The measured relaxation rate (Riobs, i = 1,2) is the sum of a 
diamagnetic contribution Rid (determined with La
3+
, Lu
3+
 and Y
3+
 complexes) and a 
paramagnetic contribution RiM: 
 
iMidiobs RRR            (5) 
 
 GdrRR iidiobs            (6) 
 
RiM represents the interaction of the magnetic field that is generated by the unpaired 
electrons of the lanthanide ion with the nuclear spin of the nucleus under study. This 
electron-nuclear interaction is controlled by electron spin relaxation, molecular 
tumbling and chemical exchange. The overall relaxation rates are described as the 
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sum of contributions from the contact Ricon (also termed scalar or hyperfine), dipolar 
Ridip and Curie Riχ mechanisms: 
 
iidipiconiM RRRR            (7) 
 
The contact contribution is negligible for all lanthanide(III) ions except Gd
3+
, and is 
relevant only for directly bound nuclei. The dipolar contribution is a through-space 
interaction that originates from the fluctuations of the electronic magnetic field. For 
Ln ions, other than Gd
3+
, with short electronic relaxation times (T1e = T2e ≈ 10
-13
 – 
10
-12 
s, Table 1.1), the dipolar contribution can be described by the simplified 
Solomon-Bloembergen equation as: 
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where µ0/4π is the magnetic permeability of a vacuum, µeff is the effective magnetic 
moment of the Ln
3+
 ion (Table 1.1) and r is the Ln-nucleus distance. In the case of 
Gd
3+
 this simplification cannot be applied because of the relatively long electronic 
relaxation times (T1e > 2 x 10
-7 
s at fields higher than 200 MHz). The Curie or 
susceptibility contribution is another dipolar effect developing from the nuclear spin 
interaction with the electronic spin thermal average and depends on the rotational 
motion of the complex. It is given by equations 9 and 10: 
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where τR is the rotational tumbling time of the complex and ωI the Larmor frequency 
of the nucleus. The dipolar contribution in lanthanide complexes, other than Gd, 
influences to the same extent both the transverse and longitudinal relaxation rates; 
conversely the Curie effect on the transverse relaxation rate, R2χ, is larger than that 
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over the longitudinal relaxation R1χ. This is particularly evident in the case of 
macromolecules with a long τR
63
. 
Knowing τR, equations 9 and 10 can be adopted to calculate the relative distances 
between the lanthanide ion and the ligand nuclei
 
using rate data obtained at different 
fields. An example has been reported by Aime et al. using tetraaza-macrocyclic 
phosphinate complexes of Yb
3+
 36. 
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The R1 values of the 
31
P resonances have been measured (at 2.1, 6.3 and 9.4 T) and 
plotted against the square of the field B0, resulting in a linear correlation. The slopes 
of the graphs gave the distances between the metal and the phosphorus nuclei
67
. 
In clinical practice, different complexes based on Gd
3+
 are commonly used as 
contrast agents in MRI, exploiting its ability to decrease the bulk water relaxation 
time which enhances the contrast in T1 weighted images. Examples include 
GdDTPA, GdDOTA, GdDTPA-BMA and GdHPDO3A
3
.  
 
1.4  Requirements for use of fluorinated probes in magnetic 
resonance 
As discussed in the previous paragraphs, 
19
F-containing probes for magnetic 
resonance applications offer a very interesting tool for biological studies. The 
absence of an endogenous background, the high sensitivity to even small changes in 
the chemical environment or in the probe geometry render this a potential class of 
agents for future MRS and MRI analysis. During recent years, some progress has 
been made
6,68
, however important issues are still hindering the widespread usage of 
these agents.  
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1.4.1 Problems with current probes 
The main drawback in the use of 
19
F magnetic resonance is the low sensitivity, a 
problem common to all the NMR techniques. This is related to the slow longitudinal 
relaxation rate R1 of the fluorine nucleus. This is particularly problematic for CF3 
groups, for which R1 values are about 0.3 to 1 s
-1
. To obtain sufficient signal 
intensity, multiple scans are therefore required, increasing significantly the 
acquisition time of the experiment. Before a successive scan can be undertaken in 
magnetic resonance spectroscopy, it is necessary that the nucleus under study 
reaches complete relaxation, a condition that is normally ensured by allowing a 
delay time between scans of 3 to 5 times the T1. It is, therefore, evident how having 
a long longitudinal relaxation time can affect the practicability of these MRS 
analyses where each scan takes 3 to 6 seconds, especially in the case of potential 
future clinical applications for which fast analysis is necessary. Furthermore, it has 
to be considered that the signal to noise ratio varies with the square root of the 
number of scans acquired, hence a great number of repetitions are required even for 
small enhancements of signal intensity. 
To achieve adequate sensitivities, a high local concentration of fluorine is essential. 
This results in the need for high concentrations of a fluorinated probe (e.g. about 20-
50 mM), raising concerns for solubility and toxicity problems. 
The ample chemical shift range of 
19
F containing species have not been exploited to 
its maximum, with chemical shift differences in the majority of cases being too 
small to be employed in chemical shift imaging protocols. Interpretation of the 
spectra can also present some difficulties because of the large J coupling between 
proximate protons and the fluorine nucleus.  
A faster relaxation of the 
19
F nucleus of at least one order of magnitude is 
consequently desired to allow rapid acquisition of magnetic resonance data, bearing 
in mind the need to have acceptable line broadening (proportional to R2) to prevent 
signal loss. Essential requirements for a fluorinated probe to be applied in vivo are 
also high kinetic stability, increased fluorine chemical shift non equivalence and the 
possibility to be detected in the 0.1-0.5 mM range. 
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1.4.2 Possible solution: use of proximate lanthanide(III) ions 
One way to satisfy these requirements is to place a fluorine atom, for example a CF3 
group, close in space (within 7 Å) to an open shell paramagnetic ion and within the 
McConnell cone (Fig. 1.7), described as 3cos
21/r3 in equation (3), in a kinetically 
stable paramagnetic lanthanide complex or conjugate, that is responsive to the 
parameters of interest.  
 
 
Fig. 1.7 Schematic representation of the McConnell cone originated by the 
paramagnetic ions at the centre of the complex. 
 
As described in paragraphs 1.3.1 and 1.3.2, the proximity of a nucleus, fluorine in 
this case, to the lanthanide ion results in two main effects: enhancement of R1 and R2 
thanks to the contribution of the dipolar and Curie mechanisms, and amplification of 
fluorine chemical shift non-equivalence because of the pseudocontact shift or 
dipolar lanthanide induced shift (LIS). 
The consequences of these effects on the fluorinated moiety of the ligand impart 
improved performances to the NMR probe. The reduced T1 value permits the 
acquisition of a larger number of scans in a shorter time, resulting in increased signal 
intensity. The signal to noise ratio is consequently augmented with the possibility of 
obtaining sufficient signal intensity using lower probe concentrations, with benefits 
also for solubility and toxicity.  
Additionally, the increased chemical shift non-equivalence of the fluorine 
resonances amplifies the sensitivity of the probes to changes in the 
microenvironment and consequently to very minor variations of the complex 
structure, leading to improved chemical shift-based images. 
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These considerations represent the rationale of the recent work that has been carried 
out in our laboratory with interesting results
69
. Using probes with CF3 groups in 
which the fluorine nuclei are between 6 and 7 Å from the lanthanide ion, the 
enhancement of R1 was found to be greater than two orders of magnitude for 
complexes of Dy
3+
, Tb
3+
 and Ho
3+
. The parallel increase of R2 has to be carefully 
considered: it can be advantageously used in T2-weighted images, on the other hand 
it also produces larger linewidths, that renders signal detection more difficult. 
Hence, a balance between the benefits of improved relaxation and the broadening 
effect has to be preserved. 
By varying the lanthanide ion for a series of complexes of the same ligand, different 
information can be obtained exploiting the peculiar characteristics of each metal: 
Dy, Tm, Tb, Ho and Er are moderate relaxation enhancers, Eu and Yb do not affect 
relaxation significantly but introduce a large dipolar shift. Analogous Gd complexes 
can serve as possible 
1
H MRI contrast agents that have similar biodistribution and 
chemical properties. 
 
1.5  Fluorinated paramagnetic probes 
Although there has been great interest in the use of lanthanides as shift reagents and 
relaxation enhancers for simplifying interpretation of spectra or obtaining structural 
information, much less has been reported about the shift and relaxation effects on 
fluorine NMR parameters. Lately, new interest has grown around 
19
F MRS/MRI 
reporters, thanks to the recent development of more sensitive instrumentation and 
dual probes design, and examples of different paramagnetic fluorinated probes have 
been reported. 
 
1.5.1 Previous studies of 19F NMR in lanthanide systems 
The earliest reported examples of studies regarding 
19
F NMR shifts
 
of paramagnetic 
complexes includes the work of Yatsunyk and Walker focusing on the fluorine 
chemical shift of paramagnetic tetraphenyl iron(III)porphyrins (TPP) 37 derivatives.  
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They compared the 
19
F shifts of different fluorophenyl complexes with the 
1
H shift 
of their non-fluorinated analogues, with the purpose of determining the contributions 
responsible for the large shift observed for the ortho-fluorine resonance and for the 
smaller shift, also of the same sign, for the meta and para resonances. They found a 
direct correlation between the o-fluorine shift and the spin density present at the 
meso-carbon to which the phenyl rings were attached; however, discrimination 
between the possibilities of ligand-centred dipolar shift and a through space contact 
shift resulting from an overlap of the electron cloud of the o-fluorine and the 
porphyrin ring  system was not established70. 
A reversible signal regulation of 
19
F NMR has been reported using ferrocene 
complexes as switching modules. The probe is formed by a POSS scaffold (cubic 
silsesquioxanes) to which are linked the fluorine reporter in form of trifluoroacetyl 
groups and the ferrocene moiety 38. When the ferrocene is oxidised, its 
paramagnetic character enhances the relaxation of the nearby fluorine nuclei causing 
line broadening and a consequent reduction in their signal intensity, whereas after 
reduction the signal is recovered
71
.   
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Sherry and coworkers examined the 
19
F NMR spectra for a series of lanthanide 
complexes of F-DOTPME 39, a trifluoroethyl ester derivative of macrocyclic 
phosphonate, and observed that they exist in solution as a mixture of diastereomers. 
Thanks to the sensitivity of fluorine to minor structural changes, assignment of 
several of the shifted fluorine resonances to specific diastereomers was undertaken. 
Addition of cationic detergents altered the shift and population of the isomers in 
favour of the -SSSS isomer, while the neutral polyethylene glycol (PEG) 
influenced the shift of some stereoisomers but not their population
72
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The temperature and pH dependence of the longitudinal relaxation rate of 
19
F nuclei 
in a fluorinated counter ion such as CF3SO3
-
, has been measured, as a means of 
studying the local hydration sphere and the dynamics of water, prototropic and anion 
exchange in paramagnetic complexes 40
73,74
. In particular, T1 was found to be 
constant (~75 ms, 235.3 MHz) in the pH range 8 to 2, while a noticeable increase 
was observed at lower pH values, when the distance between the lanthanide ion and 
fluorine increased, as displacement of the triflate by other anions (sulfate, phosphate, 
chloride) took place. This example offers further proof of the paramagnetic effect on 
relaxation when the fluorine nucleus remains close to the metal. 
Trifluoromethylsulfonate has been studied also as a potential extracellular 
fluorinated probe in vivo, when administered with the 
1
H MRI T1 relaxation agent 
[GdDTPA]
2-
. The aim was to enhance the fluorine relaxation in order to obtain faster 
acquisition of 
19
F MR images. The fluorinated anion was administered in a brain 
abscess of an animal model and images were recorded before and after the injection 
of [GdDTPA]
2-
 in less than 5 minutes
75
. This approach is of limited use, as the Gd 
complex and the anion will repel each other, inhibiting the close encounter that is 
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required for enhanced relaxation and can be used only upon simultaneous injection 
in the same compartment.  
Furthermore, the temperature dependence of the fluorine longitudinal relaxation rate 
of ternary adducts between paramagnetic complexes and reversibly bound anions, 
such as trifluoromethyl-L-lactate 41, has been studied, showing the highest rate (R1 
~100 s
-1
, 7 T) at lower temperatures (300 K compared to 330 K of 
1
H values for L-
lactate)
76
. The replacement of the two bound water molecules with the substrate 
allowed the fluorine atoms to be sufficiently close to the metal to experience the 
paramagnetic R1 enhancement
77
. 
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Recently, a Gd based paramagnetic probe for protease activity 42 has been examined 
in vitro. It contains a Gd
3+
 complex, a 
19
F containing group and a peptidic linker, 
which is recognised as substrate by caspase-3, a marker enzyme for apoptosis. The 
compound shows a weak signal due to the relaxation enhancement of the 
paramagnetic metal on the fluorine atom, which causes a shortening of the fluorine 
T2 and therefore broadening of the resonance. Upon enzymatic cleavage of the 
peptide, the paramagnetic effect is reduced and the signal intensity increases
78
. This 
system exhibits some limitations: first, even after enzymatic hydrolysis the signal 
experiences partial intermolecular paramagnetic broadening because of the Gd 
complex in solution which hampers its total recovery, and second, the position of the 
fluorinated moiety on the cleavage product results in a fluorine signal which 
presents the usual problematic slow T1 value, common to all the diamagnetic probes.  
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One of the problems that affects the use of MRI probes in vivo is the need to 
determine their local concentration, otherwise the observed reporter signal can be 
ascribed either to variation of the parameter of interest or to changes in the probe 
concentration. To tackle this issue, different ratiometric methods can be exploited. 
Recently, a Gd/
19
F ratiometric attempt for pH mapping has been discussed. The 
probe is composed of a poly--cyclodextrin (-CD) carrier to which a pH probe and 
a fluorine reporter molecule are bound through the appended adamantane moiety, 
which ensures strong binding to the -CD cavity (Fig. 1.8). The pH probe is a Gd 
complex which exhibits pH sensitive relaxivity in the range 6 to 9; the binding with 
a macromolecule causes the increase of the rotational correlation time which yields a 
higher relaxivity for the adduct, particularly at acidic pH and in a 1 T magnetic field. 
The relaxation enhancement produced by the pH probe can be normalised with the 
fluorine signal that is proportional to the concentration, obtaining the relaxivity 
values that are now only proportional to pH. The fluorine containing molecules are 
sufficiently far from the Gd so as to avoid signal broadening. This work presents an 
interesting proof of principle but presents many drawbacks for in vivo applications. 
The cage of the Gd complex requires modifications to avoid the easy replacement of 
the two bound water molecules by oxoanions, which would impede the pH response, 
also the binding affinities of the fluorine containing group and of the complex for 
the -CD are not suitable to ensure sufficient stability of the conjugate in vivo. In 
addition, the ratio of the three components has been assumed from their affinity 
constants, but more precise adduct characterisation would be required
79
.  
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Fig. 1.8 Schematic representation of the poly--cyclodextrin pH probe. 
 
A different carrier has been exploited by Langereis et al., who used a temperature 
sensitive liposome containing within its the inner core a chemical shift agent 
[Tm(hpdo3a)(H2O)] (65 mM) for 
1
H lipoCEST detection and a fluorinated 
compound NH4PF6 (50 mM) as a probe for 
19
F MRI. At temperature values lower 
than the melting temperature of the membrane Tm (~311 K), the CEST effect is 
visualised while the fluorine signal is not observable because of the broadening 
induced by the concentrated paramagnetic agent. When the Tm is reached, the 
liposome releases the encapsulated molecules causing a decrease of the CEST signal 
and a parallel increase of the 
19
F peak. This work shows promising future 
applications as a means for localised therapy or imaging in the tissue of interest 
using focused ultrasound to induce local hyperthermia, but improvements are needed 
to increase fluorine sensitivity
80
.  
Perfluorocarbon nanoparticles, stabilised by a lipid-surfactant monolayer 
surrounding the internal liquid core, have been discussed in previous paragraphs as 
fluorinated probes with different applications. Recently, the addition of Gd chelates 
in the external lipid monolayer of the particles has been considered as a mean of 
increasing the 
19
F signal intensity. At first, the introduction of Gd complexes on the 
surface of the probes has been only exploited for common 
1
H relaxation 
enhancement for allowing dual detection of the nanoparticle via 
1
H and 
19
F NMR
81
. 
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Lately, the relaxation enhancement produced by the paramagnetic ion on the 
fluorine nuclei of the perfluorocarbon core has been exploited, in order to obtain a 
decrease of the 
19
F T1 to achieve better fluorine signal intensity. The best 
compromise between increased R1 and smaller R2 was reached at 1.5 T (R1 = 4.2 s
-1
, 
R2 = 16 s
-1
). The particles have been targeted to fibrin clots by addition of anti-fibrin 
antibodies to the formulation. One limitation of this approach is that only nuclei in 
sufficient proximity to the lanthanide cation are affected by the paramagnetic effect, 
which varies with distance as r
-6
; therefore the process is limited by the diffusion of 
the fluorine nuclei within the range of action of the metal. Furthermore, the chelating 
agent DTPA used in these studies can undergo metal dissociation in vivo and should 
be therefore substituted with a more stable analogue
82
. 
 
1.5.2 Our previous work and aims 
The main aim of this work was the development of practicable 
19
F probes for 
magnetic resonance spectroscopy and imaging, with the potential to report for pH 
(as described in Chapter 2) and enzyme activity (Chapter 4), by an observable 
change in chemical shift or signal intensity. Previous work in Durham has 
established the ability of fluorinated macrocyclic ligands based on 
tetraazacyclododecane to form stable lanthanide complexes. They present faster 
relaxation rates and increased chemical shift sensitivity of the fluorinated moiety 
with respect to the diamagnetic analogues
69
. Cyclen-based complexes of lanthanides 
ions are well known to be kinetically inert and thermodynamically stable and several 
analogues are currently commercially available as contrast agents for 
1
H MRI (Gd). 
The introduction of a CF3 group in their structure allows the probe to be visualised 
by 
19
F NMR and the careful positioning of this label, within the range of action of 
the paramagnetic effect of the metal ion, imparts improved relaxation and chemical 
shift sensitivity (see section 1.4.2).   
Therefore, this work focussed on the synthesis and characterisation of novel stable 
fluorinated lanthanide complexes that can report changes in pH and enzyme activity. 
Their NMR properties and structural dynamics have been also investigated (Chapter 
3). Furthermore, and with the aim of further increasing signal intensity, we set out to 
prepare and characterise a chitosan-based conjugate which combines faster 
relaxation rates with a higher local fluorine concentration (Chapter 5). 
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Chapter 2 
 
Fluorinated responsive probes: pH 
studies 
 
2.1 Introduction 
As previously discussed (Chapter 1), the careful positioning of a fluorine nucleus 
within 7Å of the paramagnetic ion in a stable lanthanide complex, causes the 
fluorine longitudinal and transversal relaxation rates to be strongly enhanced
1,2
. This 
allows faster MR signal acquisition, reducing the sample concentration and 
acquisition time required to obtain the desired signal intensity. The lanthanide ion 
also enhances the chemical shift sensitivity of the fluorine nucleus to changes in the 
chemical environment. This characteristic can be exploited to develop responsive 
probes able to report various parameters of interest such as pH, enzyme activity or 
gene expression. A variation of the parameter under study will result in an 
observable change of 
19
F chemical shift or signal intensity of the probe.  
With this in mind, we have synthesised a series of lanthanide complexes with the 
purpose of developing pH reporters to be employed in 
19
F magnetic resonance 
spectroscopy and imaging.  
 
2.2  DO3A-based complexes 
The lanthanide complexes under study are based on tetra-substituted 1,4,7,10-
tetraazacyclododecane. In particular, DO3A (1,4,7,10-cyclododecane-1,4,7-
triacetate) mono-amide derivatives (Fig. 2.1) were chosen because of the good 
kinetic and thermodynamic stability of their lanthanide complexes with respect to 
metal dissociation, making them safe systems for in vivo application. The presence 
of an ortho-trifluoromethyl group on the aromatic ring of the amide arm allows the 
complex to be visualised by 
19
F NMR, and its proximity to the paramagnetic ion 
ensures fast relaxation. The amide functionality provides the pH sensitive moiety. 
Normally, its deprotonation equilibrium gives rise to a pKa value higher than 9.5, not 
suitable for physiological measurements. However, this value can be modulated by 
introducing appropriate substituents on the aromatic ring, able to influence the 
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amide proton acidity. Hence, a series of complexes bearing different functional 
groups in the para or ortho position of the aromatic ring has been synthesised and 
the pH dependence of their NMR properties assessed.  
      
     
 
 
 
 
 
 
 
Fig. 2.1 Schematic representation of the pH probe general structure. 
 
A direct comparison can be made with ortho and para-substituted phenols - a similar 
system that has been extensively studied. pKa values in the presence of different 
substituents have been reported
3,4 
and form the reference for our studies.  
The lanthanide induced shift effect increases the sensitivity of the 
19
F chemical shift 
to changes in the chemical environment; therefore, the deprotonation process should 
lead to an observable variation due to the presence of two different forms, 
protonated and non-protonated.  
The ideal NMR probe for pH analysis in vivo should possess the following features:  
- significant observable change, 
- pKa value centred at 7, 
- observable change in the range 6 to 8, 
- narrow linewidths. 
This chapter outlines the studies that we performed towards the achievement of 
these goals.  
 
2.2.1  Synthesis 
The general synthetic scheme for the preparation of DO3A ligands involved the 
mono-alkylation of the tri-protected cyclen with the appropriate fluorinated -
chloroamide, as illustrated in Scheme 2.1. The tris(tert-butylacetate) compound 1 
was prepared under mild basic conditions (NaHCO3) at room temperature. Stronger 
N N
NN
O
O
OO
O
O
H
N
O
Y
F3C
Ln
OH2
X
DO3A monoamide 
complex 
19
F reporter  
pH sensitive 
moiety 
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bases and heating were found to give a majority of the tetra-substituted analogue. 
The desired product was isolated by recrystallisation from hot toluene, with better 
yields compared to purification using column chromatography over silica gel 
(MeOH in DCM), than had been previously reported.  
The -chloroamide arm was prepared by acylation with chloroacetyl chloride of the 
para- or ortho-substituted trifluoromethylaniline, using only slightly different 
conditions according to the nature of the substituents.  
O
O
Br
N N
NN
H
HH
H
Cyclen
N N
NN
H
O
O
OO
O
O
H2N
CF3
Y
O
Cl
Cl
X
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NaHCO3
CH3CN
32%
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NN
O
O
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O
O
H
N
O
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F3C
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K2CO3
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CH3CN
N N
NN
HO
O
OHO
HO
O
H
N
O
Y
F3C
X
CH2Cl2
TFA
N N
NN
O
O
OO
O
O
H
N
O
Y
F3C
Ln
OH2
[LnLn]
X
Ln
Ln(III)Cl3
H2O 
pH 5.5
L1a  X=H, Y=COOEt
L1b  X=H, Y=COOH
L2    X=H, Y=NO2
L3    X=H, Y=CN
L4a  X=COOEt, Y=H
L4b  X=COOH, Y=H
L5    X=CN, Y=H
1
 
Scheme 2.1 General synthetic procedure for mono-amide DO3A derivatives. 
 
A preliminary step (Scheme 2.2) was required for the formation of the two ethyl 
ester derivatives from the commercially available acid or nitrile precursors. In each 
case, esterification proceeded using sulfuric acid in ethanol. The ethyl derivative was 
preferred over the methyl ester because it showed greater stability and ease of 
preparation.  
NH2
F3C
NH2
F3C
H2SO4
EtOH
89%
COOH COOEt
H2N
CF3
CN
H2N
CF3
COOEtH2SO4
EtOH:H2O 10:1
52%
 
Scheme 2.2 Esterification step from the commercially available precursors. 
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The purification steps involved careful neutralisation of the sulfuric acid by addition 
of a stoichiometric amount of K2CO3 in water. The products were then acylated with 
chloroacetyl chloride in dichloromethane with triethylamine to obtain the desired -
haloamide. The same reaction was performed for the para-nitro and cyano 
derivatives in tetrahydrofuran, using DMAP as an acyl transfer catalyst. Harsher 
conditions were required in the case of the ortho-cyano arm; NaH in DMF was used 
to increase the nucleophilicity of the amino group.  
The alkylation of the tri-ester 1 with the given -chloroamide was performed under 
basic conditions using KI as a catalyst. Treatment with trifluoroacetic acid in 
dichloromethane resulted in removal of the tert-butyl protecting groups, to give the 
ligand as its trifluoroacetate salt. Anion exchange chromatography afforded the 
hydrochloride salt, which ensured the water solubility of the compound. Reaction of 
the ligand in water at pH 5.5 with a slight excess of the appropriate lanthanide 
chloride salt yielded the final complex. The unreacted excess metal ion was removed 
by precipitation as the hydroxyl salt at pH 10, while the NaCl contaminating the 
sample after pH adjustment was eliminated by extraction of the complex into 20% 
MeOH in dichloromethane or by dialysis to yield the clean complex. Ligand and 
complex homogeneity was confirmed by reverse phase HPLC.  
During treatment with TFA of the ortho-cyano ligand L
5
, the formation of small 
amounts of a primary amide by-product was observed, as confirmed by mass 
spectrometry analysis. In order to avoid formation of this side product the same 
reaction was attempted under different reaction conditions. Lower temperature 
(0°C), alternative acids such as formic acid and varying reaction times were 
attempted, but none were particularly successful. The best compromise between 
complete ligand deprotection and minimum amide formation was found using the 
standard conditions, i.e. TFA in dichloromethane at room temperature overnight. 
The partial hydrolysis of the nitrile group is probably assisted by the presence of the  
amide functionality in the ortho position, as suggested by the lack of any side-
product formation for the para-cyano analogue, where this phenomenon cannot 
occur. 
The acid ligands, L
1b
 and L
4b
, were prepared by hydrolysis of the respective ethyl 
ester analogues, as illustrated in Scheme 2.3.  
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N N
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HO
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OHO
HO
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L1a: R1 = COOEt 
        R2 = H
L1b: R1 = COOH
        R2 = H
N N
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HO
O
OHO
HO
O
H
N
O
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F3C
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MeOH:H2O 2:1
0.1M KOHL2a: R1 = H
        R2 = COOEt
L2b: R1 = H
        R2 = COOH
  
Scheme 2.3 Synthesis of L
1b
 and L
4b
 by hydrolysis of their ethyl ester precursors. 
 
The para carboxylic acid derivative L
1b
, was obtained using 0.1 M KOH over 48 
hours at 50°C. The ortho acid derivative L
4b
, required the use of LiOH in a 
water/methanol mixture at room temperature for two days. The product was 
obtained after extraction of the desired ligand with ethyl acetate from the water layer 
at pH 4. Formation of the Ln(III) complex was undertaken at pH 6 using the 
appropriate LnCl3 salt. Partial hydrolysis occurred during the complexation reaction 
of the ester ligand L
1a
 resulting in a mixture of ester and acid form. Isolation of the 
ester was achieved performing the reaction at room temperature or leaving the 
mixture in ethanol with 1% of acetyl chloride for one week, while the acid form 
could be obtained by hydrolysis at room temperature at pH 10 (KOH) over one 
week. The ortho ester analogue proved to be more stable during the complexation 
reaction; therefore, no hydrolysis occurred. The acid [LnL
4b
] was obtained by 
leaving [LnL
4a
] in a solution of KOH at pH 10 for one week at room temperature. 
The glucosamide complex [HoL
13
] was prepared starting from the para acid 
derivative [HoL
1b
] as illustrated in Scheme 2.4. The acid group was activated with 
N-methylmorpholine and TBTU in DMF and then reacted with the free 
glucosamine, obtained from the commercially available hydrochloride salt, after 
treatment with anion exchange resin.  
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Scheme 2.4 Synthesis of [HoL
13
]. 
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2.2.2  pH Dependent spectroscopic behaviour 
The first complexes to be studied as pH reporters were the dysprosium complexes of 
L
1a
 and L
1b
, which contained respectively an ethyl ester and a carboxylic acid group 
in the para position of the aromatic ring. Amide deprotonation occurred under basic 
conditions and was reflected in each case in a change in the chemical shift of the 
CF3 group. Between pH 6 and 10.5, this varied from -64.3 ppm to -17.7 ppm for 
[DyL
1a
], and from -65.0 ppm to -24.8 ppm in the case of [DyL
1b
]. Therefore, the 
deprotonation process produced a large chemical shift variation, reaching a 
maximum difference between the protonated and deprotonated forms of 46.6 ppm 
for the ester complex and 40.2 ppm for the acid. The acid-base equilibrium is fast on 
the NMR time scale, hence only one signal is observed in the fluorine spectrum. The 
chemical shift corresponds to the weighted average of the individual chemical shifts 
of the acid and its conjugate base, as illustrated in Scheme 2.5.  
 
O
N
N
COOEt
CF3
OH2
O
N
N
COOEt
CF3
OH2
- H+
+ H+
H
 
Scheme 2.5 Acid-base equilibrium between the protonated and deprotonated form in 
[LnL
1a
]. 
 
The pH dependence of the 
19
F chemical shift of [DyL
1a
] and [DyL
1b
] can be clearly 
observed in the pH titration curve (Fig. 2.2), performed using a dilute (~1mM) 
solution of the complex in 0.1 M NaCl at 295 K and 188 MHz. The aqueous solution 
of NaCl was employed in order to maintain a constant ionic strength. A coaxial 
insert containing D2O was used to lock the instrument.  
The resulting plots show the continuous chemical shift change as a function of pH, 
following a typical acid-base equilibrium profile. The least-squares fitting of the 
experimental data resulted in a pKa of 8.80 ± 0.03 for [DyL
1a
] and 9.61 ± 0.04 for 
[DyL
1b
]. These values reflect the different electron withdrawing nature of the two 
substituents.  
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Fig. 2.2 pH titration curve of a solution (~1mM) of the ester [DyL
1a
] and the acid 
[DyL
1b
] (0.1 M NaCl in H2O, 295 K, 188 MHz, D2O lock) showing the fit (line) to the 
data. [DyL
1a
]: pKa = 8.80 ± 0.03, F = 46.6 ppm; [DyL
1a
]: pKa = 9.61 ± 0.04, F = 
40.2 ppm. 
 
The electron withdrawing ability of different substituents can be quantified with the 
Hammett constant, , based on the ionisation of substituted benzoic acids5. The 
ethyl ester is a strong electron withdrawing group, consistent with a value of para = 
0.45. The acid group instead for pH values >4 is in the deprotonated form and 
possesses a value of para = 0.00. Hence, the different protonation constant of L
1a
 
and L
1b
 is related to the stability of the deprotonated amide form in each case: the 
ester group allows a more effective delocalisation of negative charge in the 
conjugate base compared to the negatively charged carboxylate group. This is 
confirmed by the lack of 
19
F chemical shift variation observed in the case of para 
electron-donating groups such as NH2 (para = -0.66) or OH (para = -0.37) over the 
pH range 3.5 to 9, consistent with a pKa >9.5
2
.  
The variation of linewidth of the 
19
F resonances for [DyL
1a
] and [DyL
1b
] with pH 
was also recorded (Fig. 2.3). The linewidth (in Hz) is defined as the width of the 
peak at half-height, v1/2 or ω1/2. It can be directly related to the transverse relaxation 
rate, R2 (equation 11). 
 
                                                   2/12  R           (11) 
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Fig. 2.3 Linewidth profiles for [DyL
1a
] and [DyL
1b
] (295 K, 188 MHz). 
 
The profile showed a maximum at the pH corresponding to the pKa, which 
decreased at more acidic or basic values and was similar for each complex. This 
exchange broadening is probably caused by the chemical exchange between the 
protonated amide and its conjugate base. For the dysprosium complexes, the 
maximum broadening reached 1300 Hz for the ethyl ester and 800 Hz for the acid. 
However, by using different lanthanide ions it was possible to obtain much smaller 
linewidth values. In the case of the holmium complexes, for example, the maximum 
linewidths were 197 Hz and 131 Hz for the ester and the acid respectively, 
considerably less than the values for the Dy complexes. 
A pH titration, using the same conditions as for the Dy complexes, was performed 
for [HoL
1a
] and [HoL
1b
] (Fig. 2.4). The same pH-dependent behaviour was 
observed, showing that the homologous complexes possessed similar pKa values. 
The maximum difference between protonated and non-protonated forms, in this 
case, was about 15 ppm for the ester and 11 ppm for the acid. These values were 
lower than for the dysprosium complexes (F = 46.6 ppm (ester) and 40.2 ppm 
(acid)), but this is still a large variation over two units of pH. Therefore, holmium 
complexes seemed to be better candidates for comparing the different pH probes. 
They show good shift variation with pH and exhibit narrower linewidths. 
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Fig. 2.4 pH titration curve of [HoL
1a
] and [HoL
1b
] (0.1 M NaCl in H2O, 295 K, 188 
MHz, D2O lock) showing the fit (line) to the data. [HoL
1a
]: pKa = 8.78 ± 0.06, F = 
14.6 ppm; [HoL
1b
]: pKa = 9.46 ± 0.11, F = 11.0 ppm. 
 
A titration curve over the same pH range was also undertaken for [TbL
1b
] 
monitoring the process using luminescence emission. No significant change was 
observed in spectral form as a function of pH, probably because of the known low 
sensitivity of the terbium emission to the chemical environment. The complex was 
also employed to measure the hydration number (q value) in both a basic (pH 11) 
and acidic regime (pH 5). Lifetime data were consistent with the presence of one 
water molecule directly coordinated to the metal, as expected for DO3A mono-
amide complexes
6
. The q value was obtained by analysis of the radiative rate 
constants associated with depopulation of the lanthanide excited state. Values were 
measured in both H2O and D2O, allowing computation of q according to equation 12 
for the terbium complexes
6
,  
 
)06.0(5
22
 ODOHTb kkq           (12) 
 
where OHk 2  and ODk 2  are the reciprocals of the luminescence lifetimes of each 
complex, OH2   and OD2 , respectively. Lifetimes and calculated q values are 
reported in Table 2.1. 
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Table 2.1 Measured lifetimes (± 10%) and calculated hydration numbers (± 20%) for 
[TbL
1b
]. 
pH OH2  OD2  q 
11 2.01 ms 3.29 ms 0.67 
5 1.95 ms 3.25 ms 0.73 
 
The glucosamide derivative [HoL
13
], with an amide substituent in the para position, 
exhibited a similar pH-shift variation (Fig. 2.5). The electron withdrawing ability of 
a secondary amide group is comparable to that of an alkyl ester and is reflected in 
the similar pKa values of 8.98 ± 0.02 for [HoL
13
] and 8.78 ± 0.06 for [HoL
1a
].  
 
 
Fig. 2.5 pH titration curve of [HoL
13
] (0.1 M NaCl in H2O, 295 K, 188 MHz, D2O 
lock) showing the fit (line) to the data. pKa = 8.98 ± 0.02, F = 15.0 ppm. 
 
The chemical shift difference for the acid/conjugate base was 15 ppm. The 
linewidth values were slightly less than those observed for [HoL
1a
] and followed 
the same trend (Fig. 2.6), reaching a maximum at the pKa. 
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Fig. 2.6 Linewidth profile for [HoL
13
] (295 K, 188 MHz). 
 
Each of the Ln(III) complexes of L
1a
, L
1b
 and L
13
 display a large 
19
F chemical shift 
variation with pH, with differing linewidths according to the metal used. However, 
their pKa values were too high to allow pH measurements under physiological 
conditions. More electron withdrawing substituents were therefore chosen to further 
increase the acidity of the amide hydrogen. 
The nitro functionality is one of the most electron-withdrawing groups (para = 0.78) 
and has been introduced in the para position on the aromatic ring to give L
2
. The pH 
dependence of the 
19
F chemical shift of [HoL
2
] is shown (Fig. 2.7). The titration was 
performed as before at 295 K, 188 MHz, in 0.1 M NaCl with a D2O coaxial insert to 
lock the instrument. The pH dependence showed the acid-base equilibrium profile 
was shifted towards more acidic pH values compared to the previous examples. The 
fitting of the experimental data resulted in a pKa of 7.77 ± 0.02. This lower value 
reflects the influence of the increased electron withdrawing effect of the nitro group. 
In the case of para nitrophenol the pKa is 7.15. The complex maintained a large 
chemical shift variation of 18 ppm between the acid and its conjugate base. 
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Fig. 2.7 pH titration curve of [HoL
2
] in 0.1 M NaCl in H2O, mouse urine and mouse 
plasma (295 K, 188 MHz, D2O lock) showing the fit (line) to the data. pKa = 7.77 ± 
0.02, F = 18.2 ppm. 
 
To assess the effect of biological fluids on the pH response of the probe, the same 
experiment was undertaken in mouse urine and mouse plasma, over the 
physiologically relevant pH range 6-8 (Fig. 2.7). Mouse urine allowed the presence 
of various anionic species to be evaluated, while mouse plasma allowed the study of 
possible interaction of the complex with proteins. In each case, the complex 
maintained its behaviour without evidence of any interaction with proteins or anions, 
consistent with the suitability of the complex as a responsive pH probe for use in 
vivo. Indeed, the pH of a sample undergoing analysis can be directly obtained from 
the observed chemical shift of the probe by referring to the calibration curve. 
Compared to the ester and acid analogues, [HoL
2
] showed a different profile for the 
linewidth variation as a function of pH (Fig. 2.8). In the conjugate base an abrupt 
increase of the linewidth by a factor of 8 was observed, compared to the protonated 
amide. To explain this behaviour, a variable temperature experiment was carried out 
between 278 and 328 K, at both pH 5 and pH 8.5 at 470 MHz (urine sample with 
D2O insert). 
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Fig. 2.8 R2 variation as a function of pH for [HoL
2
] (295 K, 188 MHz). 
 
A linear variation of the 
19
F chemical shift with the inverse of the second power of 
the absolute temperature in Kelvin was observed (as expected from equation 3
7
) 
(Fig. 2.9). At higher temperatures, the linewidth of the deprotonated form decreased 
noticeably, with a thermal contribution to the narrowing of the resonances which 
was greater than what it would be expected according to equation 10
7
, while it was 
normal for the protonated form. Values for the linewidth of the protonated form 
were as expected. 
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This behaviour suggested the presence of a unique conformational exchange process 
for the deprotonated complex, that was giving rise to additional exchange 
broadening. 
Two possible processes were considered: lanthanide ion re-coordination from 
oxygen to nitrogen and cis-trans isomerization around the C=N double bond. On the 
basis of DFT calculations performed by Dr. Ilya Kuprov (Oxford University), the 
first hypothesis can be excluded. To simplify the process yttrium and lanthanum 
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were used as the metal ions in the DFT calculations with very similar results. The 
Y
3+
 ion has an ionic radius that is within 0.02 Å of Ho
3+
 and the structures of 
complexes with other lanthanides are likely to be identical. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.9 Linear variation of the observed 
19
F shift of [HoL
2
] as a function of T
-2
 from 
278 K to 328 K at pH 5 and 8.5. 
 
The calculations on [LaL
2
], showed an energy difference of 62 kJ/mol between the 
two coordination isomers in favour of the oxygen-bound isomer. A smaller energy 
difference of only 18 kJ/mol was calculated between the cis and trans isomers, 
making this second process a more probable explanation (Scheme 2.6).  
 
N
N
H
OH2
N
N
OH2
O O
N
N
OH2
O
CF3
O2N
F3C
NO2
- H+
      pKa 7.8 E = 18 kJ/mol
F3C
NO2
trans cis
 
Scheme 2.6 Acid-base equilibrium between the protonated and non-protonated form in 
[LaL
2
] showing the conformational exchange between cis/trans amide forms in the 
deprotonated species. 
 
The forward and backward calculated activation energies for the cis-trans 
isomerization are 27 and 45 kJ/mol respectively and are consistent with the observed 
exchange broadening in the 
19
F NMR spectra. The bulky CF3 group favours those 
structures that direct this group away from the amide oxygen, as illustrated in the 
following calculated structures for the yttrium analogue. 
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Fig. 2.10 DFT calculated structure of [YL
2
H]. 
 
a)  
 
b)  
Fig. 2.11 DFT calculated structures of the two isomers of [YL
2
]
-
. a) cis form. b) trans 
form. 
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The fluorine chemical shift of [HoL
2
] was examined over different complex 
concentrations and in different NMR solvents. The shift was independent of the 
complex concentration over one order of magnitude (mM), while it varied according 
to the solvent used: with respect to the chemical shift in D2O, the fluorine resonance 
shifts to higher frequency by 2.9 ppm in deuteriated methanol and by 10.7 ppm in 
DMF-d7. In this latter case the peak broadened significantly, most likely due to a 
slow exchange of DMF molecules coordinated to the metal. The chemical shift 
variation followed the trend in solvent polarity and can most simply be rationalised 
in terms of the qualitatively effect of changing the axial donor from D2O to CD3OD 
or DMF
8
. 
A very similar pH profile was observed for the p-cyano complex. The pH/F titration 
curve for [HoL
3
] is reported below (Fig. 2.12). 
 
Fig. 2.12 pH titration curve of [HoL
3
] (0.1 M NaCl in H2O, 295 K, 188 MHz, D2O 
lock) showing the fit (line) to the data. pKa = 8.15 ± 0.03, F = 17.3 ppm. 
 
The pH-shift profile shows a variation over two units of pH with a difference of 17.0 
ppm between protonated and non-protonated forms. The para cyanophenol has a 
pKa of 7.95. The p-CN group has a significant electron withdrawing ability, with 
para = 0.66. The fitting of the data by a non-linear least squares iterative analysis 
resulted in a pKa of 8.15 ± 0.03. These values are comparable to those obtained for 
the nitro analogue (F = 18.0 ppm, pKa = 7.77 ± 0.02). However, in the latter case 
                                                                        Chapter 2: Results and Discussion - pH  
 
64 
the pH dependence of the linewidth was complex. As previously described, the 
linewidth of the nitro compound increases dramatically at basic pH due to the 
conformational exchange process present in the deprotonated form. In the case of 
[HoL
3
], the linewidth increased around the pKa value and decreased further (Fig. 
2.13), as expected for a chemical exchange process between the amide and its 
conjugate base, as noted for the para ester, acid and amide analogues.  
A comparison of the R2 profiles for the para nitro [HoL
2
] and para cyano [HoL
3
] 
complexes is reported in Fig. 2.13. The remarkable decrease of linewith is evident in 
the case of the cyano complex [HoL
3
], in particular at basic pH values. This implies 
that the conformational exchange process occurring in the p-NO2 system [HoL
2
] 
was not present here. Such a difference in behaviour is surprising, considering the 
similar electron-withdrawing ability of these two functional groups (para = 0.45 
nitro, 0.66 cyano). Each substituent can delocalise the negative charge in the 
deprotonated amide form, as revealed by the similar pKa values. The line 
broadening, as well as the lower pKa for [HoL
2
], is probably related to a slightly 
greater conjugative stabilising effect of the para-nitro group. This could enhance the 
stabilisation of the cis stereoisomer, leading to the increased linewidth. The p-cyano 
system [HoL
3
] therefore, represents an improvement compared to the nitro 
analogue.  
 
Fig. 2.13 Comparison of R2 variation with pH for the p-nitro [HoL
2
] and the p-cyano 
[HoL
3
] (295 K, 188 MHz). 
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The series of para-substituted complexes discussed so far allowed the pKa to be 
decreased up to a value of 7.77 in the nitro analogue. The introduction of additional 
CN or NO2 groups into the structure was not pursued because of the likely reduced 
solubility of the final complex and the synthetic accessibility of such systems. Based 
on the analysis of the pKa values of the ortho and para-substituted phenols
3,4
, 
subsequent work investigated the effect of the presence of ortho substituents in the 
ligand structure. 
 
The first example was the ortho ethyl ester L
4a
. Its lanthanide complexes appeared 
in the fluorine spectrum as two resonances of equal intensity (instead of only one as 
seen for the para-analogues) but with very different chemical shifts. The separation 
between the two signals varied from 20 to 55 ppm according to the metal ion. As 
will be discussed in Chapter 3, the two resonances probably correspond to two 
isomers resulting from the rotation of the aromatic ring on the amide arm around the 
C-N bond. The two rotamers are characterised by very different positions of the CF3 
group with respect to the pseudocontact shift field created by the paramagnetic ion 
(Scheme 2.7).  
 
O
N
HN
F3C
OH2
COOEt
O
N
HN
EtOOC
OH2
CF3
 
Scheme 2.7 Schematic representation of the two isomers of [LnL
4a
] arising from the 
rotation of the aromatic ring around the CN bond. 
 
For each complex, the two resonances exhibit a slightly different pH dependence, as 
illustrated in the pH titrations undertaken for [HoL
4a
] and [TmL
4a
] in 0.1 M NaCl at 
295 K and 188 MHz (Fig. 2.14). The different lanthanide complexes of the same 
ligand L
4a 
maintained similar protonation constants (as previously observed for the 
different complexes of L
1a
), with values of 8.65 ± 0.02 for [HoL
4a
] and 8.61 ± 0.02 
for [TmL
4a
], analogous to 8.78 ± 0.06 and 8.80 ± 0.03 for the para ester [HoL
1a
] 
and [DyL
1a
] complexes. The opposite shifting effect observed for the two metals, as 
well as the different size of the chemical shift non-equivalence, is related to the sign 
and magnitude of the Bleaney constants (see Table 1.1 of section 1.3.1). These are -
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39 for Ho
3+
 and +56 for Tm
3+
 (relative to -100 for Dy). The pKa is lower than 
expected, in comparison to the value of 10.2 for the phenol analogue
4
. 
 
 
Fig. 2.14 pH titration curve for [HoL
4a
] and [TmL
4a
] (0.1 M NaCl in H2O, 295 K, 188 
MHz, D2O lock) showing the fit (line) to the data. [HoL
4a
] major: pKa = 8.65 ± 0.02, 
F = 22.9 ppm; [TmL
4a
] major: pKa = 8.61 ± 0.02, F = 19.1 ppm. 
 
A summary of the main features obtained from the pH titration is shown in Table 
2.2. 
 
Table 2.2 Summary of data obtained from the pH titration of [HoL
4a
] and [TmL
4a
]. 
complex 
(isomer) 
F acidic form 
(ppm) 
F basic form 
(ppm) 
F (ppm) pKa 
Ho major - 49.5 - 26.6 22.9 8.65 ± 0.02 
Ho minor - 82.8 - 68.8 14.0 8.93 ± 0.02 
Tm minor - 37.1 - 41.7 4.6 8.84 ± 0.05 
Tm major - 90.8 - 109.9 19.1 8.61 ± 0.02 
 
[HoL
4a
] exhibits a chemical shift variation of ~23 ppm for the major isomer over 2.5 
units of pH, larger than that obtained for the para analogue (15 ppm over 2 units of 
pH). The linewidth profile for each isomer (Fig. 2.15) follows the normal pattern of 
increased broadening around the pKa value, as observed for [HoL
1a
]. The latter 
possess intermediate linewidth values compared to those of the major and minor 
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isomers of [HoL
4a
] (maximum linewidth for [HoL
1a
] is 197 Hz, 211 Hz for the 
major form of the ortho complex [HoL
4a
] and 156 Hz for the minor form). 
 
 
Fig. 2.15 Linewidth variation as a function of pH for [HoL
4a
] (295 K, 188 MHz). 
 
With the ortho acid lanthanide complexes [LnL
4b
], two resonances were observed 
with a large chemical shift difference, corresponding to two rotameric forms. The 
signals have similar chemical shifts to the corresponding ortho ester complexes 
[LnL
4a
], but in a 3:1 ratio and with larger linewidths.  
The pH profile for each isomer was also undertaken for the analogous thulium 
complex (Fig. 2.16). 
 
 
Fig. 2.16 pH titration curve for [TmL
4b
] (0.1 M NaCl in H2O, 295 K, 188 MHz, D2O 
lock) showing the fit (line) to the data. Major: pKa = 10.40 ± 0.09, F = 14.0 ppm. 
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The amide pKa of 10.40 ± 0.09 in this case was apparent only for the major isomer 
and was higher than the values of 9.61 and 9.46 for the para-substituted analogues 
[DyL
1a
] and [HoL
1a
]. At pH values lower than 4, the acid protonation started to be 
visible.  
The ortho ester and acid series of complexes introduce an interesting approach to pH 
measurement compared to the previous examples. The para-substituted compounds 
[LnL
1a
] appear in the fluorine spectrum as one observed resonance. The observed 
chemical shift has to be referenced to a standard before accurate pH measurement is 
possible. In the case of the ortho analogues [LnL
4a
], two resonances in the 
19
F NMR 
spectrum occur, which exhibit differing sensitivity to pH. This allows pH 
measurement simply by measuring the shift difference between the two isomers. 
This method is advantageous because it does not require any chemical shift 
reference. The plot of the difference between the two isomers is reported for 
[HoL
4a
] (Fig. 2.17). It varies from 33.3 ppm at acidic pH to 42.3 ppm in basic 
conditions. The same variation ranged from 53.7 to 68.1 ppm for [TmL
4a
] and 51.5 
to 67.0 ppm for [TmL
4b
]. 
 
Fig. 2.17 Chemical shift difference between the two isomers of [HoL
4a
] with pH 
(295K, 188 MHz) showing the fit (line) to the data. pKa = 8.31 ± 0.02. 
 
Ligand L
5
 was investigated after observing the behaviour of the previous complexes. 
The introduction of the cyano functionality in the ortho position was proposed to 
increase the acidity of the amide hydrogen, based on its high electron withdrawing 
ability and on pKa values of about 7.0 for analogous systems.  
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A pH titration was performed in 0.1 M NaCl in water for [HoL
5
] (Fig. 2.18). 
 
Fig. 2.18 pH titration curve of [HoL
5
] (0.1 M NaCl in H2O, 295 K, 188 MHz, D2O 
lock) showing the fit (line) to the data. pKa = 7.13 ± 0.02, F = 24.5 ppm and 10.5 
ppm.  
 
The complex [HoL
5
] had a pKa of 7.13 ± 0.02. This is centred in the optimal region 
for physiological pH measurements, with a chemical shift difference between the 
protonated amide and its conjugated base of 24.5 ppm for the major isomer and 10.5 
ppm for the minor. The working pH range was 6 to 8. The lower pKa is probably due 
to the additional inductive -polarisation effect exerted by the ortho-cyano group. 
The compound also gave rise to two distinct isomers in the fluorine spectrum, with a 
large pH variation of chemical shift ranging from 29.2 to 43.2 ppm. When plotted 
against the pH (Fig. 2.19), the difference in chemical shift of the two isomers 
allowed an internally referenced calibration curve to be created for measurement of 
pH.  
N N
NN
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Fig. 2.19 Chemical shift difference between the two isomers of [HoL
5
] with pH (295K, 
188 MHz) showing the fit (line) to the data. pKa = 6.97 ± 0.02. 
 
The same study was also performed in mouse urine and plasma to assess the effect 
of anionic species and proteins in solution on the pH responsiveness of [HoL
5
] (Fig. 
2.20). No variations were observed in the pH behaviour of the probe; such 
characteristics favour possible future in vivo experiments. 
 
 
Fig. 2.20 pH titration of [HoL
5
] in 0.1 M NaCl in H2O, mouse urine and mouse plasma 
(295 K, 188 MHz, D2O lock). 
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The linewidth variation at different pH values exhibited a peculiar profile. Under 
basic conditions, [HoL
5
] showed two sharp fluorine signals that broadened when 
reaching neutral pH corresponding to the pKa value. Under acidic conditions 
however, instead of exhibiting reduced linewidths, the two signals broadened again, 
up to a value of 1/2 = 800 Hz. This characteristic was independent of the metal ion 
used. The fluorine resonances are actually formed by two pairs of overlapping peaks 
corresponding to four diastereoisomers. These isomers may be ascribed to rotation 
of the aromatic ring around the C-N bond and to cyclen ring inversion and 
concurrent acetate group rotation. Further work has investigated this stereochemical 
complexity in an effort to explain these processes and will be discussed later in 
Chapter 3. 
Chemical exchange broadening may be reduced by structural modification aimed at 
suppressing these dynamic processes. One possible solution could be the 
substitution of the carboxylate pendant arms with more rigid donors such as 
phosphinate arms, as will be discussed in the next section. 
A summary of the principal features for the series of ligands presented in this section 
are listed in the table below: 
 
Table 2.3 Summary of pH data for complexes of ligands L
1
-L
5
 and L
13
. 
Complex F (ppm) 
a pKa Phenols pKa
 
[HoL
1a
] p-ester 46.6 8.78 ± 0.06 8.34
 c 
[HoL
1b
] p-acid 40.2 9.46 ± 0.11 / 
[HoL
13
] p-amide 15.0 8.98 ± 0.06 / 
[HoL
2
] p-nitro 17.2 7.77 ± 0.02 7.15
 b 
[HoL
3
] p-cyano 17.3 8.15 ± 0.03 7.95
 b 
[HoL
4a
] o-ester 22.9 8.65 ± 0.02 10.2
 c 
[TmL
4b
] o-acid 14.0 10.40 ± 0.09 / 
[HoL
5
] o-cyano 24.5 7.13 ± 0.02 7.0
 c 
a 
Major isomer only; 
b 3
; 
c
 
4
. 
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2.3  DOTP-based complexes 
The ortho cyano holmium complex [HoL
5
] proved to be the best 
19
F NMR pH probe 
of the series under study (section 2.2.2). It has a pKa of 7.13 centred in the range of 
interest and observable over two units of pH with a variation in shift of nearly 25 
ppm. In addition, the presence of two isomers with different sensitivity to the pH 
allows measurements of pH to be made without the need for chemical shift 
reference. In an attempt to minimise the broadening of the resonances at acidic pH, 
the phosphinate analogues of the corresponding DO3A monoamide complexes 
(DOTP) were prepared (Fig. 2.21).  
N N
NN
P
P
O
O
P
OO
O
O
H
N
O
F3C
CNLn
[LnL6]
N N
NN
O
O
OO
O
O
H
N
O
F3C
Ln
OH2
[LnL5]
CN
carboxylate arm
phosphonate arms:
increased rigidity
 
Fig. 2.21 DO3A monoamide complex [LnL
5
] vs DOTP monoamide complex [LnL
6
]. 
 
Lanthanide complexes of tri and tetraphosphinate
9,10 
ligands maintain the high 
kinetic stability as seen for their carboxylate analogues with respect to metal 
dissociation, which makes them suitable for in vivo studies. Upon complexation, the 
three phosphinate pendant arms form a more rigid cage around the metal compared 
to the carboxylate analogues. In particular, the more bulky phosphinate moiety 
suppresses cooperative arm rotation about the principal axis and also favours the 
formation of one major isomeric species, at least with P-Me and P-Bn 
phosphinates
11
. The enhanced rigidity may then reduce the linewidth of the fluorine 
signals. 
 
2.3.1 Synthesis 
In this case, mono-alkylation of the macrocycle was undertaken by reaction of a 10 
fold excess of cyclen with one equivalent of the -chloroamide in the presence of 
K2CO3 in acetonitrile (Scheme 2.8). A homogeneous product was obtained after a 
series of consecutive washes partitioning between water, dichloromethane and 
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chloroform in order to eliminate the excess cyclen and any impurities formed during 
the reaction. A different strategy previously attempted involved the reaction of the 
-haloamide with the tri-BOC (tert-butoxycarbonyl) protected cyclen, and 
successive TFA deprotection to yield the desired monoamide. This procedure was 
unsuccessful. This was tentatively attributed to the higher steric hindrance around 
the ring nitrogen caused by the presence of the tri-BOC substituents. Reaction of the 
mono-substituted cyclen with paraformaldehyde and diethoxymethylphosphine in 
dry tetrahydrofuran, yielded the desired tri-ester in low yield (19%). Hydrolysis of 
the ester groups was achieved using a solution of KOD (0.1 M) over one week at 
room temperature. The lanthanide complex [HoL
6
] was prepared by reaction of L
6
 
with HoCl3 in water at 50°C. The product was purified by dialysis. 
 
N N
NN
H
HH
H
Cyclen
N N
NN
H
H
H
N
O
H
F3C
CNN
H CN
O
Cl
F3C
N N
NN
P
P
EtO
O
P
OEtO
EtO
O
H
N
O
F3C
CN
N N
NN
P
P
HO
O
P
OHO
HO
O
H
N
O
F3C
CN
N N
NN
P
P
O
O
P
OO
O
O
H
N
O
F3C
CNHo
K2CO3
CH3CN
L6[HoL6]
Ho(III)Cl3
H2O 
pH5.5
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Scheme 2.8 Synthetic scheme for [HoL
6
]. 
 
2.3.2 pH Dependent spectroscopic behaviour 
In the 
19
F NMR spectrum of [HoL
6
] three main resonances were observed in the 
ratio 1:2.7:3.1 at -46.8, -59.6 and -95.5 ppm (pH 6.8). The resonance at F = -59.6 
ppm was observed close to the shift of the ligand itself (F = -61.6 ppm). Further 
studies, that will be discussed in Chapter 3, suggest that the signal may be actually 
formed by two pairs of overlapping resonances, in a similar fashion as for the 
carboxylate analogue. These four resonances may be attributed to four 
diastereoisomers related by restricted rotation around the aryl C-N bond, as well as 
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the  and  isomers associated with cyclen ring inversion and acetate 
pendant arm rotation. A pH titration for [HoL
6
] was undertaken in 0.1 M NaCl at 
295 K and 188 MHz (Fig. 2.22). The unshifted resonance remained at the same 
position over the whole pH range, while the other two peaks showed very similar pH 
dependence to that observed for [HoL
5
]. The same pKa value of 7.09 ± 0.02 was 
estimated (7.13 ± 0.02 for [HoL
5
]). This offers additional proof that the pKa is 
associated with amide NH deprotonation and not to any other structural feature, such 
as coordinated water. The chemical shift difference between the protonated and non-
protonated forms was greater than for the carboxylate analogue: F was 36.3 and 
20.0 ppm for the two isomers of [HoL
6
] compared to 24.5 and 10.5 ppm for [HoL
5
]. 
 
Fig. 2.22 pH titration of [HoL
6
] (0.1 M NaCl in H2O, 295 K, 188 MHz, D2O lock) 
showing the fit (line) to the data. pKa = 7.09 ± 0.02, F = 36.3 ppm and 24.5 ppm. 
 
The variation of F with pH for [HoL
6
] was also undertaken in mouse plasma (Fig. 
2.23). No change in the pH dependence of F was observed, auguring well for future 
in vivo studies.  
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Fig. 2.23 pH titration of [HoL
6
] in mouse plasma (295 K, 188 MHz, D2O lock) 
showing the fit (line) to the data. 
 
The linewidth variation of [HoL
6
] followed the same trend as observed for the 
carboxylate analogue [HoL
5
], but with much narrower resonances, reaching a 
maximum of only ~230 Hz, compared to over 800 Hz for [HoL
5
]. 
 
2.4  Tetra-substituted cyclen 
A different tetra-substituted complex [HoL
7
] was prepared, containing four identical 
fluorinated arms as substituents on the cyclen nitrogens. The 12 fluorine atoms were 
introduced with the purpose of increasing the signal intensity in the 
19
F NMR 
spectrum. The compound was considered to undergo four consecutive deprotonation 
equilibria, resulting in a wider pH variation of F with pH.  
 
2.4.1 Synthesis 
The ligand L
7
 was prepared by reacting one equivalent of cyclen with five 
equivalents of the CF3-labelled para-ethyl -chloroamide ester, under the same 
conditions used for the DO3A analogues (Scheme 2.9). The purification procedure 
required two successive separations by columns chromatography over silica gel to 
obtain the product, and proceeded in very low yield (9%). Attempts to prepare the 
ortho-ester analogue were unsuccessful, probably due to steric congestion. 
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Complexation was performed in acetonitrile with the triflate salt of the lanthanide 
ion and the product was obtained after precipitation in diethyl ether and anion 
exchange to give the chloride salt. 
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Scheme 2.9 Synthetic scheme for [HoL
7
]
3+
Cl3. 
 
2.4.2 pH Dependent spectroscopic behaviour 
A pH titration of [HoL
7
]
3+
 was performed in a solution of MeOH/H2O 4:1 at 295 K 
and 188 MHz, using a D2O capillary to lock the instrument (Fig. 2.24). The complex 
was not soluble in water due to the increased liphophilicity of the structure with four 
trifluoromethyl and four ethyl ester groups. 
A single 
19
F resonance was observed consistent with the C4 symmetry of the 
complex. The F/pH profile showed a 
19
F chemical shift variation of about 20 ppm, 
over a range of more than 3 pH units centred at 8.7. This agrees with the hypothesis 
of extending the pH range by the presence of consecutive pKa equilibria. No pKa 
determination was possible, as the presence of two closely spaced protonation 
equilibria inhibits an accurate estimate from being made. In addition, after 
deprotonation of the first amide, the compound loses the C4 symmetry, resulting in 
multiple resonances in the fluorine spectrum.  
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Fig. 2.24 pH titration curve of [HoL
7
] (MeOH/H2O 4:1, 295 K, 188 MHz, D2O lock) 
showing only the major resonance. F = 18.0 ppm. 
 
A further consideration was to hydrolyse the complex fully to allow examination of 
the tetracarboxylate derivative. This compound should have improved solubility 
with respect to the ester precursor. Unfortunately, the hydrolysis, attempted in a 
solution of MeOH and water at pH 11 over a period of four weeks, was not 
successful, and was accompanied by decomplexation of the Ln
3+
 ion, with formation 
of Ln(OH)3. 
 
2.5   Conclusions 
The purpose of this study was to develop a pH responsive probe to be used in 
19
F 
MRS/MRI. The series of lanthanide complexes discussed, allowed the evaluation of 
the effect that different substituents of the aromatic ring have over the NH 
protonation constant of the amide group. The results were comparable to those 
obtained for analogous systems reported in the literature (see Table 2.3).  
The tetra-substituted [HoL
7
] did not possess the pKa and solubility properties 
desired but it was useful because it highlighted the limitations of the system. In fact, 
a constant symmetry needs to be maintained for both acidic and basic forms in order 
to avoid the formation of multiple 
19
F resonances. In addition, the introduction of 
liphophilic groups into the structure has to be carefully evaluated to preserve the 
water solubility of the compound. 
                                                                        Chapter 2: Results and Discussion - pH  
 
78 
The complexes based on DO3A-monoamide ligands and their phosphinate 
analogues are kinetically and thermodynamically stable, sufficiently soluble in water 
and can be safely used for in vivo applications. This was also confirmed by toxicity 
studies performed on [HoL
2
], which was tested on two cell lines, NIH 3T3 and CHO 
cells, with an incubation time of 24 hours. No toxicity was found up to 150 M (IC50 
> 150 M). The absence of toxicity may be due to the fact that the complex is not 
internalised by the cell under these conditions. 
From the first series, L
1
-L
5
 and L
13
, the best candidate was L
5
. [HoL
5
] showed a 
pKa of 7.13 with a shift variation of nearly 25 ppm over two units of pH. 
Furthermore, the presence of two isomers with different pH sensitivity allows the pH 
to be measured without need of chemical shift reference.  
Substitution of the carboxylate pendant arms with the corresponding phosphinate 
analogues, as in L
6
, led to a 4 times improvement of the linewidth, while 
maintaining the pKa value. [HoL
6
] therefore, represents the best pH reporter within 
the series under study thanks to a pKa of 7.09, with a variation of the fluorine 
chemical shift of more than 36 ppm over nearly three pH units, spanning the normal 
range of physiological and pathological pH conditions. The presence of two 
independent resonances allows an internal calibration, without the need for external 
referencing. Finally, the reduced linewidths enhance its suitability for chemical shift 
imaging (CSI) studies in vivo. 
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Chapter 3 
 
NMR characterisation of exchange 
phenomena and relaxation behaviour 
 
3.1 Introduction 
A series of lanthanide complexes has been described in Chapter 2, based on mono-
amide derivatives of DO3A, L
1
-L
5
 and DOTP, L
6
 and their characteristics as pH 
reporters for 
19
F NMR analysis discussed. Here, we report the spectroscopic 
properties of the same series of complexes, in particular their 
19
F NMR shift and 
relaxation properties, as well as 
1
H relaxivity studies on the Gd
3+
 analogues.  
 
3.2 Spectroscopic properties and conformational analysis 
The 
19
F NMR spectra of various lanthanide ion complexes of ligands L
1
-L
6
 have 
been recorded and their peculiar characteristics will be discussed here. 
 
3.2.1  p-Substituted systems  
The Ho, Tb, Er, Dy and Tm complexes of the para-substituted systems L
1
-L
3
 (Fig. 
3.1) showed similar characteristics. Upon dissolution of the complex in water, one 
main species was observed (>60%) by both 
19
F and 
1
H NMR spectroscopy (pD 5.4, 
295 K). Other minor species (up to eight) were observed, whose proportion varied 
according to the nature of the lanthanide ion. The relative isomeric composition did 
not change with time, while changes in the 
19
F spectrum were evident at different pH 
values (Fig. 3.2).  
 
N N
NN
O
O
OO
O
O
H
N
O
R
F3C
Ln
OH2
L1a  R = COOEt
L1b  R = COO-
L2    R = NO2
L3    R = CN
 
Fig. 3.1 General structure of the para-substituted complexes. 
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Indeed, as described in the previous chapter, the deprotonation equilibrium of the 
amide proton in this series of complexes, gives rise to two species: the protonated 
form and its conjugate base. These are in fast exchange on the NMR time scale. 
Therefore, they appear as a single signal corresponding to the weighted average of 
the chemical shifts of the two forms. At different pH values, the population of these 
two forms changes, and is reflected by a variation of the chemical shift.  
 
 
Fig. 3.2 
19
F NMR spectra for [LnL
2
] (H2O with D2O insert, 295 K, 376 MHz). Left: pH 
9 for Tb (upper), Ho (centre), Er (lower). Right: pH 5 in the same order. The 
differences in chemical shift, linewidth and number of species for the various 
lanthanide complexes of the same ligand, are evident at pH 5 and 9. 
 
Furthermore, the linewidth of the fluorine resonance also varied with pH, reaching a 
maximum at pH values corresponding to the pKa of the amide proton and decreasing 
at higher or lower values. This line broadening phenomenon is associated with 
chemical exchange between the protonated and non-protonated forms. For the p-
Tb 
Ho 
Er 
pH 9 pH 5 
                                                                    Chapter 3: Results and Discussion - NMR 
 
82 
nitro complexes, [LnL
2
], the linewidth variation with pH exhibited an unusual 
dependence, reaching a maximum in basic conditions. This behaviour, already 
explained in chapter 2, is probably due to a conformational exchange process 
associated with the cis-trans isomerisation around the C-N double bond. This 
produces line broadening selectively at basic pH.  
 
 
                     -30         -40          -50         -60          -70         -80          -90    ppm  
Fig. 3.3 
19
F NMR spectra for [LnL
3
] (H2O with D2O insert, 295 K, 376 MHz) 
illustrating the difference in chemical shift for each lanthanide complex of L
3
. For each 
metal F is proportional to the Bleaney constant CJ (Ho -39, Tb -86, Tm +53, Er +33), 
relative to the chemical shift of the ligand F = -61.9 ppm, or the diamagnetic Y
3+
 
complex at -62.0 ppm. 
 
ligand L
3 
Er 
Ho 
Tm 
Tb 
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For each complex, the chemical shift and linewidth changed according to the nature 
of the metal ion used (Fig. 3.2 and 3.3). The observed dipolar shift is related to the 
sign and magnitude of the Bleaney constant CJ (see section 1.3.1), which is a 
characteristic of each lanthanide ion. For example, Ho and Tb exhibit negative 
values of -39 and -86 respectively, while Tm and Er possess positive values of +53 
and +33, relative to -100 for Dy.
1
 Therefore, the fluorine resonance of Ho or Tb 
complexes are shifted to higher frequency, while Tm and Er analogues move to 
lower frequency, with respect to the chemical shift of the diamagnetic ligand (Fig. 
3.3), or its diamagnetic complex with Y
3+
.  
The Gd analogue, prepared for L
1b
, appeared in the 
19
F spectrum as a very broad 
signal (1325 Hz, 295 K, 188 MHz) with a chemical shift very similar to that of the 
ligand (F = -61.6 ppm). This is expected as the Gd
3+
 ion induces fast relaxation of 
the CF3 resonance, but causes no dipolar shift (CJ = 0)
1
. 
 
3.2.2  o-Substituted systems 
Very different behaviour was observed for the complexes of the ortho-substituted 
ligands, L
4a
, L
4b 
and L
5
 (Fig. 3.4).  
 
N N
NN
O
O
OO
O
O
H
N
O
F3C
Ln
OH2
L4a  R = COOEt
L4b  R = COO-
L5    R = CN
R
 
Fig. 3.4 General structure of the ortho-substituted series of complexes. 
 
In the 
1
H and 
19
F spectra of each lanthanide complex, two major species were 
observed. These were in 1:1 ratio for [LnL
4a
] and [LnL
5
] and 3:1 ratio for [LnL
4b
], 
with very different chemical shifts. For the [LnL
4a
] series for example, the two 
fluorine resonances were separated by 49.7 ppm for Tb, 33.4 ppm for Ho, 20.0 ppm 
for Er and 53.6 ppm for Tm. For the ortho-carboxylate series of complexes [LnL
4b
], 
the two signals had very similar fluorine chemical shifts to the ester analogues, but 
exhibited larger linewidths. For the ortho-cyano complexes [LnL
5
], under certain 
conditions of pH and according to the nature of the lanthanide used, one or two other 
resonances were observed. Their proportion and chemical shift varied for different 
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lanthanides and for each ortho-substituent. As will be explained in section 3.2.2.1, 
there are indeed four species in solution for the lanthanide complexes of L
4a
, L
4b 
and 
L
5
, but in most cases they were not resolved, so that only two resonances are noted.  
Different experiments were undertaken in order to explain this behaviour and 
identify the nature of the major species observed. Initially, the coordination 
environment around the Ln ion in each of the three series of complexes was 
interrogated. The europium emission spectra for both the ester and acid complexes 
were recorded at pH values between 5 and 8. They were identical in each case, as 
shown (Fig. 3.5, pH 7).   
 
Fig. 3.5 Emission spectrum of the ethyl ester [EuL
4a
] (blue) and the carboxylate 
[EuL
4b
] (red) (H2O, 295 K, pH 7).  
 
The metal hydration state (q value) was also assessed for the europium and terbium 
complexes of ligands L
4a
, L
4b 
and L
5
 by measuring the radiative lifetime of the 
lanthanide excited state, k, in H2O and D2O. The q values were calculated using 
equation 11 for Tb(III) and equation 12 for Eu(III).
2  
 
)06.0(5
22
 ODOHTb kkq           (12) 
 
)075.025.0(2.1
22
nkkq ODOHEu            (13) 
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where OHk 2  and ODk 2  are the reciprocals of the luminescence lifetimes of each 
complex, OH2   and OD2  respectively, and n is the number of carbonyl-bound amide 
NH oscillators. Lifetimes and calculated q values are reported in Table 3.1. 
 
Table 3.1 Measured lifetimes (± 10%) and calculated hydration numbers (± 20%) for 
Eu and Tb complexes of L
4a
,
 
L
4b 
and L
5
. 
Complex OH2 (ms) OD2 (ms) q 
[EuL
4a
] 0.54  1.87  1.2 
[TbL
4a
] 1.99  3.41 0.8 
[EuL
4b
] 0.59 1.67 0.9 
[TbL
4b
] 2.47 3.70 0.4 
[TbL
5
] 1.90 2.99 0.7 
 
The results are consistent with the presence of one water molecule directly bound to 
the metal centre in each case (except for [TbL
4b
]), consistent with the behaviour of 
published mono-amide DO3A derivatives
2 
and as observed for the para-substituted 
analogues. The identical Eu(III) emission spectra for the ester and acid complexes 
and the very similar hydration state observed, suggests that the same metal 
coordination environment is adopted in solution in each case. This strongly suggests 
that direct coordination of the carboxylate group to the lanthanide ion for [LnL
4b
] is 
not occurring.  
The observation of two major species in slow exchange on the NMR timescale 
suggested the presence of two isomers. Hence, a series of variable temperature 
19
F 
NMR experiments were performed in order to seek evidence for the presence of a 
dynamic exchange process between the two species.  
The fluorine spectrum of [TmL
4a
] was recorded at pH 5 over the temperature range 
283 K to 323 K (470 MHz). The two resonances (F = -38.0 ppm and F = -91.6 ppm 
at 293 K) shifted very slightly towards each other as the temperature increased and 
showed an increased linewidth passing from 1/2 ~ 70 Hz at 293 K to 1/2 ~ 600 Hz 
at 323 K. Only a small change in chemical shift (less than 5 ppm) was observed and 
no coalescence phenomenon was noted in the temperature range under study.  
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The same experiment was carried out for [TmL
4b
] at pH 5 (D2O insert, 470 MHz). 
The two 
19
F resonances (F = -37.0 ppm and F = -90.0 ppm at 293 K) shifted and 
broadened with increasing temperature. In this case, a coalescence phenomenon was 
observed, with a single major resonance formed at 320 K at F = -84.0 ppm (1/2 = 
1800 Hz). This behaviour is consistent with the presence of a dynamic exchange 
between the two species for [TmL
4b
], with an activation energy of the order of 50 
kJmol
-1
 ( = 24,500 Hz), based on an Eyring analysis3. The Eyring equation is 
expressed as: 
 
RT
G
b
r e
h
Tk
k
#

           (14) 
 
where kb is Boltzmann’s constant, h Planck’s constant and R the gas constant. 
Equation 14 can be rewritten as: 
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or 



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







rk
T
RTG ln760.23#            (16) 
 
Knowing the rate constant kr for the dynamic exchange and the temperature of 
coalescence Tc, it is possible to estimate the activation energy G
#
 for the process. 
The rate constant kr at the coalescence temperature is expressed as: 
 
2

rk           (17) 
 
where  is the separation in Hz of the two peaks in the slow exchange regime, i.e. 
at lower temperature.  
The same behaviour was also noted in 
1
H and 
19
F NMR variable temperature 
experiments using [EuL
4b
] between 278 and 323 K at pH 5 and 470 MHz. In each 
case, a coalescence phenomenon was observed. In the 
19
F NMR spectrum, a single 
resonance was observed at F = -61 ppm (1/2 = 900 Hz) at 310 K, becoming 
narrower at higher temperature (1/2 = 460 Hz at 323 K). 
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In the case of the ortho-cyano system L
5
, variable temperature experiments were 
performed with the dysprosium and yttrium complexes between 278 and 323 K 
(D2O insert, 470 MHz). For [DyL
5
], the two signals (F = -60 ppm and F = -111 
ppm at pH 5, F = 0 ppm and F = -80 ppm at pH 9, 293 K) shifted and broadened at 
higher temperatures, both at pH 5 and 9, but no coalescence was observed.  
Different behaviour was found for [YL
5
]. Its 
19
F NMR spectrum at room 
temperature (293 K) showed a single broad resonance at pH 5 (F = -61.6 ppm, 1/2 
= 126 Hz, 376 MHz), that resolved into two broad resonances at pH 9 (F = -61.6 
ppm, 1/2 ~ 560 MHz and F = -62.8 ppm, 1/2 ~ 560 MHz, 376 MHz). In the basic 
sample, the two signals coalesced at higher temperature (310 K) to form a single 
resonance (F = -62.0 ppm, 1/2 ~ 250 Hz), that narrowed on increasing the 
temperature (1/2 ~ 110 Hz at 323 K). At lower temperatures, the two signals 
resolved and sharpened (Fig. 3.6). The activation energy, calculated with the Eyring 
analysis, in this case is of the order of 60 kJmol
-1
, higher than for the acid 
compound.  
The Y
3+
 ion has a very similar ionic radius to Ho
3+
,
 4
 and its complexes are 
frequently isostructural. The isostructural nature of the various lanthanide complexes 
of the same ligand and the common coordination environment that characterises 
each case, allows us to extend consideration of the dynamic process observed for 
[YL
5
] to the paramagnetic complexes in which the coalescence phenomenon was not 
apparent. In these cases, the fluorine resonances are significantly separated in Hz 
(large), therefore a higher temperature is required to observe the coalescence 
phenomenon. In particular for the complexes of the ortho cyano and ester ligands, 
L
5
 and L
4a
, where the activation energy is higher, the temperature required to 
observe a coalescence phenomenon is probably out of the observable range. As 
expressed in equation 14 in fact, the rate constant kr and the coalescence temperature 
Tc are directly proportional, and kr is related to the chemical shift difference 
between the resonances of the two species in exchange. Therefore, for larger  
values, it is necessary to reach higher temperatures to observe the coalescence 
process.  
In order to explain the observed exchange phenomena, the rotation of the phenyl 
ring around the C-N bond was considered. This varies the CNCC dihedral angle, 
resulting in a repositioning of the CF3 group with respect to the metal centre. To 
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address the likelihood of this hypothesis, DFT calculations on these systems were 
performed by Ilya Kuprov and Naomi Hogg at the University of Durham. 
 
 
Fig. 3.6 
19
F NMR variable temperature of [YL
5
] (D2O insert, pH 9, 470 MHz). From 
the bottom: 278, 288, 310 and 323 K. A coalescence phenomenum is visible at ~310 K. 
 
278 K 
288 K 
310 K 
323 K 
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 A relaxed potential energy scan was undertaken with respect to the CCNC dihedral 
angle for the Y(III) complex of ligands L
4a
, L
4b
 and L
5
. Indeed, two distinctive 
minima were identified, characterised by very different positions of the CF3 group 
relative to the lanthanide ion (Fig. 3.7), and separated by an energy barrier of more 
than 20 kJmol
-1
. If the metal-water-oxygen vector is taken as the principal axis, the 
CF3 groups for each isomer are oriented at angles of -114° and +44°, which would 
result in opposite pseudocontact shifts. The direction and size of the observed 
chemical shift of the fluorine signals agrees well with the calculated theoretical 
values.   
 
 
              Major   = -114°                                Minor   = +44° 
 
Fig. 3.7 DFT calculated structures showing the two low-energy isomers of [LnL
4a
] 
associated with the rotation of the phenyl ring around the C-N bond.   
 
3.2.2.1  In depth stereochemical analysis 
As previously mentioned (section 3.2.2), the 
19
F NMR spectra of the ortho cyano 
complexes, [LnL
5
], often exhibited one or two resonances in addition to the two 
major species. This was particularly clear in the fluorine spectrum of [TmL
5
] at pH 
9 were four major resonances were observed at F = -39.9, -41.2, -63.9 and -109.0 
ppm. They appeared as two sets of paired resonances of equal intensity (Fig. 3.8).  
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Fig. 3.8 
19
F NMR spectrum of [TmL
5
] (H2O, D2O insert, pH 9, 470 MHz), showing the 
presence of four major species (     ). 
 
A 
19
F EXSY experiment performed on [TmL
5
] (470 MHz) confirmed the 
occurrence of chemical exchange between at least two exchange sites. The clear 
presence of four fluorine resonances in slow exchange suggested that additional 
dynamic processes, to those discussed in the previous section, had to be considered 
to explain the observed behaviour. Normally, for DO3A mono-amide systems, the 
main coordination geometry adopted in solution is mono-capped square-
antiprismatic (CAP), consisting of two enantiomeric species  and  
present in a 50:50 ratio, that are indistinguishable by NMR. The two isomers can 
interconvert by inversion of configuration of the macrocyclic ring () and 
concurrent (but independent) rotation of the acetate arms () (Fig. 3.9).5,6  
The introduction of an ortho-substituent on the aromatic ring slows down the rate of 
rotation around the C-N bond, and renders the mono-amide arm a chiral element. 
Thus, the CF3 group can be positioned at different angles with respect to the metal 
centre. This increases the number of observable diastereoisomers present in solution. 
Therefore, it is postulated that the four species observed are: -CF3 up; 
-CF3 down; -CF3 up and -CF3 down. As noted above, the rate 
of interconversion is slower for the ortho-cyano [LnL
5
] and ortho-ester [LnL
4a
] 
series of complexes, and is faster for the carboxylate analogue [LnL
4b
]. 
Furthermore, the activation energy differs for the protonated amide and its conjugate 
base, and varies for each series of complexes. 
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Fig. 3.9 Schematic representation of the two coordination geometry adopted in DOTA 
complexes: mono-capped square-antiprismatic (CAP) and twisted square-antiprismatic 
(TSAP) and their interconvertion processes. The DO3A mono-amide complexes 
normally adopt the CAP configuration (Figure taken from reference 
6
).
 
 
As noted for the para-isomers, the isomeric composition of all the ortho-substituted 
systems did not vary with time. Also, a characteristic pH dependent variation of the 
19
F chemical shift and of the observed linewidth for each resonance was found, as 
previously described in Chapter 2. The linewidth variation with pH was different in 
the case of the cyano complexes, [LnL
5
]. An increase in 1/2 was observed not only 
around pH values corresponding to the pKa due to the chemical exchange between 
protonated and non-protonated form, but also in an acidic environment. At pH 5, the 
line broadening was independent of the Ln(III) ion (1/2 ≈ 500 Hz for Tb, Dy, Ho, 
Er, Tm at 9.4 T) and for a given metal was independent of the applied field (1/2 ≈ 
550 Hz at both 4.7 and 9.4 T for Tb). The activation energy for the dynamic 
CAP 
          CAP TSAP 
        TSAP 
 
ring 
inversion 
 
ring 
inversion 
arm 
rotation 
arm 
rotation 
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exchange between two conformers is different for the protonated amide and its 
conjugate base, the latter probably inhibiting slightly more the rotation of the ring 
around the C-N bond due to the effect of increased -conjugation (Fig. 3.10). This 
hypothesis is consistent with the observed behaviour in the 
19
F NMR spectra for the 
[YL
5
] at basic and acidic pH. As described in section 3.2.2, at pH 5 it appears as a 
single signal, which resolves to two broad peaks at pH 9.  
 
O
N
H
N
CN
OH2
- H+
+ H+
F3C O
N
N
C
OH2
F3C
N
higher G#lower G#
 
Fig. 3.10 Schematic representation of the effect of -conjugation in the deprotonated 
form. This may inhibit the rotation around the C-N bound, leading to different 
activation energy for the protonated (left) and deprotonated form (right) in [LnL
5
]. 
 
3.2.3 o-Substituted phosphinate analogue: a system of added 
complexity 
The replacement of the carboxylate groups by phosphinates, adds three 
supplementary chiral centres in the complex, as each P can have an S or R 
configuration (Fig. 3.11). In theory, 32 isomers are possible
7,8
 (because of ,  
and R/S permutations). In practice, one main favoured species was observed in the 
original investigations of such systems
7,8
.
 
This corresponds to a pair of enantiomers 
with a twisted square-antiprism geometry (TSAP),  or , with the same 
configuration at each phosphorus centre, i.e. enantiomeric RRR/and 
SSS/isomers were the preferred species7,8.  
 
N N
NN
P
P
O
O
P
OO
O
O
H
N
O
F3C
CNLn
R/S
R/S
R/S  
Fig. 3.11 General structure for ortho-substituted phopsphinate complexes [LnL
6
]. 
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The presence of the second substituent in the ortho position on the aromatic ring, 
introduces a chiral element. The slower rate of rotation of the aryl ring around the C-
N bond leads to two isomeric species, as observed for the ortho substituted DO3A 
analogues. Therefore, if the stereogeniticy at P is the same for a given isomer, the 
four most likely diasteroisomers will be: RRR/-CF3 up; RRR/-CF3 
down; SSS/-CF3 up and SSS/-CF3 down. These diastereoisomers are 
likely to be present in different relative ratios. Furthermore, the presence of the 
bulky phosphorus groups, serves to reduce the rate of cooperative arm rotation 
interchange
9
 (). This may result in sharper resonances.  
The observed 
19
F NMR spectra, for each [LnL
6
] complex, appeared as four main 
resonances: two overlapped (often non resolved) with chemical shift very close to 
that of the protonated ligand (F = - 61.6 ppm). The other two species had large 
dipolar shifts. [HoL
6
] for example, at pH 6.8 showed three main resonances at -46.8, 
-59.6 and -95.5 ppm in the ratio 1:2.7:3.1.  
The isomeric composition did not change with time (up to 48 h) in this case and the 
characteristic pH dependence of chemical shift and linewidth, already described in 
chapter 2, was observed for the two more shifted resonances, while the peak at -59.6 
ppm showed only very small shift changes. Overall, the resonances appeared much 
sharper than those of the carboxylate analogues, reducing from 1/2 ~ 800 Hz to 1/2 
~ 230 Hz (188 MHz for [HoL
5
] vs [HoL
6
]).  
Variable temperature 
19
F NMR experiments were performed on [HoL
6
] at pH 5 and 
9 between 278 and 323 K. The two most shifted resonances moved towards each 
other as the temperature increased, and became slightly narrower at higher 
temperatures in each case; no coalescence phenomenon was observed in the 
temperature range under study. It is likely that the activation energy associated with 
this dynamic exchange process is high and observation of coalescence is beyond the 
range of temperatures under study, as explained in the previous section (3.2.2). 
The hydration state of the phosphinate complex [TbL
6
] was measured (Table 3.2), 
using equation 12 (page 84). The q value was 0.02 so that no water molecules are 
directly coordinated to the metal, as expected for such phosphinate derivatives
2
, in 
which the bulky side arms inhibits approach of a water molecule to the metal centre.  
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Table 3.2 Measured lifetimes (± 10%) and calculated hydration numbers (± 20%) for 
[TbL
6
]. 
Complex OH2 (ms) OD2 (ms) q 
[TbL
5
] 3.28 4.03 0.02 
 
3.3 
19
F relaxation model for Ln(III) complexes and 
relaxation properties 
The relaxation process of a 
19
F nucleus in a non-viscous solution of a paramagnetic 
molecule is regulated by five principal mechanisms: chemical shift anisotropy 
(CSA), inter-nuclear dipole-dipole (DD) interaction, electron-nucleus contact 
interaction, electron-nucleus dipole-dipole interaction and a special case of the latter 
one named Curie relaxation.  
To describe the 
19
F relaxation in the specific case of the lanthanide complexes here 
reported, some simplifications can be introduced. The CSA contribution for a 
trifluoromethyl group is generally small, and the inter-nuclear dipole-dipole (DD) 
interaction is negligible compared to the larger electron-nuclear interactions. 
Together they cannot account for more than 1 Hz, for relaxation rates that are 
normally of the order of 100 Hz, and therefore they can be neglected. The electron-
nucleus contact interaction is not significant on the basis of DFT models which 
showed an expected value of zero for fluorine nuclei over 5 Å from the metal
10
. The 
other two mechanisms, electron-nucleus dipole-dipole interaction (equations 18-19) 
and Curie relaxation (equations 20-21), contribute considerably and are respectively 
described as follows
11,12
 (a simplified version has been presented in Chapter 1): 
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where )( 11
1 
  eReR T and ee TT 21  ,R is the rotational correlation time, T1,2 the 
electronic relaxation rates, F the fluorine Larmor frequency, γF the fluorine 
gyromagnetic ratio, μB the Bohr magneton, k the Boltzmann constant, ge the electron 
g-factor (or Landé factor), µ0/4π the magnetic permeability of a vacuum, S(S+1) the 
total electron angular momentum and r is the Ln-fluorine distance. 
The combination of these two mechanisms gives the following equations that 
describe the total relaxation rates:  
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where 2222 Sg Beeff    is the effective magnetic moment of the Ln
3+
 ion and e is 
the electron Larmor frequency. 
Volumetric plots have been produced based on these equations, calculating the 
19
F 
longitudinal and transversal relaxation rates R1 and R2 as a function of the applied 
magnetic field (B0), the rotational correlation time (R) and the distance between the 
fluorine nucleus and the paramagnetic centre (r). Values of eff   = 10.0 and T1e = 
0.20 ps were used for an idealised complex (Fig. 3.12).  
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a)                                                                           b) 
 
Fig. 3.12 Volumetric plots showing a) R1 and b) R2 as a function of the applied 
magnetic field B0, the rotational correlation time R, and the distance from the 
lanthanide ion r, for a idealised complex with eff  = 10.0 and T1e = 0.20 ps. 
 
The plots visualise the rapid decrease of R1 and R2 with the distance from the 
Ln(III), as expected from the r
-6
 dependence expressed in equations 22 and 23; R2 
rises with the increase of the correlation time and the field applied.   
The correlation between the longitudinal relaxation rate and the 
19
F-Ln distance 
expressed in equation 21, allows the latter parameter to be readily calculated by 
fitting R1 values recorded at different magnetic fields to the equation
10
. For this 
purpose 
19
F longitudinal relaxation times for selected complexes of ligands L
1
-L
5
 
were recorded at four different magnetic fields using the inversion recovery 
technique (1 mM, D2O, pD 5.4, 295 K). The large number of data collected allowed 
a direct global fit to equation 22 to be performed, without any further 
simplifications. Values of eff and R reported in the literature are estimated using 
the coordinated water protons of Gd complexes, i.e. an intermolecular effect. In 
contrast, in our case there is an intramolecular interaction between the lanthanide ion 
and the fluorine nuclei.  Hence, we calculated eff and R directly from the 
experimental data using a global fitting procedure. Because of the small difference 
in ionic radius over the series of lanthanide metals under study (Tb, Ho, Er, Tm), r 
and R were considered global variables, thus the same in each case. The value of 
eff instead was allowed to vary for each lanthanide. The eff values estimated from 
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the calculations are listed in Table 3.3, as well as the values reported in the 
literature. When using the literature values of eff, the error in the calculations of the 
distance r and the correlation time R is smaller, but the measurement may be 
affected by the approximations used. On the contrary, by allowing calculation of 
eff, the error increases because of the larger number of variables in the computation.  
 
Table 3.3 eff  values reported in literature and measured from experimental data. 
Ln(III) Literature
1 
Estimated 
Tb 9.7 9.8 ± 1.8 
Dy 10.6 10.6 ± 1.9 
Ho 10.6 10.4 ± 1.9 
Er 9.6 9.1 ± 1.6 
Tm 7.6 7.6 ± 1.4 
 
An example of the analysis is reported for the Tb, Ho, Er and Tm complexes of L
4a
. 
The experimental R1 values are reported in Table 3.4 for the two isomers in 1:1 
ratio, present in the 
19
F NMR spectrum (see section 3.2.2). 
 
Table 3.4 
19
F Longitudinal relaxation rates (Hz) for [LnL
4a
] (295K, pD 5.4, D2O). 
[LnL
4a
] 4.7 T 9.4 T   
Tb  
149 250 323 565 
100 147 179 192 
Ho 
91 233 333 588 
71 137 172  313 
Er 
59 152 20.5 313 
45 88 110 161 
Tm  
53 100 135 294 
37 56 68 152 
 
The global least square fitting of the data is reported below (Fig. 3.13). 
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a)                                                                        b)                     
 
 
 
 
 
 
 
 
 
 
 
 
c)                                                                        d)                     
Fig. 3.13 R1 of the two isomers of [LnL
4a
] as a function of F (4.7, 9.4, 11.7, 16.5 T, 
D2O, 1mM, 295 K), showing the global least squares fit (line). a) Ho, b) Er, c) Tb, d) 
Tm. 
 
The analyses were performed by Dr. Ilya Kuprov at the University of Durham. The r 
values obtained for the two isomers were 5.7 ± 0.1 Å and 6.3 ± 0.2 Å with τR = 270 
± 10 ps. The DFT calculated structures (section 3.2.2) resulted in values of 5.6 Å 
and 6.2 Å, with an estimated τR = 300 ps. Based on the calculated distances of 5.7 
and 6.3 Å, a volumetric plot is reported to describe the R1 variation as a function of 
eff and B0, using a τR = 250 ps and a τe = 0.2 ps (Fig. 3.14). The plot shows a 
noticeable increase of the longitudinal relaxation rate at higher fields for Ho and Er 
complexes and a smaller change for Tm. Hence, to achieve fast relaxation (R1) 
without excessive line broadening (R2) within the distance range of 5.7 to 6.3 Å, Tb 
and Dy complexes seem to be the metals of choice for lower magnetic field analyses 
between 3 and 7 T. Ho and Er look more promising in the medium strength range, 7 
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to 11.5 T, as for higher fields line broadening intervenes. At fields higher than 11.5 
T, Tm seems to be the metal of choice.  
 
 
Fig. 3.14 Volumetric plot showing the variation of R1 as a function of the applied 
magnetic field B0, the effective magnetic moment eff  for r = 5.7 and 6.3 Å.R = 250 
ps, e = 0.2 ps. 
 
The calculated Ln-F distances are supported also by independent crystallographic 
measurements (for crystallographic details see appendix B). The crystal structure of 
the trisubstituted para-ethyl ligand 4 has been obtained (Fig. 3.15). Thanks to the 
sodium cation positioned at the centre of the macrocycle, which is coordinated to the 
oxygen and the nitrogen atoms, the macrocycle assumes the same conformation as in 
the corresponding lanthanide complexes. In the X-ray structure, the CF3 group is 
distorted by libration about one of the three fluorine atoms, resulting in partial 
occupancy of two sites (occupied as 80:20). The nearest distances of the Na
+
 ion to 
the fluorines in the partially occupied sites were 6.05 and 6.14 Å. The ionic radio for 
the eight coordinated Na
+
 ion is 1.32 Å, slightly larger than the value of 1.21 Å for 
the nine coordinated Ho
3+
 and Y
3+ 4
. The smaller minimum distances obtained with 
the sodium ion are consistent with its larger size. This supports the values calculated 
by fitting of R1 values to equation 22 and with the computed DFT structures.  
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Fig. 3.15 Crystal structure of the trisubstituted para-ethyl ligand 4, containing an 
octadentate Na
+
 ion with bromide as the counter ion, hydrogen-bonded to the amide 
proton. The two structures are the same molecule seen from above and below (for 
crystallographic details see appendix B). 
 
The experimental relaxation rates and chemical shift data for selected lanthanide 
complexes of ligands L
1
-L
6
 are reported below (Table 3.5-3.12). As expected from 
the presence of the eff
2
 and eff
4
 terms in equations 22 and 23, the relaxation rates 
follow the order Dy>Tb>Ho>Er>Tm.  
For the para-substituted complexes [LnL
1
]-[LnL
3
] the longitudinal relaxation rates 
for a given lanthanide were very similar in each case (Table 3.5-3.6). As discussed 
in chapter 2, the chemical shift and the linewidth changed with pH. Here, we note 
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also that T1 varies with pH, following the change in the linewidth. In general, for 
larger values of 1/2, smaller values of T1 are observed and vice versa. 
 
Table 3.5 Longitudinal relaxation times (T1/s) and chemical shifts (ppm) for [LnL
1a
]. 
[LnL
1a
] Tb Dy Ho Er Tm 
F (ppm) - 49.3 - 53.8 - 48.8 - 62.4 - 78.1 
188 MHz 0.014 0.011 0.018 0.034 0.039 
376 MHz 0.0080 0.0073 0.0083 0.015 0.022 
470 MHz 0.0067 0.0052 0.0063 / 0.018 
658 MHz 0.0052 0.0038 0.0042 / 0.014 
 
 
Table 3.6 Longitudinal relaxation times (T1/s) and chemical shifts (ppm) for [LnL
1b
]. 
[LnL
1a
] Tb Dy Ho Er Tm 
F (ppm) - 51.2 - 62.3 - 54.6 - 62.0 - 79.9 
188 MHz 0.014 0.012 0.020 0.034 0.035 
376 MHz 0.0080 0.0066 0.0075 0.015 0.020 
470 MHz 0.0066 0.0053 0.0065 / 0.017 
658 MHz 0.0050 0.0039 0.0046 / 0.013 
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Table 3.7 Longitudinal relaxation times (T1/s), chemical shifts (ppm) and linewidths 
(1/2/Hz) for [LnL
2
] at pH 5 and 9. 
Tb F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 26.4 366 0.013 
pH 5 - 50.2 73 / 
376 MHz 
pH 9 - 26.7 513 0.0076 
pH 5 - 50.0 128 / 
Dy F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 59.0 700 0.012 
pH 5 - 65.5 74 / 
Ho F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 38.1 340 0.019 
pH 5 - 55.0 31 0.025 
376 MHz 
pH 9 - 41.0 403 0.011 
pH 5 - 56.8 73 0.010 
Er F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 73.8 118 0.030 
pH 5 - 64.7 63 / 
376 MHz 
pH 9 - 74.6 277 0.014 
pH 5 - 64.8 74 / 
Tm F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 90.0 277 0.026 
pH 5 - 77.5 45 0.057 
376 MHz 
pH 9 - 89.6 442 0.017 
pH 5 - 77.8 43 0.033 
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Table 3.8 Longitudinal relaxation times (T1/s), chemical shifts (ppm) and linewidths 
(1/2/Hz) for [LnL
3
] at pH 5 and 9. 
Tb F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 33.1 190 0.012 
pH 5 - 50.1 60 0.016 
376 MHz 
pH 9 - 32.9 480 0.0072 
pH 5 - 50.0 130 0.0096 
Ho F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 42.5 125 0.020 
pH 5 - 55.4 45 0.024 
376 MHz 
pH 9 - 42.4 332 0.0084 
pH 5 - 55.4 72 0.011 
Er F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 72.2 95 0.029 
pH 5 - 64.1 39 0.040 
376 MHz 
pH 9 - 72.3 130 0.014 
pH 5 - 64.2 52 0.018 
Tm F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 87.6 99 0.028 
pH 5 - 78.2 36 0.058 
376 MHz 
pH 9 - 87.8 153 0.017 
pH 5 - 78.2 41 0.034 
 
The ortho-substituted complexes of L
4a
 and L
5
 showed different relaxation rates for 
the two isomers (Table 3.9-3.11), consistent with their different position with respect 
to the metal centre, as previously discussed. In the case of the ortho-acid analogue 
[LnL
4b
] the two isomers possess similar values of R1 (Table 3.10), evident in 
particular at lower fields, consistent with the presence of a lower energy dynamic 
exchange process between the two species in solution that have been already 
described (section 3.2.2, page 86). 
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Table 3.9 Longitudinal relaxation times (T1/s), chemical shifts (ppm) and linewidths 
(1/2/Hz) for [LnL
4a
] at pH 5 and 9. 
Tb F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 19.6/- 81.5  203/148 0.010/0.0068 
pH 5 - 39.3/- 89.0 89/125 0.010/0.0067 
376 MHz 
pH 9 - 19.7/- 81.5 598/284 0.0067/0.0039 
pH 5 - 39.3/- 88.9 120/182 0.0068/0.0040 
470 MHz pH 5 // 175/385 0.0056/0.0031 
658 MHz pH5 // / 0.0034/0.0018 
Ho F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 32.0/- 72.8 332/320 0.015/0.010 
pH 5 - 46.8/- 80.8 260/262 0.014/0.011 
376 MHz 
pH 9 - 31.7/- 73.2 326/268 0.0077/0.0042 
pH 5 - 47.1/- 80.5 104/162 0.0073/0.0043 
470 MHz pH 5 // 175/385 0.0057/0.0026 
658 MHz pH5 // /  /588 0.0032/0.0017 
Er F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 49.5/- 75.8 105/95 0.016/0.022 
pH 5 - 46.4/- 66.6 93/69 0.017/0.022 
376 MHz 
pH 9 - 49.5/- 75.8 164/169 0.0064/0.012 
pH 5 - 46.4/- 66.7 133/86 0.0066/0.011 
470 MHz pH 5 // 213/110 0.0057/0.0026 
658 MHz pH5 // 313/162 0.0032/0.0062 
Tm F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 38.8/- 101.6 116/128 0.015/0.021 
pH 5 - 36.8/- 90.4 87/70 0.019/0.027 
376 MHz 
pH 9 - 38.7/- 101.7 156/306 0.0078/0.014 
pH 5 - 36.8/- 90.4 109/76 0.010/0.018 
470 MHz pH 5 // 135/68 0.0074/0.015 
658 MHz pH5 // /  /147 0.0035/0.0077 
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Table 3.10 Longitudinal relaxation times (T1/s), chemical shifts (ppm) and linewidths 
(1/2/Hz) for [LnL
4b
] at pH 5 and 9. 
Tb F (ppm) 1/2 (Hz) T1 (s) 
188 MHz pH 5 - 42.1/- 89.8 / 0.0099/0.012 
376 MHz pH 5 - 41.1/- 89.2 485/622 0.0060/0.0063 
470 MHz pH 5 // / 0.0042/0.0037 
658 MHz pH5 // / 0.0036/0.0031 
Ho F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 45.3/- 79.3 371/392 0.015/0.014 
pH 5 - 46.4/- 79.3 377/530 0.015/0.016 
376 MHz 
pH 9 - 45.4/- 79.1 404/655 0.0071/0.0072 
pH 5 - 47.1/- 80.5 / 0.0071/0.0070 
470 MHz pH 5 // / 0.0045/0.0040 
658 MHz pH5 // / 0.0036/0.0029 
Er F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 45.7/ - 67.1 460/258 0.026/0.027 
pH 5 - 45.9/- 66.6 542/263 0.026/0.026 
376 MHz 
pH 9 - 46.0/- 67.1 572/293 0.011/0.011 
pH 5 - 45.9/- 66.6 565/250 0.011/0.012 
470 MHz pH 5 // / 0.0071/0.0080 
658 MHz pH5 // / 0.0047/0.0054 
Tm F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 35.4/- 89.3 220/280 0.029/0.031 
pH 5 - 35.4/- 88.9 425/351 0.039/0.034 
376 MHz 
pH 9 - 36.0/- 89.5 389/303 0.018/0.018 
pH 5 - 36.1/- 89.0 435/275 0.017/0.018 
470 MHz pH 5 // / 0.004/0.0091 
658 MHz pH5 // / 0.0016/0.0063 
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The values in brackets for [LnL
5
], refer to data for the third and fourth species when 
present (Table 3.11). One of the species exhibits longer longitudinal relaxation times 
and a smaller pseudocontact shift compared to the other species. This is probably 
related to the particular position of the CF3 group in this isomer with respect to the 
lanthanide ion. 
 
Table 3.11 Longitudinal relaxation times (T1/s), chemical shifts (ppm) and linewidths 
(1/2/Hz) for [LnL
5
] at pH 5 and 9. 
Tb F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 
- 3.9/- 73.1 
(- 68.4)  
192/232 
(173) 
0.0091/0.0081 
(0.0071) 
pH 5 
- 40.6/- 84.6 
(- 57.4) 
670/505 
(82) 
0.0091/0.0090 
(0.047) 
376 MHz 
pH 9 
- 4.0/- 73.1 
(- 68.3) 
240/270 
(216) 
0.0077/0.0037 
(0.0035) 
pH 5 
- 40.5/- 84.6 
(- 57.5) 
631/560 
(140) 
0.0061/0.0052 
(0.028) 
Dy F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 
2.5/- 76.0 
(- 63.1/- 77.8)  
281/272 
(178/92) 
0.0085/0.0079 
(0.0051/0.024) 
pH 5 
- 59.3/- 109.9 
(- 78.0) 
465/515 
(98) 
0.0089/0.0078 
(0.043) 
376 MHz 
pH 9 
3.3/- 75.5 
(- 63.0/- 78.0) 
351/334 
(258/151) 
0.0055/0.0039 
(0.0027/0.021) 
pH 5 
- 59.3/- 110.1 
(- 78.3) 
536/578 
(157) 
0.0053/0.0045 
(0.022) 
             Ho F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 25.6/- 68.8 196/212 0.013/0.012 
pH 5 
- 48.8/- 78.1 
(- 61.0) 
745/419 
(93) 
0.013/0.013 
(0.061) 
376 MHz 
pH 9 
- 26.9/- 69.3 
(- 61.1) 
310/302 
(102) 
0.0077/0.0042 
(0.027) 
pH 5 
- 49.5/- 78.9 
(- 61.8) 
562/513 
(167) 
0.0065/0.0061 
(0.027) 
Er F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 
- 53.1/- 81.5 
(- 58.3) 
281/190 
(74) 
0.016/0.019 
(0.097) 
pH 5 
- 49.6/- 67.6 
(- 58.2) 
423/453 
(94) 
0.023/0.023 
(0.098) 
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376 MHz 
pH 9 
- 53.2/- 81.5 
(- 53.7/- 58.2) 
422/210 
(489/95) 
0.0084/0.0096 
(0.0076/0.043) 
pH 5 
- 49.5/- 67.4 
(- 58.1) 
420/387 
(91) 
0.010/0.011 
(0.044) 
Tm F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 
- 39.9/- 109.0 
(- 41.2/- 63.9) 
    417/195 
   (118/101) 
0.014/0.012 
(0.013/0.14) 
pH 5 
- 39.0/- 88.1 
(- 63.7) 
444/419 
(99) 
0.022/0.024 
(0.12) 
376 MHz 
pH 9 
- 39.9/- 109.0 
(- 41.2/- 63.9) 
238/208 
(149/103) 
0.0073/0.0092 
(0.0057/0.071) 
pH 5 
- 38.9/- 88.2 
(- 63.7) 
405/468 
(131) 
0.013/0.015 
(0.058) 
 
 
For the phosphinate complexes [LnL
6
], faster longitudinal relaxation rates and 
smaller linewidths were generally observed, but with differences among the isomers 
in solution (Table 3.12). Different behaviours for each isomer was already observed 
for [LnL
5
]. Also for [LnL
6
] we observe a resonance with a relatively slow 
relaxation time, only slightly shifted from the ligand position, as for [LnL
5
].  
The substitution of the carboxylate arms with the bulky phosphinate analogues, 
results in the inhibition of the cooperative arm rotation rigidifying the system and 
therefore reducing the linewidth associated with this exchange process. The faster 
longitudinal relaxation rate can be attributed to a shorter distance between the CF3 
group and the metal, in this series of complexes, consistent with the more compact 
structure for this eight coordinate (q = 0) system. 
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Table 3.12 Longitudinal relaxation times (T1/s), chemical shifts (ppm) and linewidths 
(1/2/Hz) for [LnL
6
] at pH 5 and 9. 
Tb F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 - 62.3/- 90.6 87/75 0.31/0.0076 
pH 5 
- 52.1/- 62.7/- 
98.5 
149/160/77 0.012/0.50/0.0060 
376 MHz 
pH 9 - 62.4/- 90.5 71/142 0.41/0.0042 
pH 5 
- 52.3/- 62.7/- 
98.4 
366/281/131 0.0077/0.38/0.0038 
Ho F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 
- 26.3/- 62.0/- 
87.3 
102/111/87 0.0090/0.39/0.0071 
pH 5 
- 61.6/- 62.4/-
106.4 
101/99/83 0.019/0.038/0.0075 
376 MHz 
pH 9 
- 26.4/- 62.1/- 
62.3/- 87.2 
253/231/283/185 0.0046/0.32/0.22/0.0039 
pH 5 
- 61.7/- 62.4/-
106.3 
595/218/170 0.0056/0.064/0.0041 
Tm F (ppm) 1/2 (Hz) T1 (s) 
188 MHz 
pH 9 
-16.5/- 62.3/- 
133.6 
82/45/102 0.0064/1.07/0.030 
pH 5 
- 1.2/- 62.3/- 
106.4 
73/127/61 0.0077/0.54/0.026 
376 MHz 
pH 9 
-16.5/- 62.4/- 
134.5 
145/52/397 0.0036/0.23/0.012 
pH 5 
- 1.0/- 62.4/- 
106.9 
170/232/184 0.0047/0.27/0.015 
 
 
3.4 
1
H NMR relaxation studies of Gd complexes 
The gadolinium complexes of the ligands discussed in this work can be used as 
conventional contrast agents for proton MRI, thanks to their ability to increase the 
relaxation rate of the water protons. Hence, the proton relaxation properties of some 
examples have been studied. 
The capability of a contrast agent to enhance the water proton relaxation rates is 
called relaxivity (r1), when referred to a unit concentration of the agent. The 
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observed relaxation rate (R1obs) of the water protons in the presence of a Gd complex 
is the sum of diamagnetic R1d and paramagnetic contributions R1p: 
 
pdobs RRR 111            (24) 
 
The paramagnetic contribution is proportional to the concentration of the 
paramagnetic species in solution (Equation 25) and is formed by contributions from 
inner sphere water molecules R1
is
, which are directly coordinated to the metal, the 
second sphere water molecules R1
ss
, which form interactions through hydrogen 
bonding, and the outer sphere R1
os
, which form a layer of diffusing water molecules 
around the complex (Equation 26): 
 
 GdrRR dobs 111            (25) 
osssis
dobs RRRRR 11111            (26) 
 
The inner sphere contribution is given by equation 27: 
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5.55
          (27) 
 
where C is the concentration in mM of the Gd complex, q is the number of bound 
water molecules, τm is the water residence lifetime at the Gd and 
H
mT1 is the 
longitudinal relaxation time of the coordinated water protons
13
. The latter is 
described by the following equation: 
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where γH is the gyromagnetic ratio for proton, g the electron g-factor, B the Bohr 
magneton, S the electron spin magnetic number, rGdH the distance between Gd and 
the inner sphere water proton, H and S the Larmor frequency for the proton and 
the electron, andci (i = 1, 2) the correlational times relative to the electron-proton 
dipolar coupling
13
. The latter can be modulated by the rotational correlation time R, 
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the residence lifetime of the water on the metal ion m and the electronic relaxation 
times Tie (i = 1,2). 
 
mieRci T 
1111
           (29) 
 
For Gd complexes, T1e and T2e are interpreted in terms of the zero field splitting 
interaction (ZFS) as described in equation 30 and 31, which are known as the 
Bloembergen-Morgan theory of paramagnetic electron-spin relaxation. 
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where 2 is the mean-square zero field splitting energy and vis the correlation time 
for the ZFS modulation. 
The outer sphere term describes the contribution of the diffusion of water molecules 
near the paramagnetic complex. It is described by the Freed model and for small 
paramagnetic complexes can be expressed in the simplified form: 
 
    HS
osos
p JJ
aD
CR  37
1
1 





           (32) 
 
where C
os
 is a constant (5.8 x 10
-13
 s
-2
M
-1
), a is the minimum distance between the 
water molecules and the metal, D the diffusion coefficient and the dependence on 
the electronic relaxation times is expressed as J(i) which is the non-Lorentzian 
spectral density function.  
For low molecular weight Gd complexes of the type reported herein, the most 
significant contribution is the inner sphere mechanism
13
. 
Proton relaxation analysis of [GdL
4a
] and of [GdL
4b
] were performed at the 
University of Piemonte Orientale in Alessandria, and the fitting to the experimental 
data was undertaken by Professor Mauro Botta. The relaxivity was recorded as a 
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function of pH, over the range 2.5 to 11.5, and did not show any appreciable 
variation for each complex, confirming the high stability with respect to metal 
dissociation of mono-amide DO3A analogues. The relaxivity profile as a function of 
the applied magnetic field strength was recorded between 0.01 and 70 MHz, 
allowing computation of the rotational correlation times R. The shape of the curve 
is consistent with fast values of R in each case. Variable temperature 
17
O NMR R2p 
studies recorded at 9.4 T, allowed an estimate of water exchange lifetimes m to be 
made, by fitting the temperature dependence to a classical Swift-Connick 
approximation
14
. The fast water exchange rate is consistent with the decrease of 
relaxivity with increasing temperature. The plots and the extrapolated data for 
[GdL
4a
] and [GdL
4b
] are reported below (Fig. 3.16 and 3.17, Table 3.13). 
 
 
 
 
 
 
 
 
 
 
a)                                                                             b) 
 
 
 
 
 
 
 
 
 
 
c)                                                                             d) 
 
Fig. 3.16 Relaxivity studies for [GdL
4a
] a) 1/T1 NMRD profile. b) Variable 
temperature 
17
O NMR R2p. c) Relaxivity as function of temperature. d) Relaxivity as 
function of pH.  
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                                         c)  
Fig. 3.17 Relaxivity studies for [GdL
4b
] a) Relaxivity as function of pH. b) Relaxivity 
as a function of temperature. c) Variable temperature 
17
O NMR R2p.  
 
Small differences were observed in the parameters obtained for the ortho ethyl ester 
and the carboxylate complexes. The R value and the relaxivity of the ester analogue 
were slightly higher than for the acid. These changes suggest a small variation in the 
second sphere of hydration. 
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Table 3.13 Relaxation parameters of [GdL
4a
] and [GdL
4b
] (298 K) obtained from 
analysis of VT 
1
H relaxivity, 
17
O NMR and fitting of NMRD profiles
a
. 
Parameter [GdL
4a
] [GdL
4b
]
-
 
r1p (mM
-1 
s
-1
) 5.40 4.95 
m (s) 0.57 0.93 
R (ps) 81 81 
v (ps) 15 13 
2  1019 (s-2) 6.3 6.3 
q 1 1 
q” 2 2 
 
a) 
The Gd-H distance for the coordinated water molecule r, and the outer sphere water 
molecules a, were fixed to 3.0 and 4.0 Å and the relative diffusion coefficient D to 
2.2410-5 cm2 s-1 (298 K). 
 
Probably, this is related to different ability of the amide NH to form hydrogen bonds 
to nearby water molecules in the case of the ester [GdL
4a
] or the acid complexes 
[GdL
4b
]. The presence of the substituent in ortho-position is likely to influence the 
hydrogen bond formation, by acting as competitive acceptors. The oxygen of the 
C=O group in the ester complex [GdL
4a
], can form a six membered ring by 
hydrogen bonding with the amide proton. The same can happen for the carboxylate 
analogue [GdL
4b
], with a stronger interaction due to its negative charge. Hence, in 
the latter case the amide proton is already involved in hydrogen bonding with the 
carboxylate anion, therefore suppressing its interaction with second sphere water 
molecules (Fig. 3.18). 
 
O
N
N
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with water
OOH
O
H H
O
N
N
OH2
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OOH
O
H H
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with water
stronger interaction
with carboxylate
weaker interaction
with ester
 
Fig. 3.18 Schematic representation of the different interaction of the amidic proton 
with the second sphere water molecules in [GdL
4a
] and [GdL
4b
].  
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3.5 Conclusions 
The spectroscopic and relaxation properties of a series of fluorinated lanthanide 
complexes have been discussed, as well as their conformational exchange processes. 
The distance of the CF3 group with respect to the lanthanide ion has been calculated 
to be between 5.7 and 6.3 Å. This has been confirmed by DFT calculations and by 
single crystal X-ray diffraction. The proximity of the fluorine to the lanthanide ion 
allows an increase of the longitudinal relaxation rate R1 leading to faster signal 
acquisition, but a balance is needed with the parallel increase of R2 which causes line 
broadening. Between 5.7 and 6.3 Å, Tb and Dy complexes are most favourable at 
lower magnetic fields (3 to 7 T), while Er and Ho seem to have fast relaxation with 
‘reasonable’ linewidths in the range 7 to 11.5 T. Above 11.5 T, the resonances 
broaden considerably. Tm complexes can be used at higher fields (>11.5 T) without 
excessive line broadening.  
The substitution of the carboxylate pendant arms with phosphinate analogues, led to 
narrower linewidths because of increased rigidity of the structure. A faster 
longitudinal relaxation rate was also found due to the shorter distance of the CF3 
group to the metal ion. 
The relaxivity analysis of the Gd complexes of L
4a 
and L
4b
, showed small changes 
in the second sphere of hydration due to a competitive hydrogen bonding 
mechanism in the case of the carboxylate. 
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Chapter 4 
 
Enzyme reporters 
 
4.1 Introduction 
The enhanced sensitivity of the fluorine nucleus to changes in the 
microenvironment, produced by its proximity to a lanthanide ion in a stable complex 
(see Chapter 1), is exploited here to prepare responsive probes that can report 
enzyme activity. The introduction in the complex structure of a particular functional 
group that can be recognised as a substrate by the enzyme, can lead to the 
modification of the probe structure after enzyme catalysed transformation. This 
modification can be signalled by variation of the chemical shift or of the relative 
signal intensity of the fluorine resonance in the 
19
F NMR spectrum.  
 
4.2 Synthesis 
A series of DO3A mono-amide complexes has been synthesised, bearing different 
ester groups in the para or ortho positions on the aromatic ring. The complexes 
[HoL
1a
] and [HoL
4a
] were prepared according to the procedure described in Chapter 
2, where an ethyl ester group is introduced at the beginning of the synthetic route. 
Alternatively, the synthesis of the other complexes described here followed the 
scheme shown below (Scheme 4.1), where the ester group was introduced in the 
final stage, by reacting the para or ortho acid complexes, [HoL
1b
] and [HoL
4b
], with 
the appropriate alkyl halide. The different substituted esters were obtained by an SN2 
reaction, using the commercially available chloro- or bromo-methyl derivative, in 
DMSO, using K2CO3 as base.  
In each case, the reaction did not reach completion, leaving ~20% of unreacted 
starting acid complex. The presence of a small amount of by-product was also 
observed, caused by concomitant alkylation at the amide nitrogen, as confirmed by 
mass spectral analysis. Different conditions were attempted in order to limit the 
formation of the bialkylated product, but without complete success. Purification of 
the desired material was possible with reverse phase HPLC.  
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L12  para R = PhOCOCH3   
Scheme 4.1 General synthetic scheme for the preparation of L
8
-L
12
. 
 
In the case of [HoL
10
], the reactive -chloroester 66 was previously prepared by 
reaction of chloromethyl chloroformate with ethanol in dichloromethane and 
pyridine, to give a colourless liquid
1
. Subsequent reaction followed the general 
procedure discussed above, using DMSO-d6 as solvent to allow direct NMR analysis 
(Scheme 4.2). The reaction was followed by 
19
F NMR and mass spectrometry which 
confirmed the formation of the product. The -chloromethyl ester itself was stable 
over two days in deuterated DMSO, but after isolation and dissolution in water, it 
hydrolysed rapidly, leaving only starting material. Attempt to perform the analogous 
reaction using 1-chloroethyl ethyl carbonate was unsuccessful, possibly because of 
the steric hindrance created by the presence of the methyl group next to the chlorine.  
 
N N
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O
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N
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O
O
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Cl O O
O
Cl O Cl
O
EtOH
CH2Cl2
pyridine
K2CO3
DMSO-d6
65%
[HoL10]
66
[HoL4b]
 
Scheme 4.2 Synthesis of [HoL
10
]. 
 
4.3 Enzyme studies 
The carboxyester moiety was introduced into the complex structure with the purpose 
of being used as an enzyme substrate. Esterases should recognise this functional 
group and catalyse its hydrolysis to yield the corresponding carboxylic acid. Owing 
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to the ability of the lanthanide ion to amplify the chemical shift variation associated 
with changes in the chemical environment, it was hypothesised that we would be 
able to differentiate the two species readily. Their difference in chemical shift should 
be as great as possible to facilitate monitoring of the reaction. The fast fluorine 
longitudinal relaxation rate allowed an increase in signal intensity by reducing the 
spectral acquisition time. Analysis at higher magnetic fields, leads to a parallel 
increase of the transverse relaxation time, characterised by line broadening. The best 
compromise was found using holmium complexes at a magnetic field of 4.7 or 9.4 
T, under conditions that allow a fast relaxation with a reasonable linewidth, with 
respect to the other lanthanide ions considered, i.e. Tb, Er, Tm and Dy. 
The first compound analysed was [HoL
1a
], which contains a simple ethyl ester in the 
para position of the aromatic ring. It shows a single 
19
F peak in the NMR spectrum 
with a F = -56.3 ppm (linewidth ~102 Hz) at pH 7.4. The corresponding acid form 
appears at F = -57.1 ppm (linewidth ~56 Hz), giving a chemical shift difference of 
0.8 ppm. Upon enzymatic hydrolysis, we should observe the acid peak appearing in 
the spectrum with a concomitant reduction in the intensity of the corresponding ester 
peak. Although physiological conditions were maintained to ensure optimal enzyme 
activity, better separation between the two species can be observed by measuring the 
spectrum at higher pH values. A maximum chemical shift non-equivalence of 6.5 
ppm was noted at pH 9 (Fig. 4.1). Therefore, NMR analyses could be performed at 
this higher pH, where appropriate. 
 
Fig. 4.1 Chemical shift difference between the fluorine resonances of [HoL
1a
] and 
[HoL
1b
] as a function of pH. 
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The enzymes selected for our studies were pig liver esterase (PLE) and -
chymotrypsin. These are common esterases that catalyse hydrolysis of various ester 
groups to yield the corresponding carboxylic acids. For each enzyme, the same 
experiment was performed using 10 moles of [HoL1a] dissolved in 0.8 ml of PBS 
solution at pH 7.4. To half of the sample was added the lyophilised enzyme (5 mg, 
75 units), while the other half was used as a control. The two samples were kept at 
25ºC and 
19
F NMR spectra (188 MHz) were recorded at regular intervals. To lock 
the NMR instrument a coaxial insert containing D2O was used. The sample 
containing the enzyme showed, as expected, a decrease in the signal intensity of the 
ester resonance, while a new signal corresponding to the carboxylic acid formed 
(Fig. 4.2). The control sample remained unchanged over the length of the 
experiment, confirming the enzymatic catalysis of hydrolysis and, therefore, the 
recognition of the complex as a substrate. The reaction proceeded to a limit when 
50% of the ester had been hydrolysed. The same behaviour was observed either 
using PLE or -chymotrypsin. The process, however, occurred over a period of 
more than one week; hence it was far too slow for a possible application. Performing 
the same experiment at 37ºC gave similar results, with a doubling of reaction rate.  
 
 
 
 
 
 
 
 
 
 
 ppm          -45                -50                 -55                 -60                -65                -70           
 
Fig. 4.2 
19
F NMR spectrum of [HoL
1a
] after addition of PLE (25ºC, 188 MHz, PBS, 
pH 7.4, D2O insert) showing the presence of the corresponding acid [HoL
1b
] produced 
by enzymatic hydrolysis. 
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The second compound analysed was [HoL
4a
], the ortho analogue of the previous 
example, which was prepared to evaluate the effect that a different position of the 
substituent on the aromatic ring may have on the enzyme activity. The 
19
F NMR 
spectrum of the complex showed the presence of two resonances in 1:1 ratio with a 
large chemical shift difference of more than 30 ppm. This separation was ascribed to 
the presence in solution of two isomeric structures, bearing the CF3 group in 
different positions with respect to the metal centre. As discussed in Chapter 3, these 
isomers correspond to rotamers, attributed to the restricted rotation of the aromatic 
ring around the CN bond. 
The corresponding acid form [HoL
4b
], appeared in the spectrum as two different 
19
F 
signals but in 1:3 ratio, with similar F values to the ester but with larger linewidths. 
The chemical shift difference between the acid and the ester resonances was ~2 ppm 
for the major resonance, but the significant linewidth of the acid signal, 377 Hz 
(major) and 530 Hz (minor), somewhat inhibited spectral discrimination. It was 
possible to monitor enzymatic hydrolysis by following the change in the ratio and 
the linewidth of the two resonances. The same experiment described above was 
performed for [HoL
4a
] using PLE and -chymotrypsin at 25ºC. Surprisingly, no 
hydrolysis was observed in either case. Even after incubation at 37ºC, no signs of 
hydrolysis were visible. A possible explanation is that the ester carbonyl group in 
the ortho position is more sterically crowded compared to the para isomer, thus 
inhibiting approach to the enzymatic active site. A control experiment was carried 
out without enzyme leaving the sample in a KOH solution at pH 10 heating at 50°C, 
over one week. The chemical hydrolysis was observed through the variation of the 
signal intensity of the 
19
F resonances, passing from a 1:1 ratio to a 1:3 ratio.  
Following these observations, it was decided to introduce a small spacer between the 
aromatic ring and the ester group, in order to make the ester carbonyl group more 
exposed and facilitate its contact with the enzyme active site. The ortho position was 
maintained to exploit the greater chemical shift difference between the two fluorine 
resonances.  
For example, [HoL
8
] contains a simple acetoxymethyl group linked to the acid. 
These esters are known to be good substrates for intracellular esterases, and have 
been used over many years to mask negatively charged compounds; once inside the 
cells such compounds are readily hydrolysed
2
 (Scheme 4.3).  
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Scheme 4.3 Mechanism of cleavage of the acetoxymetyl group upon enzymatic 
hydrolysis. 
 
The complex [HoL
8
] showed the presence of more than one isomer in the 
19
F NMR 
spectrum. One main signal was observed at F = -47.4 ppm, with another resonance 
at F = -55.2 ppm in the ratio 2.4 to 1. The presence of a bulkier group may have 
modified the geometry of the complex, resulting in two resonances closer to each 
other and in different proportion with respect to the ethyl ester. The acid complex 
peaks were at F = -49.2 ppm and F = -82.2 ppm in 3:1 ratio, giving a chemical shift 
difference of 1.8 ppm between the main signal of the two species. Transformation of 
[HoL
8
] was undertaken using PLE, monitoring spectral changes at 376 MHz and 
25°C. A decrease in 
19
F signals of the ester was observed with a parallel increase in 
intensity of resonances corresponding to the acid (Fig. 4.3). The enzymatic nature of 
the catalysis was confirmed by the absence of change in the control, lacking the 
enzyme. Hence, the introduction of a methylene bridge facilitates formation of the 
enzyme-substrate complex. The enzymatic hydrolysis did not proceed to completion, 
but reached a limit (~50% conversion) after ~40 h (at 37°C), after which no further 
hydrolysis was observed. Complete cleavage was reached after three weeks, when 
chemical hydrolysis intervened. The kinetics of this reaction offered a slightly 
improvement compared to [HoL
1a
], especially when performed at 37°C, but was 
still too slow for practical application. 
 
 
 
 
 
 
 
 
O O
O O
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O O
O
O
O
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   ppm       -40                -50                -60                -70                -80               -90  
 
Fig. 4.3 
19
F NMR spectrum of [HoL
8
] after addition of PLE (25ºC, 376 MHz, PBS, pH 
7.4, D2O insert) showing the presence of the corresponding acid [HoL
1b
] produced by 
enzymatic hydrolysis. 
 
Two other substrate variations were considered. First, in the compound [HoL
9
], a 
propyl group was introduced instead of a methyl group, in an attempt to enhance the 
affinity of the substrate for the enzyme active site. Compared to [HoL
8
], no 
improvement was observed in the rate of reaction, upon incubation of the complex 
with PLE, either at 25 or 37°C. Second, in [HoL
10
] a methyl ethyl carbonate ester
1
 
was introduced. This is a more labile group, which was investigated with the 
purpose of accelerating the enzyme cleavage. Unfortunately, the compound was 
unstable in water, therefore inhibiting enzyme experiments. 
Another example of a cleavable spacer incorporates a ‘self immolative’ benzyl 
group, linked in the para position to the inverted ester
3
, which in our case 
corresponded to an acetoxy group, [HoL
11
].  
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Upon enzymatic deacetylation, the linker spontaneously decomposes, releasing the 
free acid (Scheme 4.4). 
 
O
O
enzyme
O
O O
O
O
O
O
 
Scheme 4.4 Cleavage mechanism of the self-immolative spacer upon enzymatic 
hydrolysis in [HoL
11
]. 
 
This type of linker is often used as a pro-drug for different pharmaceuticals, in order 
to reduce their toxicity and to improve the control of their release in vivo. They are 
also used to link multiple drugs together for delivery of synergic therapies
4
. Previous 
published examples employed a variety of analogues of the linker, mostly 
incorporating an amino or amide group at one or both ends of the linker
5,6
 Recently, 
the use of ester groups on either side of the spacer has been reported
3
 (Fig. 4.4).  
 
X1 O
O
enzyme
X2
R2
R1
a) X1 = NH  X2 = O
b) X1 = O    X2 = NH
c) X1 = NH  X2 = NH
d) X1 = O    X2 = O  
Fig. 4.4 Different self-immolative spacers. a) 
5
. b) 
6
. c) 
4
. d) 
3
. 
 
The ester [HoL
11
] was stable in water and the 
19
F NMR spectrum revealed a main 
signal at -47.1 ppm and two minor resonances at-48.5 and -49.8 ppm in 4.4:1:1 
ratio. In the presence of PLE, a variation in the signal intensity of the fluorine 
resonances was observed. The minor peak at F = -49.8 ppm disappeared completely 
within 29 h, accompanied over the same time interval by a slightly slower decrease 
in the signal intensity of the major species. This reached a maximum value, after 
which no further hydrolysis was noted up to 9 days (25°C). When performing the 
same experiment at 37°C the first transformation occurred in less than 2 h, and the 
limiting spectrum was obtained by 50 h. The resulting spectrum did not correspond 
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to that expected for the acid product [HoL
4b
]. Mass spectral and LC-MS analyses 
indicated that the enzymatic hydrolysis did not produce the acid compound as 
expected, but an intermediate phenol in which only the acetoxy group had been 
cleaved, as indicated in Scheme 4.5. The acetoxy group was therefore recognised 
and hydrolysed by the enzyme, but the remaining part of the linker did not fragment 
via the expected self-immolative cleavage.  
 
O
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O
O O
O
O
O
O
O
O
OH
fast
 
 
Scheme 4.5 Cleavage mechanism for [HoL
11
] showing the phenolic intermediate 
produced after incubation with PLE or -chymotripsin. 
 
The same behaviour was observed with -chymotrypsin at 25°C, but with different 
kinetic profiles. In this case the minor peak at -49.8 ppm, disappeared within 120 h 
and the major peak at -47.1 ppm decreased slowly, reaching a plateau after 170 h 
with a higher level of transformation (10% more than with PLE), as illustrated in 
Fig. 4.5. 
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Fig. 4.5 Enzyme activity profile for [HoL
11
] with PLE and -chymotripsin. The 
activity is reported as the ratio of the intensity of the invariant peak at F = -48.5 ppm 
to the intensity of the major peak at F = -47.1 ppm . 
 
The same self-immolative linker was also introduced in the para ester position, 
yielding [HoL
12
], to study any possible variation on enzymatic kinetics. The fluorine 
spectrum of [HoL
12
] showed a major resonance at -50.8 ppm and minor signals at -
48.9, -49.4 and -52.0 ppm, in the ratio 2.6:1.7:1.2:1 respectively. A decrease of the 
signal intensity for the peaks at F = -49.4 and -52.0 ppm was observed within 22 h. 
Also, in this case, the spectrum did not correspond to the acid product expected 
([HoL
1b
] single signal at F = -57.1 ppm). LC-MS data confirmed the presence of 
the phenolic intermediate, as had occurred with [HoL
11
].  
A control experiment has been undertaken for both [HoL
11
] and [HoL
12
] leaving the 
two complexes stirring in a solution of KOH at pH 10 for two weeks. The 
19
F NMR 
was then recorded. In each case, only the corresponding carboxylic acid product was 
observed, as proof that, under conditions of chemical hydrolysis, the linker 
undergoes the expected cleavage. The failure of these self immolative linkers to 
undergo complete cleavage under the experimental conditions, may be related to 
product inhibition of enzyme activity induced by the intermediate phenol. 
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4.4 Conclusions 
The preliminary studies presented in this chapter have allowed the proof of principle 
to be established. The feasibility of following an enzymatic reaction using 
19
F NMR 
has been assessed, by examining the change in signal intensity of the resonances of 
paramagnetic fluorinated complexes.  
The series examined proved the need for careful design of probe structure, as small 
changes in the structure led to large variations in the enzyme response, as observed 
for the para and ortho ethyl esters [HoL
1a
] and [HoL
4a
]. The first underwent 
catalytic hydrolysis by the esterases, while the ortho analogue was too sterically 
hindered to be a good substrate. Improvements were noted with the introduction of a 
cleavable linker, which presumably allows easier access to the enzyme active site. 
The self-immolative approach adopted for [HoL
11
] and [HoL
12
] did not give the 
expected results, but modifications to the spacer could lead to better performance. 
Changing the spacer would enable the use of different enzyme families which would 
increase the range of possible applications. One possible substrate is shown below, 
that may act as a probe for protease activity (Fig.4.6): 
 
O
O
N
H
O
 
Fig.4.6 Example of self-immolative spacer that can be used for future probes. 
 
Further work could then focus on synthesising new probes with optimised structures 
and spacers, in order to screen the activity of new enzymes.  
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Chapter 5 
 
Chitosan conjugates 
 
5.1 Introduction 
Low sensitivity is a key issue in all the classical NMR experiments. For 
19
F MRI, 
characterised by the absence of endogenous background, the signal intensity of a 
fluorinated probe is primarily related to the concentration of equivalent fluorine 
nuclei and to their relaxation rates. Possible strategies to improve the signal to noise 
ratio are, therefore, to increase the number of fluorine atoms present in the molecule 
and to reduce their longitudinal relaxation rates. As previously discussed, the 
introduction of a CF3 group in the structure of a paramagnetic lanthanide complex, 
allows the enhancement of the longitudinal and transverse relaxation rates of the 
fluorine nuclei. With the purpose of combining faster relaxation times with an 
increased number of fluorine atoms, we set out to prepare a chitosan-based 
conjugated contrast agent, in which the polymeric chitosan chain functions as a 
platform for linking numerous lanthanide complexes, each bearing a CF3 group. 
 
5.2 Synthesis of the conjugate 
The requisites of our system were, on the one hand, a macromolecular carrier with 
repeated monomers, each exhibiting a functional group which could be modified to 
form a stable linkage with the complexes and, on the other hand, a lanthanide 
complex that can be linked to the macromolecule. The ideal carrier should contain a 
functional group, such as an amino group, that allows a stable amide bond to be 
formed with the lanthanide complex. Several amino groups should be present to 
allow multiple linkages. The absence of toxicity of the conjugate is also necessary 
for its in vivo application as a contrast agent. A suitable candidate for these 
requirements is glycol chitosan, a non-toxic compound, well tolerated in vivo, 
composed of repeating glucosamine sugar units, each bearing a primary amino 
group. Normal chitosan has also been evaluated, but the lower aqueous solubility (it 
dissolves only in acidic media) has precluded its development. Glycol chitosan, 
thanks to the additional ethylene glycol groups, presents better solubility over a 
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wider pH range, including neutral physiological values. The lanthanide complex 
should have an acid group that can form an amide linkage with the chitosan. The 
complex [LnL
1b
] (synthesis: Chapter 2) contains a para-CO2H group on the 
aromatic ring, which after suitable activation can be used to form a stable amide 
linkage. At first, formation of an N-hydroxy succinimidyl ester was attempted using 
NHS in DMSO, with EDC as the coupling agent. This strategy produced small 
amounts of product, as confirmed by HPLC. Therefore, a different method was 
employed. Complete conversion of [LnL
1b
] into an active ester form was 
successfully achieved using TBTU and N-methylmorpholine (NMM) in DMF. The 
active form generated in situ was reacted immediately with the amine. 
The first example of conjugation was attempted using glucosamine, the monomer of 
which chitosan is composed. This allowed evaluation of the possibility of forming 
the amide link with the active ester. The free glucosamine, obtained from the 
commercially available hydrochloride salt by anion exchange, was dissolved in the 
minimum amount of water and added in excess to the complex. The reaction went to 
completion and the clean product was isolated by precipitation (Scheme 5.1). The 
active ester was obtained under anhydrous conditions and, once formed, the addition 
of water didn’t compromise the subsequent C-N bond forming reaction. 
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Scheme 5.1 Synthesis of [HoL
13
]. 
 
After this positive result, the conjugation was performed using the glycol chitosan 
polymer. Glycol chitosan was purchased from Sigma and purified by dialysis before 
use. After purification, the sample had a molecular weight of about 195,000 D as 
revealed by GPC analysis; its solubilisation in water required sonication over a 
period of two hours. The commercial sample was also modified to prepare a lower 
molecular weight polymer, by acidic digestion with HCl 4 M at 50°C over 24 hours. 
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After dialysis purification, the sample possessed an average MW of about 6,500 D 
(vide infra) and exhibited higher water solubility compared to the parent system. 
The conjugation was performed on both the polymer samples, using the conditions 
described for the monomer. Obviously, the different molecular weight implied that 
different volumes of water were necessary to solubilise the macromolecule (Scheme 
5.2). In the case of the larger polymer, the active ester was added dropwise to the 
viscous aqueous solution, paying particular attention to ensure homogeneous 
mixing. The enhanced solubility of the lower MW analogue allowed the reaction to 
be performed with less added water, following the procedure adopted for the 
glucosamine. The conjugate was obtained in each case following dialysis 
purification. The conjugation of the smaller polymer was performed using increasing 
complex concentrations resulting in a parallel increase of the percentage of bound 
complex. This indicates that the extent of conjugation reflects the quantity of 
complex used in the reaction, at least in the concentration range that was examined.   
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Scheme 5.2 General synthetic scheme for preparation of glycol chitosan complex 
conjugates. 
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The resulting materials were characterised by gel permeation chromatography 
(GPC) analysis to verify the presence of the conjugates. The analysis revealed the 
increase in the molecular weight of the conjugates, with respect to the unreacted 
polymer (Table 5.1). 
 
Table 5.1 Gel permeation chromatography (GPC) data for the chitosan samples and 
their conjugates. 
Sample Mw 
a 
Mn 
b 
PDI 
c 
71 (high MW chitosan) 194,000 50,750 3.8 
72 (low MW chitosan)    6,590   2,250 2.9 
73 (high MW-Ho conjugate) 278,500 54,650 5.1 
74 (low MW-Ho conjugate)   16,200   4,500 3.6 
75 (low MW-Gd conjugate)   15,950   4,155 3.8 
Mean values obtained from two successive scans. 
a
 calculated molecular weight 
averages expressed as the pullulan polysaccaride equivalent molecular weights; 
b
 
number average molecular weights; 
c
 polydispersity (Mw/Mn). 
 
Elemental analysis was performed on the glycol chitosan samples before and after 
the conjugation, as variation in the carbon/nitrogen ratio gives indications of 
structural modifications. For the higher MW chitosan, 71, the C/N ratio was 
consistent with ~20% acetylation. For the lower MW precursor, 72, the analysis 
revealed a lower ratio indicating the absence of acetylation. This was probably 
caused by hydrolysis of the amide bonds during the acidic digestion used to prepare 
the sample. 
  
 
 
 
 
 
For the conjugates, the C/N ratio reflected the addition of the complex molecules 
and lower ratios were again found when using 72, confirming the absence of 
acetylation. 
HO
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Analysis of the percentage of Gd and Ho in the purified materials was undertaken 
using the Evans NMR method
1 
and ICP-mass spectroscopic analysis. The results are 
reported below (Table 5.2). 
 
Table 5.2 Metal percentage in the conjugate samples obtained with the Evans NMR 
method and ICP-MS and calculated percentage of conjugation. 
Sample Evans
 
ICP-MS
 Calculated 
conjugation
 
73 /     1.6% Ho   3.6% 
74   12.5% Ho   12.5% Ho   9.5% 
75   14.9% Gd   14.9% Gd 11.6% 
 
The same amount of metal was found with each methods and corresponded to a 
degree of conjugation of 3.6% for the higher MW-Ho complex conjugate, 73, 9.5% 
for the lower MW-Ho complex conjugate, 74, and 11.6% lower MW-Gd complex 
conjugate, 75. The calculated levels of conjugation agreed with values estimated 
from the average MW analysis (Table 5.1). These data established the actual 
formation of covalently linked conjugates. 
 
5.3 NMR studies 
The conjugation between glycol chitosan and the lanthanide complexes bearing a 
CF3 group was undertaken with the purpose of increasing the signal intensity of the 
fluorine resonance in 
19
F MRI. The MR characteristics of the Ho
3+
 and Gd
3+
 
conjugates are discussed in this section.    
 
5.3.1 Ho complex conjugates 
[HoL
1b
], with a CO2H group in the para position of the aromatic ring was selected 
over the ortho analogue [HoL
4b
], because of the presence of one main resonance in 
the fluorine spectrum, compared to two broader signals for the ortho isomer. The 
selection of the holmium complex ensured fast relaxation (Chapter 3). Upon binding 
to a macromolecular carrier, broader linewidths for the fluorine NMR resonance of 
the complex are expected, because of the restricted mobility that the latter 
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experiences. It is important to restrict line-broadening to avoid loss of signal and this 
has been considered in the design of the contrast agent. A certain degree of mobility 
is maintained as a result of local rotation of the aromatic ring and of the complex 
with respect to the macromolecule as shown below (Fig. 5.1).  
 
H
N
F3C
complex
H
N
O
polymer
 
Fig. 5.1 Schematic representation of the possible rotation around the bonds of the 
linker. 
 
The 
19
F NMR spectra of dilute solutions of the two Ho-conjugates were recorded in 
D2O. The solubility of the higher MW conjugate maintained the characteristics of 
the parent glycol chitosan, requiring sonication to produce a rather viscous solution. 
The lower MW polymer conjugate exhibited improved solubility and did not require 
sonication to dissolve it. In each case, a single peak was observed at F = -56.8 ppm, 
at the same chemical shift as the parent complex. The linewidth was broader, as 
expected in each case. For the lower MW conjugate, a better signal to noise ratio 
was achieved for the same acquisition time compared to the higher MW sample, due 
to the higher degree of conjugation achieved. 
Longitudinal relaxation rates were measured at 188 and 376 MHz and are reported 
in Table 5.3, together with the values for the complex [HoL
13
], the simple sugar 
glucosamine conjugate.  
 
Table 5.3 
19
F NMR data for [HoL
13
], the high MW-Ho conjugate 73 and the lower 
MW-Ho conjugate 74.  
Sample 
188 MHz 376 MHz 
T1 (s) 1/2 (Hz) T1 (s) 1/2 (Hz) 
[HoL
13
] 0.017 55  0.0081 93 
73 0.012 100 0.013 262 
74 0.018 236 0.010 257 
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[HoL
13
] shows sharper signals and a T1 variation more strongly dependent on the 
applied magnetic field compared to the conjugate, where the T1 seems less 
dependent on the field and the linewidth is broader.   
The 
1
H NMR spectrum was also recorded showing only the resonances of the 
polymer because of the much higher relative signal intensity compared to those of 
the complex.  
A control experiment was performed with the lower MW chitosan 74 to verify if the 
values obtained for the conjugate can be attributed to the covalent bonding of the 
complexes to the carrier and are not simply a consequence of enhanced solution 
viscosity. The control experiment was carried out by adding glycol chitosan to a 
solution of [HoL
1b
] in the same proportion contained in the conjugate, measuring 
the linewidth of the 
19
F peak at 376 MHz, before and after the addition. This 
comparison allows the effect of increased viscosity of the solution to be assessed. 
The spectra revealed that the addition of the polymer produced only a small increase 
in the linewidth from 83 Hz to 107 Hz. This variation is much smaller compared to 
the value of 262 Hz in the case of the conjugate, proving that the effect is primarily 
related to the presence of the covalently bonded macromolecule.  
The 
19
F NMR spectrum of the holmium conjugate 74 was also recorded at different 
temperatures, monitoring any change in linewidth that could derive from the 
increased mobility (i.e. reduced viscosity) occurring at higher temperatures. No 
significant change was observed over the range 278-310 K.   
 
5.3.2 Relaxivity studies with the Gd complex conjugate 
The gadolinium analogue was prepared to enable 
1
H MRI analysis, allowing the 
tracking of the distribution of the conjugate in an animal model.  
The relaxivity of a dilute solution of the Gd-chitosan conjugate 75 in water and of 
the parent Gd complex [GdL
1b
] was measured at 60 MHz at 37°C. The parent 
complex has a value of 4.62 mM
-1
s
-1
, which is typical for a mono-aqua DO3A 
monoamide complex
2
. In the glycol chitosan conjugate, 75, the relaxivity per Gd 
was 11.2 mM
-1
s
-1
. This enhancement is associated with slower rotation of the Gd 
complex, which increases the value of the rotational correlation time R, leading to a 
higher relaxivity. The increased viscosity of the solution, due to the presence of the 
dissolved polymer, can also be responsible for a greater relaxivity value. To confirm 
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whether the bigger relaxivity value of the conjugate was related only to the viscosity 
of the solution or to the actual covalently linked macromolecule, a control 
experiment similar to that for the holmium analogue (section 5.3.1) was performed. 
A solution containing the Gd complex and the parent small molecular weight glycol 
chitosan 72 was prepared and its relaxivity measured at 60 MHz at 37°C. The value 
obtained was 4.79 mM
-1
s
-1
, which is very similar to that of the parent complex. This 
proved that the observed increased relaxivity is caused by the presence in solution of 
the covalently bonded conjugate. 
The Gd conjugate can be employed as a conventional contrast agent in proton MRI 
by virtue of its ability to enhance the rate of relaxation of the bulk water protons. 
The relaxation behaviour was assessed by Prof. Botta at the Universitá del Piemonte 
Orientale (Italy) and compared to the behaviour of the parent Gd complex. 
 
 
 
 
 
 
 
                                   a)                                                                               
 
 
                                                                               
 
 
 
 
 
 
 
 
b)                                                                   c) 
Fig. 5.2 [GdL
1b
] proton relaxivity studies showing the fit (line) to the measured data. a) 
17
O R2 vs temperature profile measured at 11.7 T (500 MHz). b) relaxivity vs 
temperature profile measured at 20 MHz and pH 7.2. c) 1/T1 NMRD profiles at 298 
(filled circles) and 310 K (open circles).  
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Variable temperature 
17
O NMR measurements for [GdL
1b
] were performed in 
17
O-
enriched water (Fig. 5.2) and the data analysed using the standard Swift-Connick 
methodology
3
 to obtain an estimate of the water exchange lifetime m. The analysis 
gave a m value of 0.92 s, which is similar to related monoamide derivatives of Gd-
DO3A
2
. 
The relaxivity profiles as a function of temperature and magnetic field were also 
measured (Fig. 5.2) allowing information on the water exchange rate and various 
associated parameters used in the Solomon-Bloembergen-Morgan equations, as 
explained in Chapter 3. The values of the main parameters that describe the proton 
relaxation behaviour of the complex are reported (Table 5.4) and are consistent with 
those expected for such low molecular weight mono-aqua complexes, with two 
second sphere water molecules
2
.    
 
Table 5.4 Relaxation data for [GdL
1b
]. 
Parameter 
a 
310 K 
r1p (mM
-1 
s
-1
) 5.2 
m (s) 0.92 
R (ps) 83 
v  (ps) 16 
2 (s-2  1019) 8.8 
q 1 
q’’ 2 
r’’ (Å) 4.4 
 a
 r1p is the proton relaxivity; M is the water exchange lifetime; R is the rotational 
correlation time; v  is the correlation time for the ZFS modulation; 
2
 is the mean-
square zero field splitting energy; q is the number of inner sphere water molecules; q’’ 
is the number of second sphere water molecules and r’’ their distance from Gd. 
 
For the Gd-conjugate 75, the relaxivity profiles as a function of temperature and 
magnetic field were also measured (Fig. 5.3). In the case of macromolecular 
conjugates, the analysis of NMRD profiles requires a different approach, since the 
presence of a relatively fast local rotation of the complex, compared to the slow 
motion of the macromolecule, needs to be considered. This is possible by 
incorporating the description of the rotational dynamics according to the ‘model-
free’ Lipari–Szabo approach into the Solomon-Bloembergen-Morgan equations for 
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the inner sphere relaxation mechanism
4,5
. This model allows the contribution of the 
global rotation of the whole paramagnetic system (τRG) to be separated from the 
contribution of a faster local motion (τRL) associated with the free rotation of the 
complex through the pendant arm.  
 
 
 
 
 
 
 
 
 
                             a) 
 
 
 
 
 
 
 
 
 
 
 
                              b) 
Fig. 5.3 Proton relaxivity studies for the Gd-conjugate 75. a) relaxivity vs temperature 
profile measured at 20 MHz. b) 1/T1 NMRD profiles at 298 (filled circles) and 310 K 
(open circles).  
 
The correlation of the two types of motions is described by the parameter S
2
 whose 
value ranges between zero (completely independent motion) and one (totally 
correlated motion). A schematic representation is reported below (Fig. 5.4). 
 
270 280 290 300 310 320 330
0
5
10
15
20
25
r 1
p
 /
s
 -
1
 m
M
 -1
T / K
0.01 0.1 1 10 100
8
10
12
14
16
18
 298 K
 310
r 1
p
 /
 m
M
 -
1
 s
 -1
Proton Larmor Frequency / MHz
                                                               Chapter 5: Results and Discussion - Chitosan 
 
138 
slow
fast
 
Fig. 5.4 Schematic representation of the slow overall motion of the macromolecule and 
the fast local motion of the complex. 
 
The fitting of the NMRD profiles with the Lipari-Szabo model is shown in Fig. 5.5 
and the resulting parameters are reported in Table 5.5. 
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Fig. 5.5 Gd-conjugate NMRD profiles analyzed with the Lipari-Szabo model. 
 
For the macromolecular conjugates, only the high field region was analyzed because 
of the inadequacy of the SBM model to reproduce the low fields data when the 
tumbling motion is so long. The parameters 2 and v were treated simply as fitting 
parameters and do not have a precise physical meaning. The values of q, r, and m 
were assumed to be identical to those found for the parent Gd complex. 
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The results are consistent with the presence of a slow tumbling motion of the 
system, superimposed on fast local rotation of the Gd-chelates. This is underlined by 
the low value of S
2
. Moreover, the relaxivity reaches a maximum value at 30 MHz 
(typically found at 20 MHz for more ‘rigid’ systems) of 15.9 mM-1s-1 at 310 K. This 
is probably a consequence of a relatively fast internal motion (0.68 ns) rather than 
the slow global rotation (30.2 ns). The relatively long residence lifetime of the inner 
sphere water molecule limits the relaxivity of the slowly tumbling system. Indeed, 
the relaxivity increases significantly with temperature. A maximum value is reached 
around 315 K. A simple simulation revealed that the relaxivity would increase to 27 
if m was 20 ns at 298 K.  
 
 
Table 5.5 Relaxation data for the Gd-chitosan conjugate. 
75 
(Gd-chitosan conjugate) 
298 K
 
310 K 
r1p (mM
-1 
s
-1
) 12.7 14.9 
m 
 
(s) 0.92 0.74 
RL (ns) 0.68 0.60 
RG (ns) 40 30 
S
2
 0.10 0.18 
v (ps) 17.0 16.5 
2 (s-2   1019) 1.7 1.7 
q 1 1 
a (Å) 4.0 4.0 
D (cm
2
 s
-1
   10-5) 2.24 3.10 
τRG is the global rotation of the whole paramagnetic system; τRL the local motion 
contribution; S
2 
the correlation between the global and local motion; a the Gd-H 
distance for the outer sphere water molecules and D the relative diffusion coefficient.  
 
5.4 MRI studies 
In vivo MRI studies of the Gd complex-chitosan conjugate 75 were performed at the 
Newcastle Magnetic Resonance Centre, using nude mice bearing an HT29 colorectal 
tumour xenograft as animal model, with the aim of assessing the distribution and the 
tumour uptake of the conjugate.  
A 2.5 mM solution of the Gd complex-chitosan conjugate 75 was administered to 
four mice by intravenous injection in the tail. Each mouse (~30 g) received 200 l of 
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the solution corresponding to a dose of 0.017 mmol/Kg. The mice were previously 
anaesthetised with a mixture of oxygen/1-2% isoflurane.  
A Dynamic Contrast Enhanced (DCE) MRI study was performed on a Varian 7 T 
Unity Inova Pre-Clinical system. A 2 mm slice containing the tumour was selected 
and the dynamic sequence applied. Five background 
1
H MR images were collected 
(30 s), before the intravenous administration of the contrast agent during the sixth 
image. The remaining 94 were dynamic images, for a total of 100 over a 10 min 
acquisition period.  
In each of the four mice analysed, an almost immediate contrast enhancement (<1 
min) was observed after administration of the conjugate, both in the desired tumour 
area and the bladder (Fig. 5.6). The compound was well tolerated by the animals. 
 
                                                              tumour 
                               
                                 a) pre-injection                    b) post-injection        
Fig. 5.6 
1
H MR images before and after administration of Gd-chitosan conjugate 75 
(0.017 mmol/Kg dose) in a nude mouse bearing an HT29 colorectal tumour xenograft. 
a) Background 
1
H MR image, before injection of the contrast agent (CA). b) Obtained 
after administration of the CA, showing contrast enhancement (brighter colour) of the 
tumour area.  
 
The tumour area was analysed to measure the mean signal intensity profile as a 
function of time (Fig. 5.7). Rapid and selective uptake of the conjugate was 
observed in the tumour, followed by its slow release (in the 10 min acquisition 
time). This behaviour is probably related to the EPR (enhanced permeability and 
retention) that is characteristic of high molecular weight molecules. This leads to 
their selective accumulation in tumours through the increased fenestration of the 
blood vessels in the area and subsequent slow clearance from the site. This 
represents an advantage of the conjugate compared to low molecular weight Gd 
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complexes, which are more rapidly excreted from the tumour and accumulate in the 
bladder quickly after administration.  
 
 
Fig. 5.7 Profile of the mean intensity over 10 min acquisition time of the selected 
tumour area, showing the increase of the signal intensity after administration of the Gd-
conjugate. 
 
The presence of conjugate in the bladder is a sign of renal excretion, which is a 
desirable characteristic, as it indicates that the conjugate is being eliminated from the 
system. Future work will include ICP-MS analysis of Gd concentration in the 
excised organs of the treated mice, that will allow the evaluation of the conjugate 
biodistribution.  
The increase of the mean signal intensity reached the value of 1.22 in the best of the 
four experiments. The values obtained from the commercially available Gd contrast 
agents Prohance and Gadovist in analogous experiments were in the range 1.20-
1.28. However, the latter were administered in higher doses, i.e. 0.1 mmol/kg against 
0.017 mmol/kg for the Gd-chitosan, which also possesses a more than 2.5 fold 
higher relaxivity compared to Prohance and Gadovist. 
A 
19
F MRI dynamic experiment was also performed using the low MW Ho 
complex-chitosan conjugate 74, using a dose of 0.034 mmol/kg on the same animal 
model. A similar dynamic sequence was used to acquire 
19
F MR images over one 
hour. Unfortunately, no fluorine signal was detected after administration of the 
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conjugate, most likely due to the rather broad linewidth which led to insufficient 
signal intensity for observation on the experimental timescale. 
 
5.5 Conclusions 
Glycol chitosan conjugates with paramagnetic fluorinated complexes have been 
prepared and their NMR properties assessed. The lower MW polymer possessed 
more desirable properties than the higher MW analogue, thanks to improved 
solubility and a higher rate of conjugation.  
The lower MW Gd-glycol chitosan conjugate exhibited higher relaxivity with 
respect to the complex [GdL
1b
]. In vivo experiments in mice allowed evaluation of 
the biodistribution, showing a rapid uptake of the conjugate in the tumour and 
subsequent slow clearance. This is an improvement compared to lower MW 
complexes that are rapidly cleared from the system
6
. 
The lower MW Gd-glycol chitosan conjugate was clearly visible using 
19
F MRS in 
vitro, but no signal was observed once administered in vivo. As described in chapter 
2 and 3, narrower fluorine signals and faster relaxation rates can be achieved using 
phosphinate complexes. Therefore, future work will focus on the conjugation of the 
phosphinate analogue of [LnL
1b
] to the lower chitosan precursor 72 employed here. 
Furthermore, a flexible spacer could also be introduced in order to increase the 
mobility of the complex and contribute further to the narrowing of the resonances. 
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Chapter 6 
 
Experimental 
 
6.1 General experimental procedures  
Reaction Conditions 
All reagents purchased from their respective suppliers were used without further 
purification. Reactions requiring anhydrous conditions were carried out using 
Schlenk-line techniques under an atmosphere of dry argon. Anhydrous solvents, 
when required, were freshly distilled over the appropriate drying agent. Water was 
purified by the ‘PuriteSTILLplus’ system, with a conductivity of ≤0.04 μS cm
- 1
. 
 
Purification Procedures 
Thin layer chromatography was carried out on silica plates (Merck Art 5554) or 
neutral alumina plates using UV irradiation (254 nm) or iodine staining as detection. 
Column chromatography was performed using silica gel (Merck Silica Gel 60, 230–
400 mesh) or neutral alumina (Merck Aluminium Oxide 90, activity II-III, 70-230 
mesh), pre-soaked in ethyl acetate. Anion exchange chromatography was performed 
using anion exchange resin DOWEX 1X8 200-400 MESH Cl (Sigma-Aldrich), pre-
treated with a solution of 1M HCl or 1M KOH in Purite water, or cation exchange 
resin DOWEX 50WX4-100 (Sigma-Aldrich) pre-treated with 1M KOH in Purite 
water. 
 
Dialysis was performed with Dialysis Tubing Cellulose Membrane MWCO 12,000D 
(Sigma-Aldrich) or Spectra/Por Dialysis Membrane MWCO 1,000D (Spectrum 
Laboratories, Inc). 
 
Characterisation Techniques: NMR Spectroscopy and Imaging 
1
H, 
13
C, 
19
F and 
31
P NMR spectra were recorded in commercially-available 
deuterated solvents on a Varian Mercury-200 (
1
H at 199.975 MHz, 
13
C at 50.289 
MHz, 
19
F at 188.179 MHz), Varian Mercury-400 or Bruker Avance-400 (
1
H at 
399.960 MHz, 
13
C at 100.572 MHz, 
19
F at 376.338 MHz, 
31
P at 161.943 MHz), 
Varian Inova-500 (
1
H at 499.772 MHz, 
13
C at 125.671 MHz, 
19
F at 470.253 MHz) 
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or Varian VNMRS-700 (
1
H at 699.731 MHz,
 19
F at 658.407 MHz, 
31
P at 283.256 
MHz) spectrometer. All chemical shifts are given in ppm and coupling constants are 
in Hz. 
19
F NMR longitudinal relaxation times (T1) were measured in dilute D2O 
solutions (1 mM) at 295 K using the inversion-recovery technique, without proton 
decoupling, with chemical shifts reported relative to fluorotrichloromethane.  
Water proton T1 measurements were recorded on a BrukerMinispec mq60 at 60 
MHz and 37˚C, and are reported as the mean value of three measurements. In some 
cases they were measured on a Stelar Spinmaster Spectrometer at 20 MHz and 25˚C 
using 0.5-2 mM aqueous solutions of the complexes. The proton NMRD profiles 
were performed at the University of Piemonte Orientale in Alessandria using a fast 
field-cycling Stelar Spinmaster FFC relaxometer for magnetic fields strengths over 
the range 0.00024 to 0.5 T (0.01-20 MHz) and a Stelar Spinmaster spectrometer 
operating at variable fields for data points from 0.47 to 1.7 T (20-70 MHz).  
Variable temperature 
17
O NMR spectra were recorded in Alessandria on a JEOL 
ECP-400 spectrometer (9.4 T) using aqueous solution of the complexes (20-30 mM) 
enriched with 3% of 
17
O isotope. The observed transverse relaxation rates (R2
obs
) 
were calculated from the signal width at half-height (1/2): R2
obs
 = 1/2. 
 
MRI in vivo studies were performed in the Newcastle Magnetic Resonance Centre 
using a Varian 7 T Unity Inova Pre-Clinical system equipped with a 
1
H 39 mm-
diameter transmit/receive birdcage coil for proton images and a 
19
F circular surface 
coil for fluorine images (12 mm diameter, 281 MHz 
19
F frequency). Nude mice 
bearing an HT29 colorectal tumour xenograft were anaesthesised with oxygen/1-2% 
isoflurane and placed in the coil. A dynamic sequence was used in which 5 
background images were collected (30 s) before the endovenous administration of 
the contrast agent during the 6
th
 image. The remaining 94 images were dynamic 
images for a total of 100 over a 10 min acquisition period. 
 
Other Experimental Instrumentation and General Procedures  
pH measurements were performed using a Jenway 3320 pH meter attached to an 
Aldrich micro–pH combination electrode, calibrated using pH 4.00 ±0.02, 7.00 
±0.02 and 10.00 ±0.02 buffer solutions by Aldrich. Diluted aqueous solutions of 
NaOH and HCl (or where required NaOD and DCl in D2O) were used for pH 
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adjustements. For measurements in D2O the pD was calculated as pD = pH + 0.41, 
where pH is the meter reading.  
Protonation constants were measured at 295 K and 188 MHz using diluted solutions 
of the complex (1 mM) in 0.1 M NaCl in H2O or in solutions of mouse plasma and 
mouse urine diluted 1:1 with Purite water. A coaxial insert containing D2O was used 
to lock the NMR instrument. The resulting curves reporting the 
19
F NMR chemical 
shift vs pH were fitted by non-linear least squares iterative analysis using Origin 8.0 
software, producing estimates of the pKa values. 
 
Enzyme activities were obtained at 25 or 37˚C and 188 or 376 MHz using diluted 
PBS solutions of the complex (1 mM) in H2O with a constant pH of 7.4. For each 
experiment, half of the sample without enzyme added was used as a negative 
control, while to the other half 5 mg of the enzyme was added as a lyophilised 
powder (15 units/mg, 1 unit hydrolyes 1.0 μmole of ethyl butyrate to butyric acid 
and ethanol per min at pH 8.0 at 25 °C). A coaxial D2O insert was used to lock the 
NMR instrument. The activity was reported as 
19
F NMR signal intensity vs time. 
 
Reverse phase HPLC traces were recorded at 298 K using a Perkin Elmer system 
equipped with a Perkin Elmer Series 200 Pump, a Perkin Elmer Series 200 
Autosampler and a Perkin Elmer Series 200 Diode array detector (operated at 254 
nm). A 4.6 x 150 mm 4m Phenomenex Synergi Fusion RP 80Å analytical column 
was used. A gradient elution with a solvent system composed of H2O + 0.1% 
HCOOH/MeCN + 0.1% HCOOH was performed for a total run time of 20 min. The 
details are reported below (Table 6.1): 
 
Table 6.1 Flow rate = 1ml/min; Solvent A = H2O + 0.1% HCOOH; Solvent B = MeCN 
+ 0.1% HCOOH. 
Time (min) Solvent A (%) Solvent B (%) Curvature 
0 95 5 0 
5 95 5 0 
20 0 100 1 
25 0 100 0 
27 95 5 -3 
30 95 5 0 
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Electrospray mass spectra were recorded on a Fisons VG Platform II, Waters 
Micromass LCT or Thermo-Finnigan LTQ FT instrument operating in positive or 
negative ion mode as stated, with methanol as the carrier solvent. Accurate mass 
spectra were recorded using the Thermo-Finnigan LTQ FT mass spectrometer. GC-
MS were acquired on a GSMS Thermo-Finnigan instrument. LC-MS were 
performed on a Waters system comprising of a 3100 Mass Detector and a 2998 
Photodiode array detector. 
 
Gel permeation chromatography was undertaken at Smithers Rapra UK using a 
Viscotek Model 301 TDA instrument with associated pump, autosampler and 
refractive index detector (with differential pressure and light scattering). PLaquagel-
OH guard plus 2 x PLaquagel-OH Mixed-H, 30 cm, 8 m columns were used with 
an eluent composed of 0.5 M NaNO3, 0.01 M NaH2PO4 at pH 2 at a flow rate of 1.0 
ml/min at 30˚C. The GPC system was calibrated using pullulan polysaccharides and 
the data were analysed using Malvern/Viscotek ‘OmniSec’ software. 
 
Melting points were recorded using a Gallenkamp (Sanyo) apparatus and are 
uncorrected. 
 
Microanalysis measurements were acquired on an Exeter CE-440 Elemental 
Analyser. 
 
UV/Vis absorbance spectra were recorded on a Perkin Elmer Lambda 900 
UV/Vis/NIR spectrometer. Emission Spectra were measured on a ISA Joblin-Yvon 
Spec Fluorolog-3 luminescence spectrometer, using DataMax v2.20 software, while 
lifetimes were measured on a Perkin Elmer LS55 luminescence spectrometer using 
FL Winlab software. Samples were contained in quartz cuvettes with a path length 
of 1 cm and pure solvent in a matched cell was used as reference. Absorbance of 
each solution at the excitation wavelength was below 0.3 to avoid inner filter effects. 
Lifetimes measurements of Tb
3+
 or Eu
3+
 complexes were measured following 
excitation of the sample by a short light pulse at 233 nm for Tb
3+
 and 397 nm for 
Eu
3+
, monitoring the integrated intensity of light (at 542-549 nm for Tb
3+
 and 618 
nm for Eu
3+
, depending on the complex) emitted after a delay time during a fixed 
gate time (0.1 ms). At least 20 delay times were used to cover more than 3 lifetimes. 
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The exponential decay curves obtained were fitted with equation 1 using Origin 8.0 
software: 
 
kteAI  0       (33) 
 
where I is the intensity at time t after the flash, A0 the pre-exponential factor and k 
the rate constant for the decay of the excited state. The excited state lifetime, , is the 
inverse of the rate constant, k. 
 
Toxicity studies were performed using two cell lines: CHO (Chinese Hamster 
Ovary) cells and NIH 3T3, mouse skin fibroblast cells. These cells lines were 
cultured in an incubator at 37˚C, average 20% humidity and 5% (v/v) CO2. IC50 
values were determined using the MTT assay
1
, which uses the conversion of MTT to 
a purple formazan product by the mitochondrial dehydrogenase enzymes of viable 
cells. The absorbance of the insoluble formazan was measured at 540 nm upon 
dissolution in DMSO. IC50 values were measured as the drug concentration required 
to reduce by 50% the absorbance of treated cells relative to the untreated cells used 
as control. 
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6.2 Synthetic procedures 
 
1. 1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane
2
   
 
N N
NN
H
O
O
OO
O
O
 
 
To a solution of 1,4,7,10-tetraazacyclododecane (2.54 g, 14.7 mmol) and NaHCO3 
(3.72 g, 44.3 mmol) in dry CH3CN (75 ml) was added tert-butylbromoacetate (6.56 
ml, 44.5 mmol) under argon. The reaction was left stirring overnight at room 
temperature. The mixture was filtered and the solvent evaporated to leave a yellow 
oil which was purified by recrystallisation from hot toluene to yield a white solid 
(2.45 g, 32%), m.p. 179-181°C (lit. 178-179°C)
3
. 
1
H NMR (700 MHz, CDCl3):  
1.20 (27H, s, CH3), 2.50-3.90 (16H, br, CH2 ring), 3.04 (2H, s, CH2CO), 3.14 (4H, s, 
CH2CO), 9.60 (1H, br, s, NH); 
13
C NMR (176 MHz, CDCl3):  28.20, 28.22 (C-
CH3), 47.43, 49.18, 51.29 (CH2 ring), 57.99 (CH2CO), 81.48, 81.68 (C-CH3), 
169.66, 170.51 (COO); ESI/MS
+ 
m/z 515.4 [M + H]
+
; MS Calcd for C26H51O6N4 
515.3803. Found 515.3799. 
 
2. Ethyl 4-amino-3-(trifluoromethyl)benzoate  
 
H2N
CF3
O
O
 
 
Sulfuric acid (1 ml) was added to a solution of EtOH (5 ml) and H2O (0.5 ml) at 
0°C. 4-Amino-3-(trifluoromethyl)benzonitrile (1.0 g, 5.4 mmol) was added and the 
mixture was stirred at 110°C for 3 days. The crude was diluted by addition of CHCl3 
(20 ml), then extracted with H2O (10 ml) carefully adjusting the pH to 7 using solid 
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K2CO3 to neutralize the excess acid. The aqueous layer was washed with CHCl3 (3 x 
20 ml) and the combined organic extracts dried over K2CO3, filtered and solvent 
removed under reduced pressure to leave a yellow oil which was purified by column 
chromatography over silica gel, with gradient elution from toluene to 
toluene/20%CH2Cl2, to yield a light yellow solid (646 mg, 52%), m.p. 83-85°C. Rf = 
0.2 (Silica, toluene/20%DCM, UV); 
1
H NMR (700 MHz, CDCl3):  1.28 (3H, t, J = 
7.0 Hz, CH2CH3), 4.25 (2H, q, J = 7.0 Hz, CH2CH3), 4.88 (2H, br, s, NH2), 6.67 
(1H, d, J = 8.0 Hz, H
5
), 7.84 (1H, d, J = 8.0 Hz, H
6
), 8.06 (1H, s, H
2
); 
13
C NMR (176 
MHz, CDCl3): 14.27 (CH2CH3), 60.88 (CH2CH3), 112.48 (q, 
2
JCF = 31 Hz, C
3
-
CF3), 116.43 (C
5
), 119.00 (C
1
), 124.78 (q, 
1
JCF = 272 Hz, CF3), 129.10 (q, 
3
JCF = 5 
Hz, C
2
), 134.26 (C
6
), 148.94 (C
4
), 166.09 (COO); 
19
F NMR (188 MHz, CDCl3):  -
63.21 (CF3); ESI/MS
- 
m/z 232.1 [M - H]
-
; MS Calcd for C10H9O2NF3 232.0591. 
Found 232.0587. Anal Calcd for C10H10NO2F3 C, 51.51; H, 4.32; N, 6.01%. Found 
C, 52.01; H, 4.47; N, 6.00%. 
 
3. 2-Chloro-N-(4-(ethoxycarbonyl)-2-trifluoromethylphenyl)-ethanamide   
 
N
H
CF3
O
OO
Cl
 
 
To a stirred solution of ethyl 4-amino-3-(trifluoromethyl)benzoate (594 mg, 2.55 
mmol) in CH2Cl2 (15 ml) was added dropwise dry triethylamine (420 μl, 3.06 mmol) 
and chloroacetyl chloride (240 μl, 3.06 mmol) at 0˚C. The reaction mixture was 
allowed to warm to room temperature and stirred for 6 h. The crude mixture was 
washed successively with HCl (aq) (pH 2-3, 30 ml), NaOH (aq) (pH 8-9, 30 ml) and 
H2O (30 ml). The organic layer was dried over MgSO4, filtered and solvent removed 
under reduced pressure. The resultant light brown solid was purified by 
recrystallisation from hexane/diethyl ether to yield light brown needles (647 mg, 
82%), m.p. 100-102°C. 
1
H NMR (500 MHz, CDCl3):  1.42 (3H, t, J = 7.0 Hz, 
CH2CH3), 4.26 (2H, s, CH2Cl), 4.41 (2H, q, J = 7.0 Hz, CH2CH3), 8.25 (1H, dd, J = 
8.5, 1.5 Hz, H
5
), 8.33 (1H, d, J = 1.5 Hz, H
3
), 8.48 (1H, d, J = 8.5 Hz, H
6
), 8.96 (1H, 
br, s, NH); 
13
C NMR (125.7 MHz, CDCl3):  14.53 (CH2CH3), 43.15 (CH2Cl), 61.80 
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(CH2CH3), 119.73 (q, 
2
JCF = 31 Hz, C
2
-CF3), 122.71 (C
6
), 123.71 (q, 
1
JCF = 273 Hz, 
CF3), 127.13 (C
4
), 128.09 (q, 
3
JCF = 5 Hz, C
3
), 134.53 (C
5
), 138.34 (C
1
), 164.54 
(CONH), 164.99 (COO); 
19
F NMR (188 MHz, CDCl3):  -60.84 (CF3); ESI/MS
- 
m/z 
308.2 [M - H]
-
; MS Calcd for C12H10O3NF3Cl 308.0307. Found 308.0303. Anal 
Calcd for C12H11O3NF3Cl C, 46.54; H, 3.58; N, 4.52%. Found C, 46.73; H, 3.71; N, 
4.32%.  
 
4. 10-[(4-Ethoxycarbonyl-2-trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7-
tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane  
 
N N
NN
O
O
OO
O
O
H
N
O
F3C
O
O
 
 
To a solution of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane (500 mg, 0.97 mmol) and 2-chloro-N-(4-(ethoxycarbonyl)-2-
trifluoromethylphenyl)-ethanamide (331 mg, 1.07 mmol) in dry CH3CN (20 ml) 
under argon, was added K2CO3 (161 mg, 1.17 mmol) and KI (5 mg, cat.). The 
mixture was boiled under reflux for 24 h. After filtration, the residue was washed 
with CH2Cl2 (2 x 30 ml) and solvent removed under reduced pressure to yield a 
brown oil which was purified by column chromatography over silica gel (CH2Cl2 to 
CH2Cl2/10%EtOH). The resultant pale brown oil was purified by recrystallization 
from hot diethyl ether yielding a white powder (597 mg, 78%), m.p. 185-186°C. Rf 
= 0.6 (Silica, DCM/5%EtOH, UV); 
1
H NMR (500 MHz, CDCl3):  1.26, 1.37 (27H, 
br, s, CH3), 1.33 (3H, t, J = 7.0 Hz, CH2CH3), 1.90-3.80 (24H, br, CH2 ring and 
CH2CO), 4.33 (2H, q, J = 7.0 Hz, CH2CH3), 7.76 (1H, d, J = 8.5 Hz, aromatic H
6
), 
8.01 (1H, dd, J = 8.5, 1.5 Hz, aromatic H
5
), 8.20 (1H, d, J = 1.5 Hz, aromatic H
3
), 
9.48 (1H, br, s, NH); 
13
C NMR (125.7 MHz, CDCl3): 14.49 (CH2CH3), 27.99, 
28.07 (CH3), 48.52, 52.63 (br, CH2 ring), 55.74, 55.82, 57.01 (CH2CO), 61.64 
(CH2CH3), 82.07 (C-CH3), 123.35 (q, 
1
JCF = 274 Hz, CF3), 124.91 (q, 
2
JCF = 32 Hz, 
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aromatic C
2
-CF3), 127.83 (aromatic C
4
), 128.05 (q, 
3
JCF = 5 Hz, aromatic C
3
), 
128.29 (aromatic C
6
), 133.23 (aromatic C
5
), 139.60 (aromatic C
1
), 165.26 (COOEt), 
172.53, 172.63, 172.75 (C=O); 
19
F NMR (188 MHz, CDCl3):  -60.51 (CF3); 
ESI/MS
+
 m/z 810.4 [M + Na]
+
; MS Calcd for C38H60N5O9F3Na 810.4235. Found 
810.4224. The structure was confirmed by single crystal X-ray diffraction (see 
Appendix B). 
 
5. 10-[(4-Ethoxycarbonyl-2-trifluoromethyl(phenyl)carbamoylmethyl]-1,4,7-
tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane, H3L
1a
    
 
N N
NN
HO
O
OHO
HO
O
H
N
O
F3C
O
O
 
 
10-[(4-Ethoxycarbonyl-2-trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7-tris(tert-           
butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (410 mg, 0.52 mmol) was 
dissolved in CH2Cl2 (1 ml), followed by the addition of CF3CO2H (4 ml). The 
solution was stirred at room temperature for 24 h. The solvent was removed under 
reduced pressure and the resulting solid washed with CH2Cl2 (5 x 5 ml) removing 
the solvent each time under reduced pressure (KOH in trap) to give the product as its 
trifluoroacetate salt (δF -76.1 CF3CO2
-
). The residue was dissolved in water (5 ml) 
and stirred overnight with anion exchange resin (DOWEX 1X8 200-400 MESH Cl, 
pre-treated with 1M HCl) in Purite H2O to give the chloride salt. After filtration, the 
aqueous solution was lyophilised to yield the product (as its dihydrochloride salt) as 
a light yellow powder (248 mg, 77%), m.p. 210-211°C (dec). 
1
H NMR (500 MHz, 
D2O):  1.19 (3H, t, J = 7.0 Hz, CH2CH3), 2.60-4.20 (24H, br, CH2 ring and 
CH2CO), 4.19 (2H, q, J = 7.0 Hz, CH2CH3), 7.63 (1H, d, J = 8.0 Hz, aromatic H
6
), 
8.01 (1H, d, J = 8.0 Hz, aromatic H
5
), 8.10 (1H, s, aromatic H
3
); 
13
C NMR (125.7 
MHz, D2O): 13.55 (CH2CH3), 47.00-56.00 (br, CH2 ring and CH2CO), 62.83 
(CH2CH3), 123.07 (q, 
1
JCF = 273 Hz, CF3), 124.40 (q, 
2
JCF = 30 Hz, aromatic C
2
-
CF3), 127.99 (q, 
3
JCF = 5 Hz, aromatic C
3
), 127.60-129.60 (br, aromatic C
4
 and C
6
), 
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133.86 (aromatic C
5
), 137.57 (aromatic C
1
), 166.95 (COOEt), 168.00-175.00 (br, 
C=O); 
19
F NMR (188 MHz, D2O):  -61.54 (CF3); ESI/MS
+ 
m/z 620.4 [M + H]
+
, 
642.4 [M + Na]
+
, 658.3 [M + K]
+
; MS Calcd for C26H37O9N5F3 620.2538. Found 
620.2534. HPLC: tR = 8.4 min. 
 
6. [HoL
1
(H2O)]   
 
N N
NN
O
O
OO
O
O
H
N
O
F3C
Ho
OH2
O
O
 
 
The ligand L
1
 (32.0 mg, 0.052 mmol) and Ho(III)Cl3 (15.4 mg, 0.057 mmol) were 
dissolved in water (3 ml) and the pH adjusted to 5.5 using diluted KOH (aq). The 
reaction was left stirring overnight under reflux. After cooling to room temperature, 
the solution pH was adjusted to 10 and the mixture centrifuged to remove the 
precipitated metal hydroxide. The supernatant was adjusted back to pH 6 with 
diluted HCl (aq) and lyophilised to yield a yellow solid that was extracted into 
20%MeOH/CH2Cl2 to give a light yellow solid. 
The powder obtained was a mixture of the ethyl ester and the hydrolysed acid. The 
1
H NMR spectral data were obtained on the mixture; the ethyl ester resonances are 
in a non-shifted region, so the major isomer resonances are expected not to change 
in both the ester and acid form. 
1
H NMR (500 MHz, D2O, pD 8.0):  major isomer: -
247.2, -57.7, 54.7, 88.5, 165.7; minor isomer -223.8, -210.8, -91.9, -78.0, -68.4, -
45.9, -36.0, -31.3, -28.3, -23.2, -16.8, -13.1, 83.9, 149.0, 157.3; 
19
F NMR (188 MHz, 
D2O, pD 8.0) : ester -54.6 (CF3, 1/2 = 120 Hz), acid -56.6 (CF3, 1/2 = 46 Hz); 
ESI/MS
+ 
m/z ester 782.2 [M + H]
+
, 804.1 [M + Na]
+
, 820.1 [M + K]
+
; ESI/MS
- 
m/z 
ester 780.1 [M - H]
-
, acid 752.1 [M - H]
-
; MS Calcd for ester C26H32O9N5F3
165
Ho 
780.1461. Found 780.1465. Calcd for acid C24H28O9N5F3
165
Ho 752.1148. Found 
752.1152. HPLC: tR ester = 8.9 min; LC-MS: tR ester = 6.7 min, m/z 782.43 [M + 
H]
+
, 780.28 [M - H]
-
. 
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The ester was obtained separately using the same procedure by carrying out the 
complexation reaction with the Ln(III) salt at room temperature or by dissolving the 
mixture of the ester and acid complexes in EtOH/dry HCl for 1 week. The acid was 
obtained separately by allowing the complex to hydrolyse at pH 10 at room 
temperature, over a period of 1 week. 
7. [TbL
1
(H2O)] (as a mixture of ethyl ester and its acid): 
1
H NMR (500 MHz, D2O, 
pD 10.0):  major isomer -407.1, -101.1, -97.2, 85.0, 139.7, 265.6; minor isomer -
369.8, -350.1, -238.0, -147.0, -131.5, -114.0, -74.9, -73.2, -71.4, -67.3, -64.1, -50.4, -
40.0, -26.0, -23.8, -20.1, 22.5, 36.0, 43.0, 50.0, 64.0, 118.0, 130.0, 238.0, 253.0; 
19
F 
NMR (188 MHz, D2O, pD 10.0):  ester -35.4 (CF3, 1/2 = 235 Hz), acid -45.6 (CF3, 
1/2 = 207 Hz); ESI/MS
+
 m/z ester 798.2 [M + Na]
+
, acid 769.9 [M + Na]
+
; ESI/MS
-
 
m/z ester 774.4 [M - H]
-
, acid 746.4 [M - H]
-
; MS Calcd for ester 
C26H33O9N5F3Na
159
Tb 798.1376. Found 798.1375. Calcd for acid 
C24H28O9N5F3
159
Tb 746.1110. Found 746.1098. 
8. [DyL
1
(H2O)] (as a mixture of ethyl ester and its acid): 
1
H NMR (500 MHz, D2O, 
pD 8.0): major isomer -108.6, -100.8, 114.0, 168.1, 318.4; minor isomer -480.7, -
210.3, -160.1, -146.2, -103.0, -72.5, -49.2, -39.1, 204.8, 225.1, 280.2; 
19
F NMR (188 
MHz, D2O, pD 8.0):  ester -59.7 (CF3, 1/2 = 551 Hz), acid -64.0 (CF3, 1/2 = 283 
Hz);  ESI/MS
+ 
m/z ester 803.3 [M + Na]
+
, 819.2 [M + K]
+
; ESI/MS
-
 m/z ester 779.5 
[M - H]
-
, acid 751.4 [M - H]
-
; MS Calcd for ester C26H32O9N5F3
162
Dy 776.1435. 
Found 776.1435. Calcd for acid C24H28O9N5F3
162
Dy 748.1114. Found 748.1123. 
9. [ErL
1
(H2O)] (as a mixture of ethyl ester and its acid): 
1
H NMR (500 MHz, D2O, 
pD 5.0):  major isomer -101.4, -56.4, 11.6, 22.6, 164.5; minor isomer -86.5, -80.6, -
70.9, -66.9, -37.0, -33.0, -27.8, 7.2, 9.7, 15.8, 21.3, 28.4, 34.3, 126.2, 132.5, 142.7, 
151.9; 
19
F NMR (188 MHz, D2O, pD 5.0):  ester -62.4 (CF3, 1/2 = 42 Hz), acid -
62.0 (CF3, 1/2 = 134 Hz); ESI/MS
+ 
m/z ester 823.2 [M + K]
+
, acid 795.2 [M + K]
+
; 
ESI/MS
- 
m/z ester 783.2 [M - H]
-
, acid 755.3 [M - H]
-
; MS Calcd for ester 
C26H33O9N5
166
ErF3K 821.1165. Found 821.1164. Calcd for acid 
C24H29O9N5
166
ErF3K 793.0852. Found 793.0851. 
10. [TmL
1
(H2O)] (as a mixture of ethyl ester and its acid): 
1
H NMR (500 MHz, 
D2O, pD 7.5):  major isomer: -248.3, -137.2, -116.3, 49.9, 65.0, 387.0; minor 
isomer -378.4, -215.9, -211.1, -209.1, -205.1, -177.5, -150.2, -143.3, -118.6, -110.8, 
-89.9, -82.3, -78.9, -70.5, 30.5, 33.6, 36.1, 37.6, 39.4, 57.7, 58.6, 74.5, 313.9, 328.1, 
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340.5; 
19
F NMR (188 MHz, D2O, pD 7.5):  ester -78.0 (CF3, 1/2 = 66 Hz), acid -
79.9 (CF3, 1/2 = 56 Hz); ESI/MS
+
 m/z ester 808.3 [M + Na]
+
, 824.3 [M + K]
+
, acid 
796.3 [M + K]
+
; ESI/MS
-
 m/z acid 756.2 [M - H]
-
; MS Calcd for ester 
C26H33O9N5F3
169
TmK 824.1204. Found 824.1204. Calcd for acid 
C24H28O9N5F3
169
Tm 756.1187. Found 756.1180. 
 
11. 10-[(4-Carboxy-2-trifluoromethyl(phenyl)carbamoylmethyl]-1,4,7-
tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane, H4L
1b
    
 
N N
NN
HO
O
OHO
HO
O
H
N
O
F3C
O
OH
 
 
Lithium hydroxide monohydrate (34 mg, 0.81 mmol) was dissolved in water (2 ml) 
and added to a solution of 10-[(4-ethoxycarbonyl-2-
trifluoromethyl(phenyl)carbamoylmethyl]-1,4,7-tris(carboxymethyl)-1,4,7,10-
tetraazacyclododecane H3L
1a
 (100 mg, 0.16 mmol) in MeOH (4 ml). The mixture 
was stirred at room temperature for 48 h. The MeOH was removed under reduced 
pressure and the pH adjusted to 4 with diluted HCl (aq). The aqueous solution was 
washed with ethyl acetate (2 x 5 ml) then lyophilised to yield the dihydrochloride 
salt of the ligand as a white powder which was directly used in complexation 
reactions without further purification, m.p. >250°C (dec). 
1
H NMR (500 MHz, 
D2O):  2.80-3.50 (16H, br, CH2 ring), 3.38, 3.73, 3.74, 3.77 (2H, br, CH2CO), 7.49 
(1H, d, J = 8.5 Hz, aromatic H
6
), 7.80 (1H, dd, J = 8.5, 1.5 Hz, aromatic H
5
), 8.11 
(1H, d, aromatic H
3
); 
13
C NMR (125.7 MHz, D2O):  48.25, 51.36, 51.68 (br, CH2 
ring), 53.61, 54.46, 56.83 (CH2CO), 123.25 (q, 
1
JCF = 273 Hz, CF3), 125.54 (q, 
2
JCF 
= 31 Hz, aromatic C
2
-CF3), 127.90 (q, 
3
JCF = 5 Hz, aromatic C
3
), 129.80 (aromatic 
C
6
), 132.82 (aromatic C
4
), 133.85 (aromatic C
5
), 136.50 (aromatic C
1
), 170.36 
(C=O), 171.34 (aromatic C=O), 172.05, 174.92 (C=O);19F NMR (188 MHz, D2O): 
 -61.62 (CF3); ESI/MS
+
 m/z 296.6 [(M + 2H)/2]
2+
, 592.2 [M + H]
+
, 614.2 [M + 
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Na]
+
, 630.2 [M + K]
+
; ESI/MS
-
 m/z 313.6 [M + Cl - H]
2-
, 628.2 [M + Cl]
-
; MS 
Calcd for C24H33O9N5F3 592.2230. Found 592.2240. HPLC: tR = 5.8 min. 
 
12. [HoL
1b
(H2O)] 
Prepared as described for [HoL
1
(H2O)] (6) at room temperature. 
 
N N
NN
O
O
OO
O
O
H
N
O
F3C
Ho
OH2
OH
O
 
 
1
H NMR (500 MHz, D2O, pD 5.2, partial assignment):  -256.7, -251.2, -227.6, -
223.9, -214.7, -94.0, -79.0, -69.7, -58.4, -46.2, -38.1, -36.0, -31.4, -29.5, -23.2, -13.6, 
17.0, 55.9, 86.3, 92.4, 152.7, 159.0; 
19
F NMR (188 MHz, D2O, pD 5.2) : -56.8 
(CF3, 1/2 = 47 Hz), -49.8 (CF3, 1/2 = 47 Hz); ESI/MS
+ 
m/z 754.1 [M + H]
+
, 776.1 
[M + Na]
+
, 792.2 [M + K]
+
; ESI/MS
- 
m/z 752.1 [M - H]
-
; MS Calcd for 
C24H28O9N5F3
165
Ho 752.1142. Found 752.1139. HPLC: tR = 7.1 min; LC-MS: tR = 
3.1 min, m/z 754.35 [M + H]
+
. 
13. [GdL
1b
(H2O)] 
19
F NMR (188 MHz, D2O, pD 5.2) : -60.9 (CF3, 1/2 = 1325 
Hz); ESI/MS
- 
m/z 745.1 [M - H]
-
; MS Calcd for C24H28O9N5F3
156
Gd 743.1067. 
Found 743.1061. 
 
14. 2-Chloro-N-(4-nitro-2-trifluoromethylphenyl)-ethanamide  
 
N
H
CF3
NO2
O
Cl
 
 
Chloroacetyl chloride (1.95 ml, 24.5 mmol) was added dropwise to a stirred solution 
of 4-nitro-2-trifluoromethyl aniline (2.01 g, 9.8 mmol), 4-dimethylaminopyridine 
(10 mg) and triethylamine (1.70 ml, 12.1 mmol) in dry THF (35 ml) at 0˚C. The 
reaction mixture was allowed to warm to room temperature and stirred for 48 h. 
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CH2Cl2 (30 ml) was added and the organic layer washed with HCl (aq) (pH 2-3, 30 
ml), NaOH (aq) (pH 8-9, 30 ml) and H2O (30 ml) then dried over K2CO3. After 
filtration, the solvent was removed to yield a brown oil that was purified by 
recrystallization from diethyl ether to yield light brown crystals (1.62 g, 59%), m.p. 
62-64°C. 
1
H NMR (700 MHz, CDCl3):  4.27 (2H, s, CH2Cl), 8.42 (1H, dd, J = 9.0, 
2.0 Hz, H
5
), 8.52 (1H, d, J = 2.0 Hz, H
3
), 8.67 (1H, d, J = 9.0 Hz, H
6
), 9.06 (1H, br, 
s, NH); 
13
C NMR (176 MHz, CDCl3):  43.09 (CH2Cl), 120.03 (q, 
2
JCF = 31 Hz, C
2
-
CF3), 122.63 (q, 
3
JCF = 5 Hz, C
3
), 122.91 (q, 
1
JCF = 274 Hz, CF3), 123.04 (C
6
), 
128.56 (C
5
), 140.13 (C
1
), 143.69 (C
4
), 164.68 (CONH); 
19
F NMR (188 MHz, 
CDCl3):  -61.70 (CF3); ESI/MS
- 
m/z 281.3 [M - H]
-
; MS Calcd for C9H5N2O3F3Cl 
280.9941. Found 280.9835. Anal Calcd for C9H6N2O3F3Cl C, 38.20; H, 2.14; N, 
9.91%. Found C, 38.30; H, 2.12; N, 9.80%.  
 
15. 10-[(4-Nitro-2-trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7-tris(tert-           
butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane  
 
N N
NN
O
O
OO
O
O
H
N
O
NO2
F3C
 
 
To a solution of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane (330 mg, 0.64 mmol) and 2-chloro-N-(4-nitro-2-
trifluoromethylphenyl)-ethanamide (200 mg, 0.71 mmol) in dry CH3CN (20 ml) 
under argon, was added K2CO3 (106 mg, 0.77 mmol) and KI (5 mg, cat.). The 
mixture was boiled under reflux for 24 h. After filtration, the residue was washed 
with CH2Cl2 (2 x 30 ml) and solvent removed under reduced pressure to give a 
brown oil which was purified by column chromatography over silica gel, eluting 
with a gradient starting from CH2Cl2 up to CH2Cl2/10%MeOH to give a pale brown 
oil (402 mg, 83%). Rf = 0.5 (Silica, DCM/5%MeOH, UV); 
1
H NMR (500 MHz, 
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CDCl3):  1.35, 1.44 (27H, br, s, CH3), 1.90-4.00 (24H, br, CH2 ring and CH2CO), 
8.13 (1H, d, J = 9.0 Hz, aromatic H
6
), 8.27 (1H, dd, J = 9.0, 2.5 Hz, aromatic H
5
), 
8.49 (1H, d, J = 2.5 Hz, aromatic H
3
); 
13
C NMR (125.7 MHz, CDCl3): 28.13 
(CH3), 48.65, 52.77 (br, CH2 ring), 55.86, 55.88, 57.66 (CH2CO), 82.26 (C-CH3), 
122.60 (q, 
1
JCF = 274 Hz, CF3), 122.76 (q, 
3
JCF = 5 Hz, aromatic C
3
), 125.03 (q, 
2
JCF 
= 32 Hz, aromatic C
2
-CF3), 127.13 (aromatic C
5
), 128.37 (aromatic C
6
), 141.25 
(aromatic C
1
), 144.50 (aromatic C
4
), 172.83, 172.88 (C=O); 
19
F NMR (188 MHz, 
CDCl3):  -61.17 (CF3); ESI/MS
+
 m/z 783.4 [M + Na]
+
; ESI/MS
-
 m/z 759.5 [M - H]
-
; MS Calcd for C35H54N6O9F3 759.3910. Found 759.3900. 
 
16. 10-[(4-Nitro-2-trifluoromethyl(phenyl)carbamoylmethyl]-1,4,7-
tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane, H3L
2
    
Prepared as described for H3L
1a
 (5).  
 
N N
NN
HO
O
OHO
HO
O
H
N
O
NO2
F3C
 
 
The product was isolated as the dihydrochloride salt as a light yellow powder (113 
mg, 47%), m.p. 196-198°C (dec). 
1
H NMR (500 MHz, D2O):  2.60-4.30 (24H, br, 
CH2 ring and CH2CO), 7.83 (1H, d, J = 9.0 Hz, aromatic H
6
), 8.31 (1H, d, J = 9.0 
Hz, aromatic H
5
), 8.46 (1H, s, aromatic H
3
); 
13
C NMR (125.7 MHz, D2O):  42.42, 
47.83, 48.51, 49.33, 51.78 (br), 52.12, 53.20, 54.68 (br, CH2 ring and CH2CO), 
122.48 (q, 
1
JCF = 274 Hz, CF3), 122.95 (q, 
3
JCF = 5 Hz, aromatic C
3
), 124.13 (q, 
2
JCF 
= 34 Hz, aromatic C
2
-CF3), 128.02 (aromatic C
5
), 129.04 (aromatic C
6
), 144.82, 
168.90 (br, aromatic C
1
, C
4
), 169.40 (br), 174.57 (C=O);19F NMR (188 MHz, D2O): 
 -61.84 (CF3); ESI/MS
+
 m/z 615.3 [M + Na]
+
, 631.2 [M + K]
+
, 655.0 [M + Cu]
+
; 
ESI/MS
-
 m/z 629.1 [M + Cl]
-
; MS Calcd for C23H31O9N6F3K 631.1736. Found 
631.1739. Calcd for C23H31O9N6F3Cu 655.1395. Found 655.1403. HPLC: tR = 7.1 
min; LC-MS: tR = 4.8 min, m/z 593.31 [M + H]
+
. 
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17. [HoL
2
(H2O)]   
Prepared as described for [HoL
1
(H2O)] (6).  
 
N N
NN
O
O
OO
O
O
H
N
O
NO2
F3C
Ho
OH2
 
 
1
H NMR (500 MHz, D2O, pD5.2):  -256.2, -249.7, -224.2, -218.9, -210.2, -96.4, -
80.0, -69.7, -58.1, -45.4, -40.1, -33.2, -28.0, -20.5, -16.2, 55.6, 88.7, 94.0, 147.1, 
156.4, 166.9; 
19
F NMR (188 MHz, D2O, pD 5.2):  (exists as mixture of isomers) -
57.7 (CF3, 1/2 = 51 Hz, major isomer 88%); ESI/MS
+ 
m/z 777.0 [M + Na]
+
, 793.0 
[M + K]
+
; MS Calcd for C23H28O9N6F3
165
HoNa 777.1065. Found 777.1067. MS 
Calcd for C23H28O9N6F3
165
HoK 793.0805. Found 793.0816. HPLC: tR = 7.5 min. 
18. [TbL
2
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.2):  -409.0 (1H, br), -365.9 (1H, 
br), -363.7 (1H, br), -342.7 (1H, br), -151.4 (1H), -133.6 (1H), -114.1 (1H), -99.4 
(1H), -96.5, -74.6 (1H), -64.4 (1H), -60.7 (2H), -46.2 (1H), -30.5 (1H), 30.1 (1H), 
36.4, 84.0, 121.4 (1H), 133.2 (1H), 232.9 (1H, br), 241.4 (2H, br), 246.0 (1H, br); 
19
F NMR (188 MHz, D2O, pD 5.2):  -50.2 (CF3, 1/2 = 73 Hz); ESI/MS
+ 
m/z 749.3 
[M + H]
+
, 771.3 [M + Na]
+
, 787.3 [M + K]
+
; ESI/MS
-
 m/z 747.3 [M - H]
-
; MS Calcd 
for C23H28O9N6F3
159
TbK 787.0755. Found 787.0758.  
19. [DyL
2
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.2):  -479.2, -440.5, -422.2, -
392.1, -217.6, -165.3, -149.3, -117.4, -108.5, -103.1, -100.9, -87.5, -69.8, -48.4, -
43.9, -33.5, -30.3, -5.0, 112.7, 166.4, 211.8, 231.2, 268.8, 316.9, 357.1; 
19
F NMR 
(188 MHz, D2O, pD 5.2):  (exists as mixture of isomers) -65.5 (CF3, 1/2 = 74 Hz, 
major isomer 70%); ESI/MS
+ 
m/z 776.0 [M + Na]
+
; MS Calcd for 
C23H28O9N6F3
164
DyNa 776.1054. Found 776.1064. 
20. [ErL
2
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.2):  -99.1 (1H, br), -84.2 (1H, br), 
-80.3 (2H, br), -78.4 (2H, br), -71.0 (1H, br), -66.9 (1H), -56.6 (1H), -55.0 (1H), -
35.9 (1H), -31.1 (1H), -25.8 (1H, br), 10.0 (1H), 14.3 (1H), 20.8 (1H), 22.0 (1H), 
23.2 (1H), 24.1 (1H), 33.6 (1H), 35.0 (1H), 120.4 (1H, br), 127.7 (1H, br), 138.2 
(1H, br), 148.4 (1H, br), 160.1 (1H, br); 
19
F NMR (188 MHz, D2O, pD 5.2):  -64.7 
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(CF3, 1/2 = 63 Hz); ESI/MS
+ 
m/z 778.3 [M + Na]
+
, 796.2 [M + K]
+
; ESI/MS
-
 m/z 
756.3 [M - H]
-
; MS Calcd for C23H28O9N6
166
ErF3K 794.0805. Found 794.0816.  
21. [TmL
2
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.3):  -203.0 (2H), -196.1 (1H), -
194.4 (1H), -149.5 (1H), -141.9 (1H), -117.0 (1H), -109.7 (1H), -81.9 (1H), -76.1 
(1H), -73.0 (1H), -63.2 (1H), 31.4 (1H), 34.1 (2H), 36.9 (1H), 38.4 (1H), 46.2 (1H), 
50.2 (1H), 57.2 (1H), 58.0 (1H), 74.5 (1H), 302.7 (2H), 315.6 (1H), 331.0 (1H); 
19
F 
NMR (188 MHz, D2O, pD 5.4):  -77.5 (CF3, 1/2 = 45 Hz); ESI/MS
+ 
m/z 759.1 [M 
+ H]
+
, 781.1 [M + Na]
+
, 797.1 [M + K]
+
; ESI/MS
-
 m/z 757.2 [M - H]
-
; MS Calcd for 
C23H28O9N6F3K
169
Tm 797.0844. Found 797.0849. 
 
22. 2-Chloro-N-(4-(cyano)-2-trifluoromethylphenyl)-ethanamide  
 
N
H
CF3
CN
O
Cl
 
 
To a stirred solution of 4-amino-3-(trifluoromethyl)benzonitrile (2.01 g, 10.8 mmol), 
and 4-dimethylaminopyridine (10 mg) in dry THF (35 ml) were added dropwise dry 
triethylamine (1.87 ml, 13.5 mmol) and chloroacetyl chloride (2.15 ml, 26.9 mmol) 
at 0˚C. The reaction mixture was allowed to warm to room temperature and stirred 
overnight. The crude was washed successively with HCl (aq) (pH 2-3, 20 ml), NaOH 
(aq) (pH 8-9, 20 ml) and water (20 ml). The organic layer was dried over MgSO4, 
filtered and solvent removed under reduced pressure to yield a yellow oil. 
Recrystallisation from ethyl acetate/hexane yielded an off-white solid (2.94 g, 99%), 
m.p. 113-114°C. 
1
H NMR (700 MHz, CDCl3): 4.25 (2H, s, CH2Cl), 7.86 (1H, dd, 
J = 8.5, 1.5 Hz, H
5
), 7.93 (1H, s, H
3
), 8.60 (1H, d, J = 8.5 Hz, H
6
), 8.99 (1H, br, s, 
NH); 
13
C NMR (176 MHz, CDCl3):  43.06 (CH2Cl), 108.84 (C
4
), 117.33 (CN), 
120.43 (q, 
2
JCF = 31 Hz, C
2
-CF3), 123.32 (C
6
), 122.97 (q, 
1
JCF = 274 Hz, CF3), 
130.57 (q, 
3
JCF = 5 Hz, C
3
), 137.00 (C
5
), 138.53 (C
1
), 164.63 (CONH); 
19
F NMR 
(188 MHz, CDCl3):  -61.77 (CF3); ESI/MS
- 
m/z 261.1 [M - H]
-
; MS Calcd for 
C10H5N2OF3Cl 261.0048. Found 261.0045. Anal Calcd for C10H6N2OF3Cl C, 45.73; 
H, 2.30; N, 10.67%. Found C, 45.41; H, 2.47; N, 10.72%. 
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23. 10-[(4-Cyano-2-trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7-tris(tert-
butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane 
 
N N
NN
O
O
OO
O
O
H
N
O
CN
F3C
 
 
To a solution of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane (205 mg, 0.40 mmol) and 2-chloro-N-(4-(cyano)-2-
trifluoromethylphenyl)-ethanamide (115 mg, 0.44 mmol) in dry CH3CN (10 ml) 
under argon, was added K2CO3 (66 mg, 0.48 mmol) and KI (5 mg, cat.). The 
mixture was boiled under reflux for 24 h. After filtration, the residue was treated 
with CH2Cl2 (2 x 30 ml), the organic extracts were combined and the solvent 
removed under reduced pressure to leave a brown oil which was purified by column 
chromatography over silica gel eluting from CH2Cl2 to 5%MeOH/CH2Cl2. 
Recrystallisation from diethyl ether yielded a white amorphous solid (110 mg, 37%), 
m.p. >250°C (dec). Rf = 0.5 (Silica, DCM/5%MeOH, UV); 
1
H NMR (700 MHz, 
CDCl3):  1.1-1.5 (27H, br, CH3), 1.80-3.90 (24H, br, CH2 ring and CH2CO), 7.67 
(1H, d, J = 9.0 Hz, aromatic H
5
), 7.85 (1H, s, aromatic H
3
), 7.98 (1H, d, J = 9.0 Hz, 
aromatic H
6
), 9.23 (1H, br, s, NH); 
13
C NMR (176 MHz, CDCl3):  28.09 (CH3), 
48.77, 52.77 (br, CH2 ring), 55.86, 57.52 (CH2CO), 82.19 (C-CH3), 109.52 
(aromatic C
4
), 117.57 (CN), 122.62 (q, 
1
JCF = 274 Hz, CF3), 125.76 (q, 
2
JCF = 33 Hz, 
C
2
-CF3), 128.85 (aromatic C
6
), 130.73 (q, 
3
JCF = 5 Hz, C
3
), 135.58 (aromatic C
5
), 
139.62 (aromatic C
1
), 172.76, 172.79 (CO); 
19
F NMR (188 MHz, CDCl3)  -61.16 
(CF3); ESI/MS
+ 
m/z 740.9 [M + H]
+
, 762.9 [M + Na]
+
; MS Calcd for 
C36H55N6O7F3Na 763.3977. Found 763.3973. 
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24. 10-[(4-Cyano-2-trifluoromethyl(phenyl)carbamoylmethyl]-1,4,7-
tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane, H3L
3 
Prepared as described for H3L
1a
 (5).  
 
N N
NN
HO
O
OHO
HO
O
H
N
O
CN
F3C
 
 
The product was isolated as the dihydrochloride salt as a light yellow powder (71 
mg, 84%), m.p. 204-206°C (dec.). 
1
H NMR (700 MHz, D2O):  2.70-4.10 (24H, br, 
CH2 ring and CH2CO), 7.75 (1H, d, J = 8.5 Hz, aromatic H
5
), 7.88 (1H, d, J = 8.5 
Hz, aromatic H
6
), 8.05 (1H, s, aromatic H
3
); 
13
C NMR (176 MHz, D2O):  47.00-
56.00 (br, CH2 ring and CH2CO), 109.84 (aromatic C
4
), 118.27 (CN), 122.62 (q, 
1
JCF 
= 273 Hz, CF3), 124.90 (q, 
2
JCF = 30 Hz, C
2
-CF3), 129.43 (q, 
3
JCF = 5 Hz, C
3
), 
131.50 (aromatic C
6
), 137.01 (aromatic C
5
), 138.01 (aromatic C
1
), 168.15 (br, CO); 
19
F NMR (188 MHz, D2O):  -61.93 (CF3); ESI/MS
+
 m/z 573.3 [M + H]
+
, 595.3 [M 
+ Na]
+
; MS Calcd for C24H32O7N6F3 573.2279. Found 573.2283. HPLC: tR = 6.9 
min. 
 
25. [HoL
3
(H2O)] 
Prepared as described for [HoL
1
(H2O)] (6).  
 
N N
NN
O
O
OO
O
O
H
N
O
CN
F3C
Ho
OH2
 
 
1
H NMR (500 MHz, D2O pD 5.3):  -252.4, -245.9, -222.2, -216.8, -208.7, -94.2, -
78.5, -69.0, -58.0, -45.1, -39.4, -33.9, -28.1, -21.3, -16.9, 14.2, 54.5, 86.7, 91.8, 
146.1, 153.1, 164.7; 
19
F NMR (188 MHz, D2O, pD 5.4):  -55.4 (CF3, 1/2 = 45 Hz); 
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ESI/MS
+ 
m/z 735.1 [M + H]
+
, 757.1 [M + Na]
+
; MS Calcd for 
C24H28O7N6F3
165
HoNa 757.1167. Found 757.1173. HPLC: tR = 7.5 min. 
26. [TbL
3
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.2):  -411.9, -407.8, -368.3, -
346.3, -151.1, -133.4, -114.8, -101.1, -100.0, -97.3, -74.2, -64.6, -61.9, -55.1, -46.5, -
29.4, -5.1, 31.6, 38.2, 85.3, 122.1, 134.0, 140.0, 234.6, 240.5, 245.6, 265.6; 
19
F 
NMR (188 MHz, D2O, pD 5):  -50.1 (CF3, 1/2 = 63 Hz); ESI/MS
+ 
m/z 751.2 [M + 
Na]
+
, 767.1 [M + K]
+
; ESI/MS
- 
m/z 727.2 [M - H]
-
; MS Calcd for 
C24H28O7N6F3Na
159
Tb 751.1117. Found 751.1120. 
27. [ErL
3
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.3):  -100.3, -85.0, -79.5, -71.2, -
67.0, -57.0, -55.8, -35.8, -31.3, -26.5, 9.6, 11.0, 15.0, 21.1, 21.1, 22.3, 24.0, 31.6, 
35.2, 122.6, 129.3, 140.0, 150.0, 162.5; 
19
F NMR (188 MHz, D2O, pD 5.4):  -64.1 
(CF3, 1/2 = 39 Hz); ESI/MS
+ 
m/z 758.1 [M + Na]
+
, 776.2 [M + K]
+
; ESI/MS
- 
m/z 
735.3 [M - H]
-
; MS Calcd for C24H28O7N6
166
ErF3Na 758.1167. Found 758.1164. 
28. [TmL
3
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.4):  -243.2, -207.4, -204.9, -
200.9, -197.8, -196.4, -149.8, -142.3, -133.3, -117.5, -113.3, -110.2, -86.0, -83.3, -
79.0, -77.0, -74.0, -64.7, 1.5, 2.0, 3.3, 6.1, 6.3, 7.9, 8.3, 31.7, 32.8, 34.4, 34.8, 36.0, 
38.6, 46.7, 47.8, 49.1, 57.4, 58.0, 63.8, 74.5, 304.8, 309.3, 317.8, 332.8, 375.8; 
19
F 
NMR (188 MHz, D2O, pD 5.4):  -78.2 (CF3, 1/2 = 36 Hz); ESI/MS
+
 m/z 739.1 [M 
+ H]
+
, 761.1 [M + Na]
+
; MS Calcd for C24H28O7N6F3Na
169
Tm 761.1206. Found 
761.1203. 
 
29. Ethyl 2-amino-3-(trifluoromethyl)benzoate 
 
NH2
CO2EtF3C
 
 
Sulfuric acid (2 ml, 18 M) was added dropwise to a solution of 2-amino-3-
(trifluoromethyl)benzoic acid (2.0 g, 9.75 mmol) in EtOH (30 ml). The mixture was 
left stirring at 105°C overnight. The crude mixture was diluted by addition of CHCl3 
(20 ml), then extracted with H2O (10 ml) carefully adjusting the pH to 7 using solid 
K2CO3 to neutralize the excess acid. The aqueous layer was extracted with CHCl3 (3 
x 20 ml) and the combined organic extracts were dried over K2CO3, filtered and 
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solvent removed under reduced pressure to give a pale yellow solid (2.02 g, 89%), 
m.p. 72-73°C. 
1
H NMR (700 MHz, CDCl3):  1.36 (3H, t, J = 7.0 Hz, CH2CH3), 
4.31 (2H, q, J = 7.0 Hz, CH2CH3), 6.45 (2H, br, s, NH2), 6.63 (1H, t, J = 8.0 Hz, H
5
), 
7.55 (1H, dd, J = 8.0, 1.5 Hz, H
4
), 8.05 (1H, dd, J = 8.0, 1.5 Hz, H
6
); 
13
C NMR (176 
MHz, CDCl3): 14.36 (CH2CH3), 60.99 (CH2CH3), 112.66 (C
1
), 114.77 (q, 
2
JCF = 
29 Hz, C
3
-CF3), 114.79 (C
5
), 124.89 (q, 
1
JCF = 273 Hz, CF3), 131.88 (q, 
3
JCF = 5 Hz, 
C
4
), 135.65 (C
6
), 148.34 (C
2
), 167.79 (C=O); 
19
F NMR (188 MHz, CDCl3):  -63.98 
(CF3); ESI/MS
+
 m/z 234.1 [M + H]
+
; MS Calcd for C10H11O2NF3 234.0742. Found 
234.0739. Anal Calcd for C10H10NO2F3 C, 51.51; H, 4.32; N, 6.01%. Found C, 
51.64; H, 4.26; N, 5.76%. GC-MS: tR = 12.2 min, m/z 233.1 [M]
+
. 
 
30. 2-Chloro-N-(6-(ethoxycarbonyl)-2-trifluoromethylphenyl)-ethanamide  
 
N
H
CO2Et
O
Cl
F3C
 
 
To a stirring solution of ethyl 2-amino-3-(trifluoromethyl)benzoate (1.36 g, 5.9 
mmol) in CH2Cl2 (10 ml) were added dropwise dry triethylamine (2.43 ml, 17.5 
mmol) and chloroacetyl chloride (1.40 ml, 17.5 mmol) at 0˚C. The reaction mixture 
was allowed to warm to room temperature and stirred overnight. The crude was 
washed successively with HCl (aq) (pH 2-3, 20 ml), NaOH (aq) (pH 8-9, 20 ml) and 
water (20 ml). The organic layer was dried over MgSO4, filtered and solvent 
removed under reduced pressure to leave a pale brown oil which was filtered 
through a layer of silica gel, washing with diethyl ether. Removal of solvent under 
reduced pressure afforded a pale yellow solid (1.65 g, 91%), m.p. 79-81°C. 
1
H NMR 
(700 MHz, CDCl3):  1.33 (3H, t, J = 7.0 Hz, CH2CH3), 4.16 (2H, s, CH2Cl), 4.31 
(2H, q, J = 7.0 Hz, CH2CH3), 7.43 (1H, t, J = 8.0 Hz, H
4
), 7.80 (1H, d, J = 7.0 Hz, 
H
3
), 8.05 (1H, d, J = 7.0 Hz, H
5
), 8.68 (1H, br, s, NH); 
13
C NMR (176 MHz, 
CDCl3):  14.05 (CH2CH3), 42.62 (CH2Cl), 61.82 (CH2CH3), 123.11 (q, 

JCF = 273 
Hz, CF3), 127.38 (C
4
), 130.16 (q, 
3
JCF = 5 Hz, C
3
), 130.29 (C
6
), 133.30 (C
1
), 134.45 
(q, 
2
JCF = 29 Hz, C
2
-CF3), 134.54 (C
5
), 165.22 (COO), 165.75 (NHCO); 
19
F NMR 
(188 MHz, CDCl3):  -61.58 (CF3); ESI/MS
+
 m/z 310.1 [M + H]
+
, 332.1 [M + Na]
+
; 
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ESI/MS
-
 m/z 308.2 [M - H]
-
; Found 310.0447. MS Calcd for C12H12NO3F3Cl 
310.0452. Found 310.0447. Anal Calcd for C12H11NO3F3Cl C, 46.54; H, 3.58; N, 
4.52%. Found C, 46.44; H, 3.66; N, 4.43%.  
 
31. 10-[(6-Ethoxycarbonyl-2-trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7-
tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane 
 
N N
NN
O
O
OO
O
O
H
N
O
F3C
CO2Et
 
 
To a solution of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane (200 mg, 0.39 mmol) and 2-chloro-N-(6-(ethoxycarbonyl)-2-
trifluoromethylphenyl)-ethanamide (132 mg, 0.43 mmol) in dry CH3CN (10 ml) 
under argon, was added K2CO3 (64 mg, 0.47 mmol) and KI (5 mg, cat.). The 
mixture was boiled under reflux for 24 h. After  filtration, the residue was washed 
with CH2Cl2 (2 x 30 ml) and solvent removed under reduced pressure to leave a 
brown oil which was purified by column chromatography over silica gel with 
gradient elution from CH2Cl2 to 5%EtOH/CH2Cl2. A pale brown oil was afforded 
(196 mg, 64%). Rf = 0.3 (Silica, DCM/5%EtOH, UV and I2); 
1
H NMR (700 MHz, 
CDCl3):  1.00-1.60 (27H, br, CH3), 1.21 (3H, t, J = 7.0 Hz, CH2CH3), 1.80-3.50 
(22H, br, CH2 ring and CH2CO), 3.69 (2H, q, J = 7.0 Hz, CH2CH3), 4.36 (2H, br, s, 
CH2CO), 7.47 (1H, t, J = 8.0 Hz, aromatic H
4
), 7.81 (1H, d, J = 8.0 Hz, aromatic 
H
3
), 8.16 (1H, d, J = 8.0 Hz, aromatic H
5
), 8.41 (1H, s, NH); 
13
C NMR (176 MHz, 
CDCl3):  18.62 (CH2CH3), 27.89 (br), 28.07 (CH3), 49.10, 52.70, 55.63 (br, CH2 
ring), 55.98, 57.42 (CH2CO), 58.58 (CH2CH3), 61.86 (CH2CO), 81.82 (br), 81.96 
(C-CH3), 123.19 (q, 
1
JCF = 274 Hz, CF3), 127.43 (aromatic C
4
), 129.95 (q, 
2
JCF = 29 
Hz, aromatic C
2
-CF3), 130.38 (aromatic C
6
), 130.59 (q, 
3
JCF = 5 Hz, aromatic C
3
), 
134.50 (aromatic C
5
), 135.47 (aromatic C
1
), 164.61 (COOEt), 170.77, 172.64 (br), 
172.83 (CH2COO and NHCO); 
19
F NMR (188 MHz, CDCl3):  -60.83 (CF3); 
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ESI/MS
+ 
m/z 788.4 [M + H]
+
, 810.4 [M + Na]
+
; MS Calcd for C38H60N5O9F3Na 
810.4235. Found 810.4235.  
 
32. 10-[(6-Ethoxycarbonyl-2-trifluoromethyl(phenyl)carbamoylmethyl]-1,4,7-
tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane, H3L
4a
 
Prepared as described for H3L
1a
 (5).  
 
N N
NN
HO
O
OHO
HO
O
H
N
O
F3C
CO2Et
 
 
The product was isolated as the dihydrochloride salt as a white powder (120 mg, 
81%), m.p. 235-236°C (dec). 
1
H NMR (700 MHz, D2O):  1.22 (3H, t, J = 7.0 Hz, 
CH2CH3), 2.80-4.10 (24H, br, CH2 ring and CH2CO), 4.22 (2H, q, J = 7.0 Hz, 
CH2CH3), 7.54 (1H, t, J = 7.5 Hz, aromatic H
4
), 7.90 (1H, d, J = 7.5 Hz, aromatic 
H
3
), 8.12 (1H, d, J = 7.5 Hz, aromatic H
5
); 
13
C NMR (176 MHz, D2O):  13.61 
(CH2CH3), 46.00-56.00 (br, CH2 ring and CH2CO), 63.06 (CH2CH3), 123.16 (q, 
1
JCF 
= 272 Hz, CF3), 128.94 (q, 
2
JCF = 30 Hz, aromatic C
2
-CF3), 129.27 (aromatic C
4
), 
130.42 (aromatic C
6
), 131.20 (q, 
3
JCF = 4 Hz, aromatic C
3
), 132.80 (aromatic C
1
), 
135.16 (aromatic C
5
), 166.49 (COOEt), 168.00-174.00 (br, C=O); 
19
F NMR (188 
MHz, D2O):  -61.57 (CF3); ESI/MS
+
 m/z 620.1 [M + H]
+
, 642.0 [M + Na]
+
; MS 
Calcd for C26H37O9N5F3 620.2538. Found 620.2538. HPLC: tR = 7.2 min.  
 
33. [HoL
4a
(H2O)] 
Prepared as described for [HoL
1
(H2O)] (6) at room temperature.  
 
N N
NN
O
O
OO
O
O
H
N
O
F3C
Ho CO2EtOH2
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1
H NMR (500 MHz, D2O, pD 5.3, two isomers 1:1):  -267.3, -257.0, -246.6, -
227.3, -224.5, -206.7, -187.9, -160.3, -146.1, -133.7, -119.0, -100.0, -98.4, -84.9, -
82.7, -73.4, -58.5, -57.0, -41.9, -36.5, -33.2, -29.9, -28.0, -23.0, -18.9, -15.8, -15.0, -
4.2, -2.3, 7.0, 8.6, 10.7, 14.2, 18.8, 54.7, 91.0, 100.6, 145.8, 151.3, 157.1, 164.8; 
19
F 
NMR (188 MHz, D2O, pD 5.4, two isomers 1:1):  -80.8 (CF3, 1/2 = 262 Hz), -46.8 
(CF3, 1/2 = 260 Hz); ESI/MS
+ 
m/z 782.2 [M + H]
+
, 804.2 [M + Na]
+
, 820.1 [M + 
K]
+
; ESI/MS
-
 m/z 780.2 [M - H]
-
; MS Calcd for C26H32O9N5F3
165
Ho 780.1461. 
Found 780.1458. 
34. [TbL
4a
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.4, two isomers 1:1):  -417.3, -
413.4, -404.9, -373.9, -341.5, -330.3, -267.4, -251.5, -200.9, -187.2, -183.1, -156.0, -
154.7, -142.2, -134.9, -121.2, -102.0, -100.8, -96.9, -94.4, -72.4, -69.6, -66.8, -65.4, -
61.1, -38.7, -30.3, -27.0, -22.2, -14.8, -10.3, -9.5, 10.8, 14.1, 16.9, 21.0, 21.6, 24.0, 
28.5, 42.2, 84.5, 125.0, 128.4, 138.7, 142.2, 147.7, 187.6, 234.3, 254.7, 258.6, 
264.0; 
19
F NMR (188 MHz, D2O, pD 5.4, two isomers 1:1):  -89.0 (CF3, 1/2 = 125 
Hz), -39.3 (CF3, 1/2 = 89 Hz); ESI/MS
+ 
m/z 797.7 [M + Na]
+
, 813.6 [M + K]
+
; MS 
Calcd for C26H33O9N5F3Na
159
Tb 798.1376. Found 798.1379. HPLC: tR = 8.1 min. 
35. [ErL
4a
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.3, two isomers 1:1):  -100.3, -
76.1, -70.9, -59.5, -55.8, -35.8, -34.8, -30.8, -28.2, -26.1, -5.6, -5.0, -3.4, 7.6, 7.8, 
11.5, 14.3, 16.2, 17.2, 21.0, 22.8, 25.8, 27.3, 36.2, 37.4, 125.0, 134.4, 145.9, 153.6, 
162.4; 
19
F NMR (188 MHz, D2O, pD 5.3, two isomers 1:1): -69.9 (CF3, 1/2 = 85 
Hz), -49.7 (CF3, 1/2 = 104 Hz); ESI/MS
+ 
m/z 807.2 [M + Na]
+
, 823.2 [M + K]
+
; 
ESI/MS
- 
m/z 783.2 [M - H]
-
; MS Calcd for C26H32O9N5
166
ErF3 779.1450. Found 
779.1445. 
36. [TmL
4a
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.3, two isomers 1:1):  -244.3 
(1H), -212.1 (2H), -207.2 (2H), -205.9 (1H), -199.4 (1H), -159.3 (1H), -156.8 (1H), 
-151.1 (1H), -143.6 (1H), -134.0 (1H), -125.3 (1H), -123.5 (1H), -113.7 (1H), -113.3 
(1H), -112.5 (1H), -90.8 (1H), -87.8 (1H), -80.1 (1H), -78.1 (1H), -74.0 (1H), -73.6 
(1H), -63.9 (1H), -57.8 (1H), -21.8 (1H), -17.5 (1H), -15.2 (3H), 1.1 (1H), 2.0 (1H), 
11.4 (2H), 14.3 (1H), 19.0 (2H), 31.8 (3H), 34.3 (3H), 35.2 (1H), 36.2 (1H), 37.7 
(1H), 42.7 (1H), 44.3 (1H), 49.5 (1H), 50.1 (1H), 51.4 (1H), 58.2 (1H), 59.0 (1H), 
62.3 (1H), 64.3 (1H), 64.7 (1H), 78.2 (1H), 80.1 (1H), 309.7 (1H), 313.3 (1H), 331.8 
(1H), 342.2 (1H), 345.7 (1H), 378.1 (1H); 
19
F NMR (188 MHz, D2O, pD 5.3, two 
isomers 1:1):  -91.6 (CF3, 1/2 = 74 Hz), -38.0 (CF3, 1/2 = 93 Hz); ESI/MS
+ 
m/z 
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807.7 [M + Na]
+
, 823.6 [M + K]
+
; MS Calcd for C26H33O9N5F3K
169
Tm 824.1204. 
Found 824.1210. 
37. [EuL
4a
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.2, two isomers 1:1):  -18.6, -
16.6, -15.8, -15.6, -15.0, -14.8, -14.4, -14.1, -13.6, -12.8, -10.8, -10.3, -9.8, -8.7, -
8.4, -8.1, -7.6, -6.8, -6.4, -5.6, -4.5, -3.6, -3.0, -2.4, -1.1, -0.2, 0.1, 1.7, 2.7, 7.2, 7.9, 
8.8, 9.3, 10.5, 11.5, 28.3, 29.6, 31.2, 34.3; 
19
F NMR (188 MHz, D2O, pD 5.2, two 
isomers 1:1): -63.8 (CF3, 1/2 = 104 Hz), -60.2 (CF3,  1/2 = 145 Hz); 
19
F NMR 
(658.4 MHz, D2O, pD 5.2,): major pair of isomers 1:1: -62.0 (CF3, 1/2 = 124 Hz), 
-58.6 (CF3, 1/2 = 140 Hz); minor pair of isomers 1:1: -59.9 (CF3, 1/2 = 605 Hz), -
59.4 (CF3, 1/2 = 528 Hz); ESI/MS
+ 
m/z 770.3 [M + H]
+
, 792.3 [M + Na]
+
, 808.3 [M 
+ K]
+
; ESI/MS
- 
m/z 768.3 [M - H]
-
; MS Calcd for C26H33O9N5
151
EuF3Na 790.1321. 
Found 790.1320. 
38. [GdL
4a
(H2O)] 
19
F NMR (188 MHz, D2O, pD 5.4, two isomers 1:1):  -60.1 
(CF3, mean 1/2 = 1130 Hz); ESI/MS
+ 
m/z 797.2 [M + Na]
+
, 813.2 [M + K]
+
; MS 
Calcd for C26H33O9N5F3
158
GdNa 797.1364. Found 797.1366.  
 
39.  10-[(6-Carboxy-2trifluoromethyl(phenyl)carbamoylmethyl]-1,4,7-
tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane, H4L
4b 
 
N N
NN
HO
O
OHO
HO
O
H
N
O
F3C
COOH
 
 
10-[(6-Ethoxycarbonyl-2-trifluoromethyl(phenyl)carbamoylmethyl]-1,4,7-
tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane H3L
4a
 (10.2 mg, 0.016 mmol) 
was stirred for 48 h at 50ºC in water (1 ml) at pH 12 (diluted KOH (aq)). The pH was 
adjusted back to 7 (diluted HCl(aq)) and the solution treated with a strong acid cation 
exchange resin (Dowex 50W/H+). After filtration the solution was lyophilized to 
yield the dihydrochloride salt as a white solid (9.5 mg, 98%), m.p. 210-211°C (dec). 
1
H NMR (700 MHz, D2O):  2.98, 3.03, 3.11, 3.18, 3.27, 3.39 (20H, br, CH2 ring 
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and CH2CO), 3.77 (4H, br, CH2CO), 7.47 (1H, t, J = 7.5 Hz, aromatic H
4
), 7.68 (1H, 
d, J = 7.5 Hz, aromatic H
5
), 7.72 (1H, d, J = 7.5 Hz, aromatic H
3
); 
13
C NMR (176 
MHz, D2O):  48.14, 48.50, 51.68 (br, CH2 ring), 52.07, 54.68, 55.48, 57.13 (br, 
CH2CO), 123.63 (q, 
1
JCF = 273 Hz, CF3), 127.53 (q, 
3
JCF = 4 Hz, aromatic C
3
), 
128.06 (q, 
2
JCF = 30 Hz, aromatic C
2
-CF3), 128.90 (aromatic C
4
), 130.10 (aromatic 
C
1
), 132.32 (aromatic C
5
), 140.62 (aromatic C
6
), 170.46, 172.51, 177.17 (C=O), 
173.96 (aromatic C=O); 
19
F NMR (188 MHz, D2O):  -61.39 (CF3); ESI/MS
+ 
m/z 
592.3 [M + H]
+
, 614.3 [M + Na]
+
, 630.2 [M + K]
+
; ESI/MS
- 
m/z 590.3 [M - H]
-
; 
Calcd for C24H31O9N5F3 590.2079. Found 590.2071. 
 
40. [HoL
4b
(H2O)] 
Prepared as described for [HoL
1
(H2O)] (6) at room temperature. 
 
N N
NN
O
O
OO
O
O
H
N
O
F3C
Ho COOH
OH2
 
 
1
H NMR (500 MHz, D2O, pD 5.2, two isomers 1:3):  -258.2, -247.8, -228.9, -
223.6, -209.8, -102.3, -97.9, -84.8, -69.2, -57.6, -53.4, -42.5, -31.5, -22.7, -18.3, -
14.2, -2.8, 7.8, 55.1, 85.1, 89.1, 94.2, 103.2, 152.0, 164.1; 
19
F NMR (188 MHz, 
D2O, pD 5.4, two  isomers 1:3):  -79.3 (CF3, 1/2 = 530 Hz), -46.4 (CF3, 1/2 = 377 
Hz); ESI/MS
+ 
m/z 776.2 [M + Na]
+
; ESI/MS
- 
m/z 752.1 [M - H]
-
; Calcd for 
C24H28O9N5F3
165
Ho 752.1137. Found 752.1137. HPLC: tR = 7.4 min. 
41. [TbL
4b
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.2, two isomers 3:1):  -415.1, -
406.1, -383.8, -375.0, -366.9, -350.7, -345.2, -158.9, -155.7, -144.1, -137.9, -120.2, -
106.3, -101.1, -99.0, -97.3, -94.1, -71.2, -65.6, -53.0, -40.7, -38.3, -24.0, 28.0, 84.6, 
124.7, 139.3, 142.1, 146.8, 248.5, 264.5; 
19
F NMR (188 MHz, D2O, pD 5.4, two 
isomers 3:1):  -89.8 (CF3, 1/2 = 311 Hz), -42.1 (CF3, 1/2 = 536 Hz); ESI/MS
+ 
m/z 
770.2 [M + Na]
+
, 786.2 [M + K]
+
; ESI/MS
-
 m/z 746.2 [M - H]
-
; MS Calcd for 
C24H29O9N5F3K
159
Tb 786.0803. Found 786.0798.  
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42. [ErL
4b
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.3, two isomers 3:1):  -101.0, -
83.6, -71.2, -59.5, -56.2, -37.6, -34.4, -29.7, -2.4, 11.5, 13.0, 16.0, 20.0, 22.6, 24.6, 
36.0, 39.0, 123.5, 133.0, 144.7, 152.3, 157.2, 163.7; 
19
F NMR (188 MHz, D2O, pD 
5.4, two isomers 3:1):  -66.6 (CF3, 1/2 = 263 Hz), -45.8 (CF3, 1/2 = 542 Hz); 
ESI/MS
+ 
m/z 779.2 [M + Na]
+
, 795.1 [M + K]
+
; ESI/MS
-
 m/z 755.2 [M - H]
-
; Calcd 
for C24H28O9N5
166
ErF3 753.1137. Found 753.1135. 
43. [TmL
4b
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.3, two isomers 3:1):  -246.1 
(1H), -213.7 (1H), -209.4 (1H), -203.6 (3H), -201.6 (3H), -152.7 (3H), -147.0 (1H), 
-144.6 (2H), -135.6 (1H), -127.6 (1H), -120.0 (2H), -115.0 (1H), -111.2 (1H), -107.8 
(2H), -101.7 (1H), -85.6 (2H), -84.3 (1H), -78.3 (2H), -71.0 (3H), -54.9 (3H), -9.1, -
7.7, -7.1, -5.7, -5.0, -4.3, 16.7 (2H), 18.5 (1H), 31.5 (6H), 33.8 (2H), 35.4 (2H), 38.4 
(1H), 39.7 (1H), 41.9 (2H), 49.8 (4H), 55.3 (3H), 63.1 (1H), 64.7 (1H), 68.0 (1H), 
78.1 (2H), 84.3 (1H), 302.0 (5H), 316.4 (1H), 321.4 (2H), 334.5 (2H), 340.2 (1H), 
347.9 (1H), 381.5 (1H); 
19
F NMR (188 MHz, D2O, pD 5.3, 2 isomers 3:1):  -89.6 
(CF3, 1/2 = 410 Hz), -37.0 (CF3, 1/2 = 556 Hz); ESI/MS
+ 
m/z 780.1 [M + Na]
+
, 
796.1 [M + K]
+
; ESI/MS
- 
m/z 756.2 [M - H]
-
; Calcd for C24H29O9N5F3K
169
Tm 
796.0891. Found 796.0900. 
44. [EuL
4b
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.2, two isomers 3:1):  -18.5, -
16.6, -16.4, -15.4, -15.0, -14.1, -13.6, -13.4, -13.1, -11.5, -9.8, -8.7, -8.3, -7.4, -6.8, -
5.2, -4.4, -3.7, -2.8, -1.1, -0.8, 1.8, 8.5, 29.1, 31.4, 34.3, 34.4; 
19
F NMR (188 MHz, 
D2O, pD 5.2, two isomers 3:1):  -61.5 (br, 2xCF3, 1/2 = 432 Hz); 
19
F NMR (658.4 
MHz, D2O, pD 5.2, two isomers): -61.7 (CF3, 1/2 = 562 Hz), -60.1 (CF3,  1/2 = 
2618 Hz); ESI/MS
+ 
m/z 764.2 [M + Na]
+
, 780.2 [M + K]
+
; ESI/MS
-
 m/z 740.3 [M - 
H]
-
; Calcd for C24H28O9N5
151
EuF3 738.1043. Found 738.1043. 
45. [GdL
4b
(H2O)] 
19
F NMR (188 MHz, D2O, pD 5.4, two  isomers 3:1):  -59.2 
(CF3, mean 1/2 = 1500 Hz); ESI/MS
+
 m/z 768.3 [M + Na]
+
, 785.2 [M + K]
+
; 
ESI/MS
- 
m/z 745.3 [M - H]
-
; Calcd for C24H28O9N5F3
156
Gd 741.1053. Found 
741.1048. 
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46. 2-Chloro-N-(6-(cyano)-2-trifluoromethylphenyl)-ethanamide  
 
N
H
CN
O
Cl
F3C
 
 
To a stirred solution of 2-amino-3-(trifluoromethyl)benzonitrile (1.00 g, 5.4 mmol) 
in dry DMF (35 ml) was added sodium hydride (60% dispersion in mineral oil) in 
portions (0.54 g, 13.4 mmol) under argon at 0˚C, accompanied by vigorous gas 
development, then chloroacetyl chloride (1.71 ml, 21.5 mmol) dropwise. The 
reaction mixture was allowed to warm to room temperature and stirred for 48 h. The 
reaction was quenched with water (5 ml) and the solution volume reduced. To the 
crude solution was added CH2Cl2 (30 ml) and the mixture was washed successively 
with HCl (aq) (pH 2-3, 20 ml), NaOH (aq) (pH 8-9, 20 ml) and water (20 ml). The 
organic layer was dried over K2CO3, filtered and solvent removed under reduced 
pressure to leave a black oil which was purified over silica gel in CH2Cl2 to yield a 
light yellow solid (0.98 g, 69%), m.p. 116-117°C. Rf = 0.2 (Silica, CH2Cl2, UV); 
1
H 
NMR (700 MHz, CDCl3): 4.23 (2H, s, CH2Cl), 7.54 (1H, t, J = 8.0 Hz, H
4
), 7.87 
(1H, d, J = 8.0 Hz, H
5
), 7.89 (1H, d, J = 8.0 Hz, H
3
), 8.56 (1H, br, s, NH); 
13
C NMR 
(176 MHz, CDCl3):  42.57 (CH2Cl), 115.31 (CN), 115.43 (C
6
), 122.60 (q, 
1
JCF = 
274 Hz, CF3), 128.34 (q, 
2
JCF = 31 Hz, C
2
-CF3), 128.58 (C
4
), 130.97 (q, 
3
JCF = 5 Hz, 
C
3
), 136.71 (C
1
), 136.99 (C
5
), 165.56 (NHCO); 
19
F NMR (188 MHz, CDCl3):  -
62.17 (CF3); ESI/MS
+ 
m/z 263.1 [M + H]
+
, 285.1 [M + Na]
+
; MS Calcd for 
C10H6N2OF3ClNa 285.0013. Found 285.0014. Anal Calcd for C10H6N2OF3Cl C, 
45.73; H, 2.30; N, 10.67%. Found C, 45.74; H, 2.27; N, 10.47%. 
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47. 10-[(6-Cyano-2-trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7-tris(tert-
butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane 
 
N N
NN
O
O
OO
O
O
H
N
O
F3C
CN
 
 
To a solution of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane (500 mg, 0.97 mmol) and 2-chloro-N-(6-(cyano)-2-
trifluoromethylphenyl)-ethanamide (281 mg, 1.07 mmol) in dry CH3CN (20 ml) 
under argon, was added K2CO3 (161 mg, 1.17 mmol) and KI (5 mg, cat.). The 
mixture was boiled under reflux for 24 h. After filtration, the residue was treated 
with CH2Cl2 (2 x 30 ml), the extracts were combined and solvent removed under 
reduced pressure to leave a brown oil which was purified by column 
chromatography over silica gel eluting from CH2Cl2 to 5%MeOH/CH2Cl2. 
Recrystallisation from hot toluene gave a white amorphous solid (612 mg, 85%), 
m.p. 262-263°C. Rf = 0.4 (Silica, DCM/5%MeOH, UV); 
1
H NMR (500 MHz, 
CDCl3):  1.0-1.5 (27H, br, CH3), 1.80-3.80 (24H, br, CH2 ring and CH2CO), 7.56 
(1H, t, J = 8.0 Hz, aromatic H
4
), 7.77 (1H, d, J = 8.0 Hz, aromatic H
5
), 7.84 (1H, d, J 
= 8.0 Hz, aromatic H
3
), 9.58 (1H, s, NH); 
13
C NMR (125.7 MHz, CDCl3):  27.95, 
28.04 (br, CH3), 48.60, 52.84 (br, CH2 ring), 55.77, 55.81, 57.02 (CH2CO), 81.97 
(C-CH3), 116.49 (CN), 116.79 (aromatic C
6
), 122.36 (q, 
1
JCF = 274 Hz, CF3), 128.36 
(aromatic C
4
), 130.01 (q, 
2
JCF = 31 Hz, C
2
-CF3), 130.95 (q, 
3
JCF = 5 Hz, aromatic 
C
3
), 136.08 (aromatic C
5
), 138.33 (aromatic C
1
), 172.70, 172.77 (CO); 
19
F NMR 
(188 MHz, CDCl3)  -60.79 (CF3); ESI/MS
+ 
m/z 741.4 [M + H]
+
, 763.4 [M + Na]
+
; 
ESI/MS
-
 m/z 739.6 [M - H]
-
; MS Calcd for C36H56N6O7F3 741.4157. Found 
741.4153.  
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48. 10-[(6-Cyano-2-trifluoromethyl(phenyl)carbamoylmethyl]-1,4,7-
tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane, H3L
5
  
Prepared as described for H3L
1a
 (5).  
 
N N
NN
HO
O
OHO
HO
O
H
N
O
F3C
CN
 
 
The product was isolated as the dihydrochloride salt as a white powder (215 mg, 
98%), m.p. 249-251°C. 
1
H NMR (700 MHz, D2O):  2.70-4.30 (24H, br, CH2 ring 
and CH2CO), 7.59 (1H, t, J = 8.0 Hz, aromatic H
4
), 7.96 (1H, d, J = 8.0 Hz, aromatic 
H
5
), 7.98 (1H, d, J = 8.0 Hz, aromatic H
3
); 
13
C NMR (125.7 MHz, D2O):  46.00-
56.00 (CH2 ring and CH2CO), 114.40 (CN), 122.44 (q, 
1
JCF = 273 Hz, CF3), 128.29 
(q, 
2
JCF = 31 Hz, C
2
-CF3), 129.20 (aromatic C
6
), 129.46 (aromatic C
4
), 132.05 (q, 
3
JCF = 5 Hz, aromatic C
3
), 132.49 (aromatic C
1
), 137.17 (aromatic C
5
), 168.39 (br), 
171.69, 174.02 (br, C=O); 
19
F NMR (188 MHz, D2O):  -61.96 (CF3); ESI/MS
+
 m/z 
573.3 [M + H]
+
, 595.3 [M + Na]
+
; ESI/MS
-
 m/z 571.3 [M - H]
-
; MS Calcd for 
C24H32O7N6F3 573.2279. Found 573.2284. HPLC: tR = 6.3 min; LC-MS: tR = 3.6 
min, m/z 573.29 [M + H]
+
. 
 
49. [HoL
5
(H2O)] 
Prepared as described for [HoL
1
(H2O)] (6).  
 
N N
NN
O
O
OO
O
O
H
N
O
F3C
Ho CN
OH2
 
 
1
H NMR (500 MHz, D2O, pD 5.0, two isomers 1:1):  -260.0, -256.1, -247.0, -
222.6, -217.0, -203.5, -163.5, -132.3, -120.1, -104.0, -86.3, -74.6, -57.0, -41.4, -32.2, 
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-30.2, -25.1, -23.3, -15.0, -10.9, 7.6, 54.9, 82.8, 88.5, 96.1, 106.3, 143.5, 157.2, 
160.8, 165.9, 173.3; 
19
F NMR (188 MHz, D2O, pD 5.4): two major isomers 1:1 -
78.1 (CF3, 1/2 = 419 Hz), -48.8 (CF3, 1/2 = 745 Hz), two minor isomers -61.0 (CF3, 
1/2 = 93 Hz); ESI/MS
+ 
m/z 735.2 [M + H]
+
, 757.2 [M + Na]
+
, 773.2 [M + K]
+
; 
ESI/MS
-
 m/z 733.3 [M - H]
-
; MS Calcd for C24H27O7N6F3
165
Ho 733.1202. Found 
733.1193. 
50. [TbL
5
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.1, two isomers 1:1):  -421.1, -
413.7, -406.8, -372.2, -367.6, -344.8, -337.8, -286.0, -276.6, -219.1, -194.2, -185.3, -
162.0, -141.1, -121.9, -101.0, -98.2, -97.0, -93.8, -85.2, -83.2, -69.4, -67.1, -65.0, -
63.3, -59.5, -54.0, -52.1, -45.2, -39.4, -37.0, -32.3, -26.1, -11.7, -10.0, -2.7, 30.1, 
85.2, 100.3, 128.0, 134.4, 139.7, 146.0, 155.1, 232.4, 244.5, 264.9; 
19
F NMR (188 
MHz, D2O, pD 5.4): two major isomers 1:1 -84.6 (CF3, 1/2 = 505 Hz), -40.6 (CF3, 
1/2 = 670 Hz), two minor isomers -57.4 (CF3, 1/2 = 82 Hz); ESI/MS
+ 
m/z 751.3 [M 
+ Na]
+
, 767.3 [M + K]
+
; ESI/MS
-
 m/z 727.4 [M - H]
-
; MS Calcd for 
C24H27O7N6F3
159
Tb 727.1152. Found 727.1148. 
51. [DyL
5
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.1, two isomers 1:1):  -455.0, -
450.2, -429.9, -425.1, -400.6, -380.2, -359.6, -270.2, -240.5, -225.5, -179.6, -164.7, -
150.5, -130.1, -110.2, -100.1, -90.4, -84.7, -60.3, -50.5, -20.3, -14.9, 10.1, 49.6, 
215.2, 240.0, 265.3, 279.8, 330.2; 
19
F NMR (188 MHz, D2O, pD 5.4): two major 
isomers 1:1 -109.9 (CF3, 1/2 = 515 Hz), -59.3 (CF3, 1/2 = 465 Hz), two minor 
isomers -78.0 (CF3, 1/2 = 98 Hz); ESI/MS
-
 m/z 731.9 [M - H]
-
; MS Calcd for 
C24H27O7N6F3
162
Dy 728.1151. Found 728.1153. HPLC: tR = 6.6, 8.8 min; LC-MS: tR 
= 3.4 min, m/z 733.06 [M + H]
+
, 731.03 [M - H]
-
, tR = 6.4 min, m/z 732.01 [M + 
H]
+
, 731.97 [M - H]
-
. 
52. [ErL
5
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.2, two isomers 1:1):  -100.3, -
87.3, -82.2, -78.1, -73.1, -60.5, -55.8, -47.4, -44.0, -37.4, -32.4, -26.5, -24.3, -19.7, -
16.0, -13.5, -5.1, -3.5, -1.3, 12.0, 14.3, 14.8, 21.1, 22.3, 26.2, 28.0, 38.7, 45.0, 56.5, 
74.8, 89.9, 120.9, 128.7, 142.8, 151.7, 155.0, 162.6; 
19
F NMR (188 MHz, D2O, pD 
5.4): two major isomers 1:1 -67.6 (CF3, 1/2 = 453 Hz), -49.6 (CF3, 1/2 = 423 Hz), 
two minor isomers -58.2 (CF3, 1/2 = 94 Hz); ESI/MS
+ 
m/z 758.3 [M + Na]
+
, 776.3 
[M + K]
+
; ESI/MS
-
 m/z 735.4 [M - H]
-
; MS Calcd for C24H27O7N6
166
ErF3 734.1202. 
Found 734.1202. 
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53. [TmL
5
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.1, two isomers 1:1):  -244.8, -
216.0, -207.3, -205.1, -202.3, -198.3, -190.9, -180.1, -177.5, -158.1, -153.3, -146.8, -
140.0, -134.6, -126.2, -118.1, -114.1, -83.7, -81.9, -77.4, -74.3, -66.8, -52.3, -48.3, -
20.2, -13.1, 12.0, 18.8, 20.2, 29.1, 32.3, 33.9, 43.0, 45.1, 46.5, 49.2, 50.0, 56.4, 64.3, 
81.1, 84.3, 104.0, 115.0, 177.7, 222.3, 271.7, 300.6, 309.5, 318.5, 325.2, 335.9, 
340.3, 379.0; 
19
F NMR (188 MHz, D2O, pD 5.4): two major isomers 1:1 -88.1 
(CF3, 1/2 = 419 Hz), -39.0 (CF3, 1/2 = 444 Hz), two minor isomers -63.7 (CF3, 1/2 
= 99 Hz); ESI/MS
+ 
m/z 739.3 [M + H]
+
, 761.3 [M + Na]
+
, 777.2 [M + K]
+
; ESI/MS
-
 
m/z 737.3 [M - H]
-
; MS Calcd for C24H27O7N6F3
169
Tm 737.1241. Found 737.1235. 
LC-MS: tR = 3.34 min, m/z 739.39 [M + H]
+
, tR = 6.54 min, m/z 739.35 [M + H]
+
, 
737.22 [M - H]
-
. 
54. [GdL
5
(H2O)] 
19
F NMR (188 MHz, D2O, pD 5.4, two  isomers 1:1):  -60.4 
(CF3, 1/2 = 899 Hz), -58.6 (CF3, 1/2 = 832 Hz); ESI/MS
+
 m/z 364.6 [(M + 2H)/2]
2+
, 
728.1 [M + H]
+
, 748.1 [M + Na]
+
, 766.1 [M + K]
+
; ESI/MS
- 
m/z 726.1 [M - H]
-
; 
Calcd for C24H27O7N6F3
158
Gd 726.1140. Found 726.1145. 
55. [YL
5
(H2O)] 
1
H NMR (500 MHz, D2O, pD 5.1, two isomers 1:1): 

t, J = 8.0 Hz), 7.7 t, J = 8.0 
Hz), 8.0 t, J = 7.0 Hz), 8.2 d, J = 8.0 Hz); 19F NMR (188 MHz, D2O, pD 5.4): 
two major isomers 1:1 -61.6 (CF3, 1/2 = 34 Hz), two minor isomers -59.8 (CF3, 
1/2 = 7 Hz); ESI/MS
+ 
m/z 659.3 [M + H]
+
, 681.3 [M + Na]
+
, 697.3 [M + K]
+
; 
ESI/MS
-
 m/z 657.3 [M - H]
-
; MS Calcd for C24H27O7N6F3
89
Y 657.0957. Found 
657.0952. 
 
56. 1-[(6-Cyano-2-trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7,10-
tetraazacyclododecane
4
 
 
N N
NN
H
H
H
N
O
H
F3C
CN
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To a solution of 1,4,7,10-tetraazacyclododecane (1.312 g, 7.62 mmol) in dry CH3CN 
(10 ml) was added K2CO3 (0.105 g, 0.76 mmol) and 2-chloro-N-(6-(cyano)-2-
trifluoromethylphenyl)-ethanamide (0.200 g, 0.76 mmol) under argon. The reaction 
was left stirring at 55°C overnight. The crude mixture was dried under reduced 
pressure, dissolved in CH2Cl2 (20 ml) and extracted with water (2 x 20 ml). The 
aqueous layer was washed with CHCl3 (3 x 20 ml), the organic layer was then 
evaporated and the residue redissolved in water then extracted with CH2Cl2 yielding, 
after solvent removal, a pale yellow oil (0.160 g, 53%). 
1
H NMR (700 MHz, 
CDCl3):  2.61, 2.62, 2.71 (16H, br, CH2 ring), 3.35 (2H, s, CH2CO), 7.46 (1H, t, J = 
7.5 Hz, aromatic H
4
), 7.82 (1H, d, J = 7.5 Hz, aromatic H
5
), 7.85 (1H, d, J = 7.5 Hz, 
aromatic H
3
); 
13
C NMR (176 MHz, CDCl3):  45.84, 46.27, 46.99, 47.26, 53.95 
(CH2 ring), 59.03 (CH2CO), 116.02 (aromatic C
6
), 116.47 (CN), 122.74 (q, 
1
JCF = 
274 Hz, CF3), 127.98 (aromatic C
4
), 129.72 (q, 
2
JCF = 30 Hz, C
2
-CF3), 131.17 (q, 
3
JCF = 5 Hz, aromatic C
3
), 136.71 (aromatic C
5
), 139.63 (aromatic C
1
), 172.50 (CO); 
19
F NMR (188 MHz, CDCl3):  -61.21 (CF3); ESI/MS
+ 
m/z 200.3 [(M + 2H)/2]
2+
, 
399.3 [M + H]
+
; ESI/MS
-
 m/z 397.3 [M - H]
-
; MS Calcd for C18H26N6OF3 399.2115. 
Found 399.2116. 
 
57. Triethyl 10-[(6-cyano-2-trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7,10-
tetraazacyclododecane-1,4,7-triyltrimethylenetri(methyl-phosphinate)
5
 
 
N N
NN
P
P
EtO
O
P
OEtO
EtO
O
H
N
O
F3C
CN
 
 
To a refluxing solution, over 4 Å molecular sieves under argon, of 1-[(6-cyano-2-
trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7,10-tetraazacyclododecane (160 mg, 
0.40 mmol) in dry THF (30 ml) was added paraformaldehyde (54 mg, 1.81 mmol) 
then diethoxymethylphosphine (0.28 ml, 1.81 mmol). The reaction was left stirring 
at 85°C overnight. Solvent was evaporated and the residue purified by column 
chromatography over alumina, eluting with a gradient starting from CH2Cl2 up to 
CH2Cl2/5%MeOH to yield a pale yellow oil (59 mg, 19%). Rf = 0.5 (Alumina, 
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DCM/5%MeOH, UV, I2); 
1
H NMR (700 MHz, CDCl3):  1.15-1.40 (9H, br, m, 
CH2CH3), 1.40-1.60 (9H, br, m, 
2
JHP = 14.0 Hz, PCH3), 2.50-3.30 (24H, br, CH2 
ring, CH2P and CH2CO), 4.02 (6H, m, CH2CH3), 7.48 (1H, t, J = 7.5 Hz, aromatic 
H
4
), 7.85 (1H, d, J = 7.5 Hz, aromatic H
5
), 7.88 (1H, d, J = 7.5 Hz, aromatic H
3
); 
13
C 
NMR (176 MHz, CDCl3):  14.00 (br, m, 
1
JCP = 89 Hz, PCH3), 16.89 (t, 
3
JCP = 5 Hz, 
CH2CH3), 53.40 (m, 
1
JCP = 95 Hz, CH2P), 54.10-55.40 (CH2 ring and CH2CO), 
60.40 (m, CH2CH3), 116.01 (aromatic C
6
), 116.16 (CN), 122.76 (q, 
1
JCF = 276 Hz, 
CF3), 127.66 (aromatic C
4
), 129.13 (q, 
2
JCF = 30 Hz, C
2
-CF3), 130.89 (q, 
3
JCF = 5 Hz, 
aromatic C
3
), 136.66 (aromatic C
5
), 139.03 (aromatic C
1
), 168.00 (CO); 
19
F NMR 
(376.4 MHz, CDCl3):  -61.20, -61.24 (CF3);
 31
P NMR (162 MHz, CDCl3): 51.4-
52.9 (3P); ESI/MS
+ 
m/z 380.2 [(M + 2H)/2]
2+
, 759.3 [M + H]
+
; ESI/MS
-
 m/z 757.3 
[M - H]
-
; MS Calcd for C30H53N6O7F3P3 759.3135. Found 759.3148. 
 
58. 10-[(6-Cyano-2-trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7,10-
tetraazacyclododecane-1,4,7-triyltrimethylenetri(methyl-phosphinic acid) H3L
6
  
 
N N
NN
P
P
HO
O
P
OHO
HO
O
H
N
O
F3C
CN
 
 
Triethyl 10-[(6-cyano-2-trifluoromethyl(phenyl))carbamoylmethyl]-1,4,7,10-
tetraazacyclododecane-1,4,7-triyltrimethylenetri(methyl-phosphinate) (18 mg, 23.7 
mol) was stirred in a solution of KOD (2 ml, 0.1M) for 1 week at room 
temperature. The pH was then adjusted to 7 with dilute HCl(aq) and the solution 
lyophilised to yield the dihydrochloride salt as a light yellow solid that was used 
directly for complexation reactions, m.p. 229-230°C (dec). 
1
H NMR (700 MHz, 
D2O):  1.00-1.30 (9H, br, m, PCH3), 2.50-3.60 (24H, br, CH2 ring, CH2P and 
CH2CO), 7.63 (1H, t, J = 7.5 Hz, aromatic H
4
), 8.01 (2H, t, J = 7.0 Hz, aromatic 
H
5,3
); 
13
C NMR (176 MHz, D2O):  16.00 (br, PCH3), 50.00-54.50 (CH2 ring, CH2P 
and CH2CO), 114.89 (aromatic C
6
), 116.65 (CN), 123.15 (q, 
1
JCF = 275 Hz, CF3), 
128.98 (q, 
2
JCF = 30 Hz, C
2
-CF3), 129.70 (aromatic C
4
), 132.21 (q, 
3
JCF = 5 Hz, 
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aromatic C
3
), 137.22 (aromatic C
1
), 137.51 (aromatic C
5
), 171.30 (CO); 
19
F NMR 
(658.4 MHz, D2O):  -61.61 (CF3);
 31
P NMR (283.3 MHz, D2O): 20.6-40.0 (br, 3P); 
ESI/MS
+ 
m/z 357.6 [(M + K + H)/2]
2+
, 714.2 [M + K]
+
; ESI/MS
-
 m/z 674.2 [M - H]
-
; MS Calcd for C24H39N6O7F3P3 673.2045. Found 673.2045. LC-MS: tR = 4.5 min, 
m/z 677.31 [M + H]
+
. 
 
59. [HoL
6
] 
Prepared as described for [HoL
1
(H2O)] (6) at 50°C and purified by dialysis (cut off 
1,000D). 
 
N N
NN
P
P
O
O
P
OO
O
O
H
N
O
F3C
CNHo
 
 
1
H NMR (500 MHz, D2O, pD 5.4):  -276.1 (br), -272.1 (br), -210.1 (br), -157.8 
(br), -146.3 (br), -119.0, -113.5, -96.0 (br), -86.9 (br), -58.3, -53.1, -39.8, -35.3, -
28.3, -17.9, -11.6, -9.1, -7.2, -4.5, 17.2, 32.8, 48.9, 55.4, 64.6 (br), 71.7 (br), 89.7 
(br), 101.5 (br), 111.7 (br), 130.8 (br), 138.9 (br), 232.5 (br); 
19
F NMR (188 MHz, 
D2O, pD 5.4):  -106.4 (CF3, 1/2 = 83 Hz), -62.4 (CF3, 1/2 = 99 Hz), -61.6 (CF3, 
1/2 = 101 Hz); ESI/MS
+ 
m/z 419.6 [(M + 2H)/2]
2+
, 838.1 [M + H]
+
; MS Calcd for 
C24H38O7N6F3P3
165
Ho 837.1270. Found 837.1294. LC-MS: tR = 5.1 min, m/z 419.80 
[(M + 2H)/2]
2+
, 838.08 [M + H]
+
, 836.03 [M - H]
-
. 
60. [TbL
6
] 
1
H NMR (500 MHz, D2O, pD 5.0):  -405.1 (br), -339.2 (br), -261.2 (br), 
-252.5 (br), -180.7, -170.7 (br), -150.8, -93.6, -91.3, -89.0, -83.4, -78.4, -53.3, -42.5, 
-39.3, -37.7, -26.3, -15.0, 17.0, 31.9, 38.8, 45.9, 75.0, 86.9, 89.0, 101.5, 142.5 (br), 
149.2 (br), 156.0 (br); 
19
F NMR (188 MHz, D2O, pD 5.0):  -98.5 (CF3, 1/2 = 77 
Hz), -62.7 (CF3, 1/2 = 160 Hz), -60.1 (CF3, 1/2 = 190 Hz), -52.1 (CF3, 1/2 = 149 
Hz); ESI/MS
-
 m/z 831.2 [M - H]
-
; MS Calcd for C24H37O7N6F3P3
159
Tb 830.1142. 
Found 830.1156. LC-MS: tR = 4.99 min, m/z 417.12 [(M + 2H)/2]
2+
, 833.24 [M + 
H]
+
, 831.21 [M - H]
-
. 
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61. [TmL
6
] 
1
H NMR (500 MHz, D2O, pD 5.0):  -356.9 (br), -350.7 (br), -344.2 
(br), -327.8 (br), -286.7 (br), -228.0 (br), -223.0 (br), -214.3 (br), -184.5, -182.3, -
163.5, -158.8, -123.6, -92.2, -82.9, -75.4, -68.5, -63.8, -46.9, -44.4, -31.8, -19.9, -
32.0, -20.1, 15.2, 21.6, 24.0, 33.0, 44.8, 46.5, 47.4, 65.1, 93.6, 134.4, 136.7, 140.8, 
147.6, 165.0 (br), 173.0 (br); 
19
F NMR (188 MHz, D2O, pD 5.0):  -106.4 (CF3, 1/2 
= 61 Hz), -62.3 (CF3, 1/2 = 127 Hz), -60.1 (CF3, 1/2 = 131 Hz), -1.3 (CF3, 1/2 = 73 
Hz); ESI/MS
-
 m/z 841.2 [M - H]
-
; MS Calcd for C24H37O7N6F3P3
169
Tm 840.1231. 
Found 840.1227. LC-MS: tR = 4.9 min, m/z 422.12 [(M + 2H)/2]
2+
, 843.27 [M + 
H]
+
, 841.22 [M - H]
-
. 
 
62. 1,4,7,10-Tetra[N-(4-(ethoxycarbonyl)-2-trifluoromethyl(phenyl))-
ethanamide]-1,4,7,10-tetraazacyclododecane, L
7
   
 
N N
NN
HN
O
NHO
N
H
O
H
N
O
F3C
O
O
F3C
CF3
CF3
O
O
O
O
OO
 
 
To a solution of 1,4,7,10-tetraazacyclododecane (20.6 mg, 0.12 mmol) and 2-chloro-
N-(4-(ethoxycarbonyl)-2-trifluoromethylphenyl)-ethanamide (185.5 mg, 0.60 mmol) 
in dry CH3CN (5 ml) under argon, was added K2CO3 (82.6 mg, 0.60 mmol) and KI 
(5 mg, cat.). The mixture was boiled under reflux for 24 h. After filtration, the 
residue was treated with CH2Cl2 (2 x 10 ml), the extracts combined and solvent 
removed under reduced pressure to leave a brown oil which was subsequently 
purified by column chromatography over silica gel, eluting from CH2Cl2 to 
10%MeOH/CH2Cl2 and then from CH2Cl2 to 8%EtOH/CH2Cl2 to give a yellow oil 
                                                                                                Chapter 6: Experimental 
180 
(13.3 mg, 9%). Rf = 0.3 (Silica, DCM/6%MeOH, UV); 
1
H NMR (700 MHz, 
CDCl3): 1.36 (12H, t, J = 7.0 Hz, CH2CH3), 1.74, 2.15, 3.01, 3.32, 1.60-3.80 (24H, 
br, CH2 ring and CH2CO), 4.34 (8H, q, J = 7.0 Hz, CH2CH3), 7.83 (4H, d, J = 8.5 
Hz, aromatic H
5
), 7.95 (4H, d, J = 8.5 Hz, aromatic H
6
), 8.00 (4H, s, NH), 8.16 (4H, 
s, aromatic H
3
); 
13
C NMR (176 MHz, CDCl3):  14.39 (CH2CH3), 51.24, 57.59, 
60.70, 47.00-54.00 (br, CH2 ring and CH2CO), 61.66 (CH2CH3), 121.72 (q, 
2
JCF = 29 
Hz, aromatic C
2
-CF3), 123.58 (q, 
1
JCF = 273 Hz, CF3), 125.96 (aromatic C
6
), 127.45 
(aromatic C
4
), 127.81 (q, 
3
JCF = 5 Hz, aromatic C
3
), 133.80 (aromatic C
5
), 138.31 
(aromatic C
1
), 164.81 (COOEt), 171.26 (CONH); 
19
F NMR (188 MHz, CDCl3):  -
60.99 (CF3); ESI/MS
+ 
m/z 633.5 [(M + 2H)/2]
2+
, 1265.4 [M + H]
+
, 1287.4 [M + 
Na]
+
; MS Calcd for C56H61N8O12F12 1265.421. Found 1265.419.  
 
63. [HoL
7
(H2O)]Cl3  
 
N N
NN
HN
O
NHO
N
H
O
H
N
O
F3C
O
O
F3C
CF3
CF3
O
O
O
O
OO
Ho
OH2
 
 
A solution of the ligand L
7
 (13.3 mg, 0.011 mmol) and Ho(OTf)3 (7.1 mg, 0.012 
mmol) in dry acetonitrile (1.5 ml) was stirred at 75°C overnight under argon. The 
solution was added dropwise to stirring dry diethyl ether (15 ml). The resulting 
precipitate was removed by centrifugation (20 min). The solid was redissolved in the 
minimum amount of acetonitrile and the procedure repeated once more. The yellow 
solid resulted was treated with anion exchange resin (DOWEX 1X8 200-400 MESH 
Cl, pre-treated with 1M HCl) in CH3CN/H2O to obtain the chloride salt.
 1
H NMR 
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(500 MHz, CD3OD, pD 5.3):  -51.2 (br), -2.0, 0.8, 1.9, 11.6, 33.8 (br), 40.9 (br); 
19
F NMR (188 MHz, CD3OD/D2O 80:20, pD 5.4):  -62.16 (CF3, 1/2 = 272 Hz); 
ESI/MS
+ 
m/z 714.4 [(M + 2H)/2]
2+
, 1427.0 [M + H]
+
; ESI/MS
- 
m/z 1425 [M - H]
-
; 
MS Calcd for C56H59O12N8F12
165
Ho 714.1677. Found 714.1676. 
 
64. [HoL
8
(H2O)] 
 
N N
NN
O
O
OO
O
O
H
N
O CF3Ho
O
O
O
O
OH2
 
 
To a solution of [HoL
4b
] (13 mg, 17 mol) in dry DMSO (0.6 ml) was added K2CO3 
(7 mg, 52 mol) and the mixture was left stirring for 30 min at room temperature 
under argon. Bromomethyl acetate (5 l, 52 mol) was then added and the reaction 
stirred overnight. The crude product was precipitated by dropping onto stirred dry 
diethyl ether (15 ml) and the solvent removed by centrifugation (10 min). The 
product was triturated with MeCN, isolated by centrifugation, then taken up into 
water and lyophilised to yield the product as a pale brown solid. 
1
H NMR (500 
MHz, D2O, pD 5.3):  -264.9, -258.6, -248.2, -230.0, -223.3, -217.6, -210.0, -203.3, 
-107.5, -103.9, -98.2, -89.7, -85.5, -69.4, -65.9, -57.3, -52.9, -50.6, -45.6, -42.9, -
33.3, -24.2, -22.8, -12.3, -11.2, -3.3, 10.9, 11.8, 12.5, 13.3, 15.7, 17.2, 55.2, 88.0, 
103.7, 141.0, 149.4, 159.6, 165.5; 
19
F NMR (376 MHz, D2O, pD 6.0):  -49.1 (CF3, 
1/2 = 183 Hz, 50%), -56.9, -96.1; ESI/MS
+ 
m/z 826.2 [M + H]
+
, 848.1 [M + Na]
+
; 
MS Calcd for C27H34O11N5F3
165
Ho 826.1510. Found 826.1502. LC-MS: tR = 5.3 
min, m/z 826.35 [M + H]
+
, 824.19 [M - H]
-
. 
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 65. [HoL
9
(H2O)] 
 
N N
NN
O
O
OO
O
O
H
N
O CF3Ho
O
O
O
O
OH2
 
 
To a solution of [HoL
4b
] (10 mg, 13.3 mol) in dry DMSO (0.5 ml) was added 
K2CO3 (6 mg, 39.8 mol) and the mixture was left stirring for 30 min at room 
temperature under argon. Chloromethylbutyrate (5 l, 39.8 mol) was added and the 
reaction stirred overnight. A crude material was precipitated by dropping the 
solution slowly onto stirred dry diethyl ether (15 ml) and the solvent removed by 
centrifugation (10 min). The product was triturated with MeCN, isolated by 
centrifugation, then taken up into water and lyophilised to yield the product as a 
light yellow powder. 
1
H NMR (500 MHz, D2O, pD 5.2):  -265.9, -248.8, -229.4, -
224.5, -218.0, -204.2, -107.6, -103.9, -89.3, -69.5, -66.2, -58.0, -54.1, -51.3, -45.1, -
43.0, -33.4, -30.2, -25.8, -23.4, -19.3, -15.2, -12.0, -10.0, 7.5, 10.8, 11.7, 12.4, 13.2, 
15.8, 17.0, 55.1, 88.5, 103.6, 142.2, 150.0, 160.0, 166.5; 
19
F NMR (376 MHz, D2O, 
pD 6.0):  -49.4 (CF3, 1/2 = 190 Hz, 46%), -53.1, -56.8, -96.4; ESI/MS
+ 
m/z 428.1 
[(M + 2H)/2]
2+
, 855.2 [M + H]
+
, 877.2 [M + Na]
+
; MS Calcd for 
C29H37O11N5F3
165
Ho 853.1745. Found 853.1780. LC-MS: tR = 7.1 min, m/z 855.16 
[M + H]
+
, 853.02 [M - H]
-
. 
 
66. Chloromethyl ethyl carbonate
6
 
 
Cl O O
O
 
 
To a solution of EtOH (70 l) in CH2Cl2 (6 ml) was added pyridine (125 l, 1.55 
mmol) then chloromethyl chloroformate (137 l, 1.55 mmol) dropwise at 0˚C. The 
mixture was left stirring for 4 h, then the crude product was washed with HCl (aq) 
(pH 2-3, 10 ml), NaOH (aq) (pH 8-9, 10 ml) and H2O (10 ml) then dried over MgSO4. 
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After filtration the solvent was carefully removed to yield a colourless liquid (140 
mg, 65%). 
1
H NMR (400 MHz, CDCl3):  1.27 (3H, t, J = 7.0 Hz, CH2CH3), 4.22 
(2H, q, J = 7.0 Hz, CH2CH3), 5.67 (2H, s, CH2Cl); 
13
C NMR (100.6 MHz, CDCl3):  
14.02 (CH2CH3), 65.17 (CH2CH3), 72.09 (CH2Cl), 153.27 (C=O). 
 
67. Reaction between [HoL
4b
] and chloromethyl ethyl carbonate, [HoL
10
(H2O)]  
 
N N
NN
O
O
OO
O
O
H
N
O CF3Ho
O
O
O
O
O
OH2
 
 
To a solution of [HoL
4b
] (10 mg, 13.3 mol) in dry DMSO-d6 (0.6 ml) was added 
K2CO3 (6 mg, 39.8 mol) and the mixture was left stirring for 30 min at room 
temperature under argon. Chloromethyl ethyl carbonate (10 l, 7.23 mol) was then 
added and the reaction stirred overnight. 
19
F NMR (376 MHz, DMSO-d6):  -61.3 
(CF3, 1/2 = 281 Hz, 88%); ESI/MS
+ 
m/z 855.6 [M + H]
+
, 894.6 [M + K]
+
; ESI/MS
- 
m/z 854.8 [M - H]
-
; Calcd for C28H34O12N5F3
165
Ho 854.1459. Found 854.1448. 
 
68. [HoL
11
(H2O)]  
 
N N
NN
O
O
OO
O
O
H
N
O CF3Ho
O
O
O
O
OH2
 
 
To a solution of [HoL
4b
] (10 mg, 13.3 mol) in dry DMSO (0.5 ml) was added 
K2CO3 (6 mg, 39.8 mol) and the mixture was left stirring for 30 min at room 
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temperature under argon. 4-(Chloromethyl)phenylacetate (6 l, 39.8 mol) was then 
added and the reaction stirred overnight. The crude was precipitated by dropping 
onto stirred dry diethyl ether (15 ml) and the solvent removed by centrifugation (10 
min). The product was triturated with MeCN, isolated by centrifugation, then taken 
up into water and lyophilised to yield the product as a light yellow powder. 
1
H NMR 
(500 MHz, D2O, pD 5.2):  -260.2, -247.8, -239.0, -228.5, -217.8, -93.7, -82.2, -
64.1, -57.5, -50.4, -47.4, -40.0, -37.3, -31.7, -22.6, -13.2, -8.5, -5.2, -3.4, 1.9, 2.1, 
2.3, 7.1, 7.4, 14.0, 14.2, 14.5, 18.4, 55.0, 81.1, 88.8, 94.2, 144.0, 151.9, 165.9; 
19
F 
NMR (376 MHz, D2O, pD 6.0):  -44.2 (CF3, 1/2 = 183 Hz, 60%), -42.0, -45.6, -
46.8; ESI/MS
+ 
m/z 903.2 [M + H]
+
, 927.2 [M + Na]
+
, 941.1 [M + K]
+
; MS Calcd for 
C33H38O11N5F3
165
Ho 902.1818. Found 902.1815. HPLC: tR = 9.4 min; LC-MS: tR = 
6.9 min, m/z 903.34 [M + H]
+
.  
 
69. [HoL
12
(H2O)] 
Prepared as described for [HoL
11
(H2O)] (68).  
 
N N
NN
O
O
OO
O
O
H
N
OHo
F3C
O
O
O
O
OH2
 
 
1
H NMR (500 MHz, D2O, pD 5.2):  -255.1 (br), -245.4 (br), -226.1 (br), -221.3 
(br), -216.0 (br), -91.3, -87.0, -77.7, -75.5, -66.3, -58.4, -55.1, -50.2, -48.0, -43.5, -
33.0, -31.3, -28.9, -12.1, -11.0, -2.3, 9.3, 9.7, 10.9, 13.1, 15.2, 16.0, 16.6, 20.0, 21.3, 
24.2, 25.4, 27.2, 57.6, 83.0 (br), 91.6 (br), 152.2 (br), 160.0 (br), 168.2 (br); 
19
F 
NMR (376 MHz, D2O, pD 6.0):  -51.1 (CF3, 1/2 = 95 Hz, 40%), -49.2, -49.7, -52.2, 
-57.2; ESI/MS
- 
m/z 900.9 [M - H]
-
. LC-MS: tR = 7.2 min, m/z 902.42 [M + H]
+
, 
900.38 [M - H]
-
. 
 
 
 
 
                                                                                                Chapter 6: Experimental 
185 
70. [HoL
13
(H2O)]Glucosamide 
 
N N
NN
O
O
OO
O
O
H
N
O CF3Ho
NH
O
O
HO
HO OH
OH
OH2
 
 
To a stirring suspension of [HoL
1b
] (20 mg, 26.5 mol) in dry DMF (0.7 ml) under 
argon was added N-methylmorpholine (4 l, 39.8 mol) and after 30 min TBTU (13 
mg, 39.8 mol). The solution was left stirring for 30 min at room temperature. 
Glucosamine hydrochloride was treated with anion exchange resin (DOWEX 1X8 
200-400 MESH, pre-treated with 1M KOH) in water to liberate the free amine, 
filtered then dried. The free glucosamine (9 mg, 39.8 mol) was dissolved in the 
minimum amount of water (4 drops) then added to the reaction mixture, which was 
left stirring at 40˚C for 2 days. The DMF volume was reduced under reduced 
pressure and the crude precipitated by dropping onto stirred dry diethyl ether (15 ml) 
and the product isolated by centrifugation (10 min). The product was triturated with 
MeCN, isolated by centrifugation then taken up into water and lyophilised to yield 
the product as a pale brown solid (20 mg, 83%).
 1
H NMR (500 MHz, D2O, pD 5.1): 
 -253.8, -248.1, -224.8, -221.2, -212.0, -93.1, -78.4, -69.1, -58.2, -45.7, -35.1, -32.3, 
-30.3, -22.7, -14.6, 17.0, 24.0, 85.7, 91.4, 151.5, 159.0, 167.0; 
19
F NMR (188 MHz, 
D2O, pD 5.4):  -56.8 (CF3, 1/2 = 55 Hz, 92%); ESI/MS
+ 
m/z 915.7 [M + H]
+
, 937.7 
[M + Na]
+
, 953.2 [M + K]
+
; ESI/MS
-
 m/z 913.2 [M - H]
-
; MS Calcd for 
C30H41O13N6F3
165
Ho 915.1987. Found 915.1984. HPLC: tR = 5.0, 5.4 min; LC-MS: 
tR = 1.7 min, 915.27 [M + H]
+
, tR = 2.2 min, m/z 915.30 [M + H]
+
. 
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71. Preparation of glycol chitosan (MW~194,000)
7 
 
HO
O
HO
NH2
O
OCH2CH2OH
O
HO
NH
OH
OCH2CH2OH
C O
CH3
x z
 
 
Glycol chitosan (500 mg, purchased from Sigma) was dissolved in water (50 ml) by 
sonication for 10 min and centrifuged. The higher molecular weight polymer 
remained as a gel whilst the supernatant solution was removed and dialysed (cut off 
filter 12,000D) against Purite water for 2 days. The solution was lyophilized to give 
a white cotton-like solid (370 mg). Anal Found C, 42.64; H, 6.61; N, 5.66%. For 
GPC analysis see Table 6.2.    
 
72. Preparation of glycol chitosan (MW~6,590)
8
 
 
HO
O
HO
NH2
O
OCH2CH2OH
O
HO
NH2
OH
OCH2CH2OH
x z  
 
Glycol chitosan (1 g, purchased from Sigma) was dissolved in a solution of HCl 4M 
(75 ml), insoluble material was manually removed from the solution. The solution 
was left stirring at 50˚C for 24 h then dialysed (cut off 12,000D) against Purite water 
until the pH of the tube contents reached neutral (2 days). Lyophilisation yielded a 
light brown powder (560 mg). Anal Found C, 37.84; H, 6.92; N, 5.57%. For GPC 
analysis see Table 6.2.       
 
 
 
 
 
 
 
                                                                                                Chapter 6: Experimental 
187 
73. Glycol chitosan Ho complex conjugate (MW~278,500) 
 
O
HO HO
NH2
O
OCH2CH2OH
O
HO
NH
O
OCH2CH2OH
O
HO
NH
OH
OCH2CH2OH
C O
CH3
x y z
N
N
N
N
O
O
O
O
O
O
HN
O
F3C
Ho
OH2
O
 
 
To a stirred suspension of [HoL
1b
] (65 mg, 86.3 mol) in dry DMF (0.7 ml) under 
argon was added N-methylmorpholine (14 l, 129.0 mol) and after 30 min TBTU 
(42 mg, 129.0 mol). The solution was left stirring for 30 min at room temperature, 
then added dropwise to a solution of glycol chitosan (MW~194,000) 71 (200 mg in 
3 ml of water dissolved by sonication for 2 h) with vigorous shaking. The viscous 
solution was left stirring overnight at 40˚C. The crude product was precipitated in 
isopropanol twice and then redissolved in water to be dialysed against Purite water 
over 2 days (cut off 1,000D). The solution was lyophilised to yield a white light 
powder. 
1
H NMR (400 MHz, D2O): only glycol chitosan visible  1.89 (br, CH3CO), 
2.65 (br, CHNH), 3.20-4.00 (br, CH and CH2), 4.4 (br, OCHO); 
19
F NMR (188 
MHz, D2O):  -56.8 (CF31/2 = 262 Hz); Ho% = 1.60; Anal Found C, 39.68; H, 
5.99; N, 5.66%. For GPC analysis see Table 6.2.   
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74. Glycol chitosan Ho complex conjugate (MW~16,200) 
 
O
HO HO
NH2
O
OCH2CH2OH
O
HO
NH
OH
OCH2CH2OH
x y
N
N
N
N
O
O
O
O
O
O
HN
O
F3C
Ho
OH2
O
 
 
To a stirring suspension of [HoL
1b
] (260 mg, 345 mol) in dry DMF (2.2 ml) under 
argon was added N-methylmorpholine (57 l, 518.0 mol) and after 30 min TBTU 
(166 mg, 518.0 mol). The solution was left stirring for 30 min at room temperature 
then a solution of glycol chitosan (MW~6,590) 72 (40 mg in 0.4 ml of water) was 
added dropwise. The mixture was left stirring overnight at 40˚C. The crude was 
diluted with water and dialysed against Purite water over 2 days (cut off 1,000D). 
The solution was lyophilised to yield a light brown solid. 
19
F NMR (376.3 MHz, 
D2O):  -56.8 (CF31/2 = 257 Hz); Ho% = 12.5; Anal Found C, 37.65; H, 4.93; N, 
7.53%. For GPC analysis see Table 6.2.    
 
75. Glycol chitosan Gd complex conjugate (MW~15,950)  
Prepared as described for 74.  
Gd% = 14.9; Anal Found C, 34.84; H, 4.64; N, 6.98%. For GPC analysis see Table 
6.2.    
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Table 6.2 Gel permeation chromatography (GPC) data for the chitosan samples and 
their conjugates. 
Sample Mw 
a 
Mn 
b 
PDI 
c 
71 194,000 50,750 3.8 
72    6,590   2,250 2.9 
73 278,500 54,650 5.1 
74   16,200   4,500 3.6 
75   15,950   4,155 3.8 
Mean values obtained from two successive scans. 
a
 calculated molecular weight 
averages expressed as the pullulan polysaccaride equivalent molecular weights; 
b
 
number average molecular weights; 
c
 polydispersity (Mw/Mn). 
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 A1 
 
Appendix A:  
Notable complex 
1
H NMR spectra 
Full 
1
H NMR spectra of [LnL
1a
] and [LnL
1b
] are shown below. It is visible the 
presence of two isomers in 1:1 ratio for [LnL
1a
] and 3:1 ratio for [LnL
1b
], as 
illustrated for the 
19
F NMR spectra. 
Fig. A.1 [EuL
4a
] (D2O, 500 MHz, 295 K). 
 
Fig. A.2 [EuL
4b
] (D2O, 500 MHz, 295 K). 
 A2 
 
Fig. A.3 [TmL
4a
] (D2O, 500 MHz, 295 K). 
 
 
Fig. A.4 [TmL
4b
] (D2O, 500 MHz, 295 K). 
 
 
 
 
 
 A3 
 
Appendix B:  
Crystal data: single crystal X-ray analysis 
The data for 10-[(4-Ethoxycarbonyl-2-trifluoromethyl(phenyl))carbamoylmethyl]-
1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (4) are 
reported below.  
Empirical formula C38H60N5O9F3Na
+
 Br
-.
1/2 C4H10O 
Formula weight 927.87 
T (K) 120 (2) 
Crystal system Tetragonal 
Space group P4/n (no. 85) 
a, b, c (Å) 27.1772(10), 27.1772(10), 12.4222(4) 
α, β, γ (deg) 90.00, 90.00, 90.00 
Volume (Å
3
) 9175.0(6) 
Z 8 
ρcalc ( mg mm
-3
) 1.343 
μ (mm-1) 0.975 
F(000) 3912 
Crystal size (mm
3
) 0.45 × 0.4 × 0.24 
Theta range for data collection 1.50 to 30.00° 
Index ranges -38 ≤ h ≤ 38, -38 ≤ k ≤ 37, -17 ≤ l ≤ 17 
Reflections collected 119016 
Independent reflections 13394[R(int) = 0.0879] 
Data/restraints/parameters 13394/0/569 
Goodness-of-fit on F
2
 0.973 
Final R indexes [I>2σ (I)] R1 = 0.0372, wR2 = 0.0952 
Final R indexes [all data] R1 = 0.0561, wR2 = 0.1007 
Largest diff. peak/hole/e (Å
-3
) 0.530/-0.377 
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Appendix C:       
Notable structures 
Notable structures discussed in this thesis are included for reference use. 
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          High MW glycol chitosan Ho complex conjugate 
 
 
 
 
 
          Low MW glycol chitosan Ln complex conjugate (Ln = Ho 74, Ln = Gd 75) 
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